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Severe skeletal muscle trauma resulting from ischemic damage, nerve transection 
injuries, or volumetric defects is an intractable problem. Dysfunction and disability owing 
to the latter are an increasingly significant clinical burden. Though skeletal muscle 
possesses robust potential for healing after injury, large volumetric wounds that occur 
during combat, accidents or surgical resection often do not heal completely, resulting in 
fibrotic scarring and limited range of motion. Current standard of care involves the 
autologous transfer of tissue but exhibits limited success and complications at both the 
donor and injury site. Moreover, extensive soft tissue injury and damage to collateral blood 
vessels prevents adequate vascularization and can result in muscle fibrosis and chronic 
muscle strength deficits. Even minor damage and or overuse of supporting connective 
tissues such as the rotator cuff tendon, and associated mechanical unloading, results in 
disorganized muscle fiber remodeling, gradual fatty/fibrous degeneration and muscle mass 
loss. And, as the sequelae of muscle injuries increases at a disproportionate rate with 
advancing age, the burden of muscle injury on an aging domestic population is increasingly 
severe. 
Microenvironmental cues within injured skeletal muscle dictate either regenerative 
or fibrotic healing outcomes. These cues include signals from blood vessels, extracellular 
matrix (ECM), immune cells, and motor neuron associations. Tightly coordinated interplay 
between these cues govern the endogenous muscle stem (satellite) cell niche and are critical 
determinants of muscle repair success. Most notably during muscle injury recovery, 
monocytes and macrophages release mitogenic growth factors that protect muscle 
 xxi 
progenitor cells from apoptosis, stimulate myogenic processes, and enhance 
revascularization. However, monocytes and macrophages are markedly heterogeneous in 
vivo, displaying both inflammatory and anti-inflammatory phenotypes, which enable a 
wide range of functions in varied tissue-specific contexts.  Thus, identifying key monocyte 
subsets and their differentiated functions within the injury niche is critical to harnessing 
function of these cells in directing repair. To address this challenge, we developed novel 
biomaterial drug-delivery systems that leverage the pro-regenerative functions of recruited 
blood monocytes to enhance muscle healing outcomes.  
Using cell tracking techniques, we identified anti-inflammatory, non-classical 
monocytes as biased progenitors of CD206+ alternatively-activated macrophages in 
injured skin. We demonstrated that we could achieve local enrichment of non-classical, 
monocytes within sites of volumetric muscle loss via the local delivery of FTY720 from a 
bulk polymer thin film. Redirection of these non-classical monocytes from circulation into 
injured muscle occurred concomitantly with increased accumulation of alternatively-
activated macrophages, coinciding with enhanced vascularization, collagen matrix 
deposition, and muscle regeneration. We then further explored how incorporating FTY720 
into an electrospun polymer fiber mesh would impact parenchymal and immune cell 
behavior in a larger volumetric defect. We found that FTY720 delivery from a nanoscale 
fiber scaffold (FTY720-NF) resulted in acute lymphopenia and decreased lymphocytes in 
the muscle tissue. Interestingly, FTY720-NF treated animals exhibited increased live 
cellularity in peri-defect tissue, which were attributed to increases in both muscle stem cell 
(satellite cell), non-classical monocyte, and alternatively-activated macrophage numbers. 
Regenerated muscle fibers exposed to FTY720 cues displayed higher diameter and notably, 
 xxii 
increased alignment to the pre-injury fiber axis.   These findings  represent an improved 
understand of the role that pro-regenerative subsets of immune cells play in promoting  
endogenous mechanisms of tissue repair after traumatic muscle injuries.
 1 
1. INTRODUCTION AND SPECIFIC AIMS 
Repair of injured skeletal muscle requires the coordinated activities of innate and 
adaptive immune cells that orchestrate the progression of inflammation and guide healing 
outcome. Circulating monocytes exist in at least two subsets in blood: classical monocytes, 
which are broadly considered as inflammatory cells, mature within peripheral blood under 
homeostasis to non-classical, anti-inflammatory monocytes. During inflammation, 
monocytes are rapidly mobilized from blood to enter the injured tissue space where they 
may persist as monocytes or differentiate into macrophages. Macrophages within tissue 
injury also display marked heterogeneity, but may be broadly classified as classically-
activated (M1) or alternatively-activated (M2). Monocytes and macrophages of both 
subtypes have been shown to accumulate in toxin-induced muscle injury, but the roles these 
cells play in a volumetric injury context in which all tissue microcompartments must be 
regenerated de novo remains unknown. The overall objective of this work is to improve 
understanding of the roles that immune cells subsets play in the regeneration of volumetric 
muscle defect injuries and to engineer biomaterial therapies that tune their recruitment and 
function. This objective will be explored via the following three specific aims: 
Aim 1: To investigate the contributions of classical and non-classical monocyte 
populations to the alternatively activated macrophage pool within traumatic soft tissue 
injury.    
We hypothesized that anti-inflammatory, non-classical monocytes recruited from 
circulation during traumatic soft tissue injury preferentially give rise to alternatively 
activated macrophages. To test this hypothesis, we tracked the fate of blood-derived 
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monocyte subsets within excisional skin injury via latex bead-based labeling techniques 
and adoptive transfer of sorted monocyte subpopulations. Loss of function studies in which 
non-classical monocytes were depleted by clodronate liposomes, and gain of function 
studies in which the small molecule FTY720 was used to selectively recruit non-classical 
monocytes, were used to confirm findings from fate tracking experiments.  
Aim 2: To characterize immune cell kinetics in the murine spinotrapezius volumetric 
muscle loss model and investigate effects of modulating myeloid cell recruitment on 
skeletal muscle healing 
A novel model of full-thickness, volumetric muscle injury was established in the 
murine spinotrapezius to enable visual inspection of healing progression. Immune cell 
accumulation kinetics were assessed via flow cytometry and whole-mount 
immunofluorescence. We hypothesized that locally enriching non-classical monocytes 
would enhance the accumulation of alternatively-activated macrophages and promote 
muscle defect healing. We employed FTY720 delivery from polymer thin films as a tool 
to redirect non-classical monocytes from peripheral blood into injured skeletal tissue. 
Muscle healing parameters were assessed via whole-mount immunofluorescence imaging 
of injured spinotrapezius muscles with or without FTY720 treatment.  
Aim 3: To assess the impact of local delivery of FTY720 via electrospun microfibers to 
volumetric skeletal muscle injury on innate and adaptive immune cell accumulation and 
regeneration in a non-healing volumetric defect.  
We expanded the spinotrapezius volumetric muscle loss model to encompass a 
defect size that does not regain full functional recovery over the experimental time course. 
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We hypothesized that nanofiber based delivery of FTY720 to a non-healing muscle defect 
would positively impact muscle healing metrics such as fiber diameter and alignment. Flow 
cytometry was used to examine changes in lymphoid, myeloid, and muscle stem cell 
(satellite cell) accumulation in response to FTY720 nanofiber treatment.  Muscle healing 
parameters were again assessed via whole-mount immunofluorescence imaging of injured 
spinotrapezius muscles.  
Significance: 
The current gold-standard of therapy for volumetric muscle loss involves the 
autologous transfer tissue which exhibits limited success and donor site morbidity. 
Strategies for treating volumetric muscle injuries will require the capability of initiating 
and promoting endogenous repair programs. Alternatively-activated, wound-healing 
macrophages drive differentiation of satellite cells in injured muscle and likely promote 
repair of other damaged microcompartments such as vasculature and motor neurons. The 
work presented represent the first studies to show that Ly6Clo non-classical monocytes are 
key contributors to the pool of wound healing macrophages. We have demonstrated that 
locally enriching pro-regenerative monocytes and macrophages within volumetric muscle 
injury via biomaterial-based delivery of FTY720 results in favorable healing outcomes 
such as increased vascularization, attenuation of fibrotic tissue deposition, and improved 
alignment of regenerated muscle fibers. Taken together, we have gained an improved 
understand of the role that pro-regenerative subsets of immune cells play in the promotion 
of endogenous mechanisms of tissue repair after traumatic injuries.  
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2. THE INFLAMMATORY CASCADE WITHIN SKELETAL 
MUSCLE HEALING: INFORMING THE DESIGN OF 
IMMUNOMODULATORY BIOMATERIAL THERAPEUTICS1  
2.1 Skeletal Muscle at Homeostasis and Injury 
2.1.1 Skeletal Muscle Function and Physiology 
Skeletal muscle is a hierarchically organized tissue comprising around 40% of total 
body weight [1]. The main function of skeletal muscle is to generate force to maintain 
posture and facilitate body movement. There are three main types of muscle action: 
isometric, dynamic concentric, and dynamic eccentric. Isometric action within a muscle 
generates force but is not accompanied by movement (such as holding a plank). 
Conversely, both dynamic actions involve force generation and joint movement, with 
dynamic concentric actions involving the shortening of the muscle, and dynamic eccentric 
motions resulting in the lengthening of a muscle from its original position.  
In addition to motion production, there are other, less obvious, roles that muscle 
tissue plays as well. Skeletal muscle serves as storage for important biomolecules such as 
amino acids and carbohydrates that may be needed by other vitally important tissues such 
as the skin, brain, or heart when nutrient supply is insufficient[2]. The release of amino 
acids from muscle stores also aids in maintaining blood glucose levels during insufficient 
                                                 
1 Portions of this chapter adapted from: Olingy CE, San Emeterio CL, Ogle ME, Krieger 
JR, Bruce AC, Pfau DD, et al. Non-classical monocytes are biased progenitors of wound 
healing macrophages during soft tissue injury. Sci Rep. 2017;7:447. Published under 
Creative Commons license. 
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nutrient intake. Skeletal muscle also contributes to basal energy metabolism and the 
production of heat for homeothermic thermoregulation [1]. Consequently, reduced muscle 
mass hinders the body’s response to stress and chronic illness.   
Muscle fibers, or myofibers, constitute the basic cellular building block of skeletal 
muscle and are multinucleated, post-mitotic cells that are arranged in bundles to form 
whole muscles. Each muscle fiber is composed of thousands of myofibrils and billions of 
myofilaments – the main myofilaments being the thick filament composed of myosin and 
the thin filament composed of actin, troponin, and tropomyosin[1]. Myofilaments are 
assembled in a characteristic, striated pattern to form sarcomeres, in which the thick and 
thin filaments slide past each other in response to calcium release from the sarcoplasmic 
reticulum. Upon neural stimulus from the motor neuron, the sarcoplasmic reticulum 
releases calcium ions that bind to troponin on the thin filament. This binding displaces 
tropomyosin to reveal myosin binding sites on the actin molecules within the thin filament. 
In the presence of adenosine tri-phosphate (ATP), the myosin within the thick filaments is 
able to then bind to actin, and hydrolysis of ATP to adenosine di-phosphate (ADP) causes 
the myosin to actively pull the actin towards the middle of the sarcomere (M line), thus 
shortening the sarcomere (known as the “sliding filament theory”)[1]. The simultaneous 
shortening of many sarcomeres within a muscle fiber is what causes the muscle fibers to 
contract, and multiple muscle fibers contracting together enables a muscle to produce force 
and movement. 
Muscle movement requires energy in the form of ATP. There are three energy 
pathways that are utilized within the muscle fiber: reserve stores of ATP and creatine 
phosphate (CP), anaerobic glycolysis, and oxidative phosphorylation. The muscle usage of 
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a specific metabolic energy pathway to use is based on the duration and intensity 
requirements of the activity at hand. Due to the highly limited reserves of ATP and CP in 
the muscle, this mechanism supports high intensity muscle activities for short durations of 
a few seconds[1]. The second mechanism, anaerobic glycolysis, produces ATP very 
rapidly (about 100 times faster than oxidative phosphorylation) and is utilized for muscle 
activity lasting a few minutes. However, anaerobic glycolysis quickly becomes detrimental 
to muscle function due to the production and buildup of the end-product, lactate, which 
causes muscle fatigue[1].  Lastly, oxidative phosphorylation, which occurs in the muscle 
mitochrondria, sustains muscle activity for minutes to hours. The dense network of 
capillaries within muscle (Figure 1) supplies oxygen to the muscle fibers to power the 
oxidative phosphorylation pathway, and interestingly, the extent of the capillary network 
is correlated with the metabolic demand of the muscle fiber to which it is coupled[1]. 
During a session of muscle activity, all three of these pathways may be activated at certain 
points depending on the intensity of the exercise 
Somewhat counterintuitively, the main fuels utilized by the muscle to produce ATP 
are carbohydrates (glucose from plasma and glycogen from muscle stores) and fats (free 
fatty acids from plasma and triglycerides from muscle.)[1] During intense muscle activity, 
muscle glycogen is the preferred fuel substrate whereas lower intensity (and longer 
duration) of exercise favors free fatty acid metabolism for energy [1]. As with utilizing the 
metabolic pathways however, the muscle will select and combine which fuels to use for 
ATP production depending on the type of muscle activity being performed.  
  Human skeletal muscle exhibits heterogeneity in the individual muscle fibers that 
comprise a single muscle. There are two main categories of muscle fibers: type I, which 
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are slower to shorten during a single twitch (a contraction in a single muscle fiber) and are 
also known as “slow twitch” fibers, and type II, which shorten fast during a single twitch 
and are known as “fast twitch” fibers. Type I and type II fibers possess their twitch speed 
based on two key characteristics: the type of myosin protein that is present, and the degree 
of dependence of the fiber on oxidative phosphorylation[1]. Myosin heavy chain I is 
present in type I, slow twitch fibers, whereas myosin heavy chain II is present in in type II, 
fast-twitch fibers [3]. Slow twitch fibers rely heavily on oxidative phosphorylation (which 
is slower to generate ATP compared to other metabolism mechanisms) and consequently, 
have more mitochondria per fiber than fast-twitch fibers. Slow-twitch fibers are slower to 
fatigue, however, and thus are more highly represented in muscles that maintain body 
posture, whereas fast twitch fibers are more highly represented in muscles that produce 
movement[4].   
2.1.2 Satellite Cells 
Satellite cells are adult muscle stem cells that reside on the outside of muscle fibers, 
located in between the sarcolemma and the basal lamina. While quiescent during tissue 
homeostasis, satellite cells rapidly activate, proliferate, and differentiate into mature 
muscle cells in response to injury stimuli[5]. These newly formed muscle cells can fuse 
with existing damaged muscle fibers to repair traumatically injured tissue. Activated 
satellite cells can also give rise to new satellite cells that repopulate and maintain the 
quiescent satellite cell compartment[5]. Quiescent and activated satellite cells can be 
distinguished via differential expression of canonical transcription factors. Quiescent 
satellite cells express the transcription factor PAX7 but not the transcription factor 
myoblast determination protein 1 (MyoD), whereas activated satellite cells express both 
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PAX7 and MyoD[5]. Activated satellite cells that proliferate and commit to differentiating 
into myotubes then express the transcription factor myogenin. Detection of quiescent 
satellite cells histologically has been technically challenging, but recent advances in 
making transgenic mice with a fluorescent reporter under the PAX7 promoter has made 
tracking the behavior of both endogenous and transplanted satellite cells more feasible. 
Satellite cells can also be detected and isolated by Fluorescence-Activated Cell Sorting 
(FACS) techniques using defined surface marker profiles[6]. A common scheme for 
identifying satellite cells via FACS involves the exclusion of hematopoietic and stromal 
cells by negative selective of lineage markers (lin-), Sca1, and CD31, then positive 
selection of satellite cells via dual expression of CXCR4 and beta-1 integrin (CD29) [7].  
 2.1.3 Skeletal Muscle during Injury, Pathology, and Aging  
Healthy skeletal muscle is able to regenerate very quickly after injury, and the 
healing process follows a specific sequence of events that ultimately result in restoration 
of tissue function. This sequence of events can be divided into roughly three phases. The 
first phase is the destruction and inflammatory phase in which damaged muscle fibers 
undergo necrosis and release damage-associate molecular patterns (DAMPs) that trigger 
an inflammatory response and the arrival of immune cells such as neutrophils, and 
inflammatory monocytes, and macrophages[8]. The second phase is the repair phase, in 
which the muscle fiber detritus is cleared by immune cells, and satellite cells activate, 
proliferate and fuse to form new muscle fibers. During the repair phase, a provisional 
extracellular matrix scar is formed as a scaffold for infiltrating immune and parenchymal 
cells[9]. The third phase is the remodeling phase in which newly regenerated muscle fibers 
are reorganized and the provisional scar tissue is remodeled, thus restoring tissue function. 
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Failure to progress through this healing sequence results in fibrosis and decrease in muscle 
function[9].  
There are many types of myopathies that stem from varied causes such as gene 
mutations, microscopic structural defects, metabolic/mitochondrial dysfunction, and 
autoimmunity[10]. Muscular dystrophy is a form of myopathy that is characterized by 
chronic cycles of muscle fiber degeneration and regeneration, fatty tissue infiltration and 
fibrosis, ultimately resulting in severe muscle weakness, with most patients being unable 
to walk by the age of 12. Duchenne Muscular Dystrophy (DMD) is the most common form 
of muscular dystrophy that is caused by a mutation in the dystrophin gene that leads to 
impaired function within both mature muscle fibers and satellite cells[11]. Lack of 
dystrophin within muscle fibers renders them incapable of attaching to the extracellular 
matrix, and leads to cyclic cycles of muscle degeneration, inflammatory response, and 
regeneration over the patient’s lifetime. Satellite cells in dystrophic mice exhibit an 
inability to establish cellular polarity, resulting in failure to undergo asymmetric cell 
division and initiation of myogenic programs. Thus, DMD is both a disease of the muscle 
fibers themselves and also a disease of the stem cells that are responsible for regenerating 
muscle[11].  
The loss of skeletal muscle mass and strength with advanced age is called 
sarcopenia, and is associated with a reduction in the number of satellite cells within the 
muscle compartment. Interestingly, there is a particular decrease in the number of satellite 
cells that are associated with type II, fast-twitch fibers which are the predominant type of 
fiber lost with advanced age[1]. Thus with any injury, the capacity to regenerate decreases 
with age, due in part to lower numbers of satellite cells. Changes within the muscle fiber 
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itself also contribute to the decrease in muscle function, such as alterations in the 
sarcoplasmic reticulum structure that isolate calcium stores to only certain areas of muscle, 
and diminished numbers of mitochondria per myofiber. The quality of the muscle fiber 
also decreases, with single fiber demonstrating reduced maximal force with age. This 
phenomenon has been attributed to a range of mechanism. For example, disruptions in 
myostatin gene transcription, or reductions in its translation to protein can account for 
diminished myosin content seen in aging. Additionally, post-translational modifications to 
myosin such as oxidation of the protein may interfere in the binding of actin to its binding 
site on myosin, resulting in lower cross-bridges and limiting force production[1].  
2.2 Contributions of Immune Cells within Skeletal Muscle Injury and Repair 
2.2.1 Systemic and Local Monocyte/Macrophage functions at homeostasis 
The mononuclear phagocyte system plays a multi-faceted role in maintaining tissue 
homeostasis and responding to both acute injuries and pathological processes including 
autoimmune diseases, cancer, and aberrant wound healing. Monocytes circulate in the 
bloodstream during steady state and have been shown to patrol for endothelium integrity 
[12] as well as extravasate into resting tissues and travel to lymph nodes where they may 
present antigen[13]. The ontogeny of macrophages varies in different tissues, such that 
some tissue resident macrophages are seeded embryonically, such as microglia in the brain, 
and self-renew in a similar manner to stem cells. However, macrophages that reside in 
tissues such as the dermis or the gut are continuously exposed to outside microorganisms 
and may be subject to low-grade chronic inflammation that induces blood monocyte 
recruitment and subsequent differentiation to replenish resident macrophages [14-18]. 
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Tissue-resident macrophages can perform a wide variety of functions at homeostasis that 
are tailored to the specific tissue in which they reside. For example, adipose-associated 
macrophages are involved in the control of insulin sensitivity and energy homestasis, 
alveolar macrophages clear surfactant in the lungs, and bone marrow macrophages support 
erythropoiesis and maintain hematopoietic stem cells within their niche[19]. When 
challenged with inflammatory insult, tissue macrophages can activate and release signals 
that drive robust recruitment of neutrophils and monocytes from blood to initiate the 
healing cascade[19].  
2.2.2 Monocyte Heterogeneity 
 Two distinct subpopulations of monocytes have been identified in mouse and 
human blood, which can be distinguished by well-characterized surface protein expression 
profiles. Classical inflammatory monocytes are identified by Ly6ChiCX3CR1loCD43lo 
expression in mice (CD14hiCD16- in human), whereas non-classical alternative monocytes 
are Ly6CloCX3CR1hiCD43hi in mice (CD14+CD16+ in human)[14]. A third population of 
intermediate monocytes characterized by intermediate expression of Ly6C in mice 
(CD14hiCD16+ in humans) are thought to complement the functions of non-classical 
monocytes and may preferentially differentiate into dendritic cells within inflamed 
tissues[20, 21]. Under homeostasis, classical Ly6Chi monocytes that are housed in the bone 
marrow are released diurnally into peripheral blood circulation under control of the 
circadian gene Bmal1[17]. Once in blood, the Ly6Chi monocyte population possess a 
relatively short half-life of 20 hours[17], whereupon they decrease Ly6C expression and 
become non-classical Ly6Clo monocytes[17, 22], which patrol the luminal side of resting 
endothelium[12]. If damaged endothelium is encountered, Ly6Clo monocytes may respond 
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to these danger signals via Toll-like receptor 7 (TLR7) and recruit neutrophils that elicit 
focal necrosis of the compromised endothelium. Ly6Clo monocytes subsequently clear the 
cellular debris. In contrast, the role of classical monocytes at homeostasis is less well-
studied, though it has been shown that classical monocytes also survey steady-state tissues 
and can traffic to lymph nodes to present antigen without differentiating into 
macrophages[13]. In response to injury stimuli, monocytes extravasate from the circulation 
into damaged tissues where they may persist as monocytes or differentiate into 
macrophages.  
2.2.3 Macrophage Origin and Heterogeneity 
Macrophages are highly responsive to cues within the injury niche, enabling them 
to dynamically modify their behavior in response to changes in the microenvironment and 
display extremely varied phenotypes. Classically activated (“M1”) macrophages are 
primary players in pathogen destruction, secretion of inflammatory cytokines, and driving 
Th1-type responses[23]. Conversely, alternatively activated wound healing (“M2”) 
macrophages (of which a number of subtypes have been described[23], where M2a 
subtypes induced by IL-4 stimulation may be pro-fibrotic, and M2c subtypes induced by 
IL-10 stimulation promote the proliferation of satellite cells[24]) are associated with pro-
regenerative activities such as angiogenesis[25, 26], extracellular matrix remodeling[27], 




Figure 1.  Monocyte and macrophage heterogeneity. Monocytes exist in two principal 
subsets in circulation and can be identified by defined surface marker profiles such as Ly6C 
and CX3CR1. Circulating classical monocytes secrete inflammatory factors, and patrol 
steady state tissue. Classical monocytes mature in the blood to become non-classical 
monocytes which secrete pro-regenerative factors and survey resting endothelium. Under 
injury conditions, these monocytes extravasate into tissue where they differentiate into 
macrophages. Wound macrophages display a wide range of phenotype broadly classified 
as either inflammatory or M1, or anti-inflammatory, M2. M1 macrophages can arise from 
classical monocyte differentiation, but M2 wound macrophages may arise from either in 
situ conversion of M1 macrophage to M2, or from direct differentiation of non-classical 
monocytes. 
The highly complex and heterogeneous nature of inflamed tissue 
microenvironments has rendered a general description of macrophage origin and function 
challenging. Within toxin-induced muscle injury[29], liver fibrosis[30], infection[31], and 
autoimmune disease[32], classical Ly6Chi monocytes are recruited from circulation and 
undergo in situ  differentiation to be the primary contributors of injury Ly6Clo 
monocytes/macrophages. In contrast, sequential recruitment of classical Ly6Chi followed 
by non-classical Ly6Clo monocyte subsets after myocardial infarction[33], and direct 
recruitment of adoptively transferred Ly6Clo monocytes within excisional skin injury[34] 
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and during the development of inflammatory arthritis[35] have been reported. Recently, 
we demonstrated that circulation-derived Ly6Clo monocytes that are directly recruited to 
injured skin are biased progenitors of CD206+ wound-healing macrophages[36]. Using 
latex bead labeling, we labeled Ly6Chi and Ly6Clo monocytes in the circulation and tracked 
their accumulation within the dorsal skinfold window chamber model of partial-thickness 
excisional skin injury. We observed that a significantly higher proportion of labeled Ly6Clo 
monocytes within injured skin were immunophenotyped as CD206+F4/80+ alternatively-
activated macrophages, whereas labeled Ly6Chi monocytes did not display this 
differentiation bias. Adoptive transfer of Ly6Chi or Ly6Clo monocytes from CD45.1 mice 
into CD45.2 mice revealed that though the number of adoptively transferred cells per 
milligram of tissue did not vary between the two donor cell types, there was a higher 
frequency of CD206+CD301b+ wound healing macrophages derived from Ly6Clo 
monocytes compared to Ly6Chi monocytes.  
2.2.4 Monocytes and Macrophages are required for Skeletal Muscle Repair 
Macrophages govern nearly all stages of tissue repair and are required for effective 
healing, which has been demonstrated by depletion studies in a wide array of injured tissues 
such as skeletal muscle[29, 37], skin[38], myocardium[39], and cornea[40]. Depletion of 
macrophages in these studies by clodronate liposomes or diphtheria toxin administration 
to LysM-Cre/DTR mice restricted injured tissues to the acute and mid-phases of tissue 
healing, with failure to progress into the healing and resolution stages.  
  Monocyte/macrophage depletion studies within skeletal muscle injury models 
have highlighted the crucial role that these cells play at the onset of injury, with depletion 
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of all circulating monocytes before toxin-induced muscle injury resulting in incomplete 
healing and fibrotic muscle. Intramuscular depletion of macrophages in the later stages of 
healing severely impairs muscle regeneration indicating that macrophages present within 
the muscle are actively involved in reparative processes at this later stage of healing[29]. 
Depletion of CD11b-expressing cells via diphtheria toxin at days 1 or 2 post-cardiotoxin 
injury resulted in persistence of necrotic fibers and smaller regenerated fiber diameter, 
whereas depletion at 4 days did not result in any changes in muscle regeneration compared 
to control (of note, this depletion method depletes circulating CD11b+ cells, indicating that 
at day 4, myeloid cells already recruited to tissue are sufficient for complete regeneration) 
[29]. Interestingly, depletion at day 0 did not result in differences in regenerated fiber 
diameter but did result in elevated fat accumulation suggesting that the microenvironment 
at day 0 may be involved in adipogenic progenitor proliferation and differentiation[41].  In 
cryo-injured muscles, depletion of circulating monocytes resulted in persistent 
inflammation and necrosis of muscle, and at later time points, significantly higher fatty 
infiltration among regenerated fibers[37]. Taken together, these results highlight the 
critical role that monocytes play in resolving inflammation and initiating muscle repair. 
2.2.5 Myeloid Cell Functions within Acute Muscle Injury 
The progression of inflammation during muscle regeneration is tightly associated 
with stages of reparative myogenesis. Inflammatory monocytes and macrophages have 
been shown to promote the proliferation of activated satellite cells in vitro [42] whereas 
anti-inflammatory monocytes and macrophages govern satellite cell differentiation. In 
vivo, the range of cells that make up the immunological repertoire changes in accordance 
with the repair state of the injured muscle, and influences not only satellite cell proliferation 
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and differentiation, but also other required processes such as angiogenesis, nerve 
regeneration, and extracellular matrix deposition and remodeling.  
Following muscle damage, the number of intramuscular leukocytes increases both 
rapidly and drastically. Within a few hours, neutrophils (commonly immunophenotyped as 
CD11b+SSChiLy6G+) accumulate in the tissue, and reach peak numbers at around 24 
hours. Acting as the “first responders” to injury, neutrophils phagocytose apoptotic cells 
and debris, and secrete cytokines such as interferon-gamma (IFN) and tumor necrosis 
factor-alpha (TNF) that shifts the injury microenvironment towards a pro-inflammatory 
state. Upon the arrival of monocytes and macrophages from both circulation and peri-
muscular/vascular niches, the pre-conditioned, pro-inflammatory environment educates 
these cells to likewise adopt a pro-inflammatory state. Pro-inflammatory macrophages 
dominate for the first few days after injury (day 1-2), where they phagocytose cellular 
debris and exert a pro-proliferative, anti-differentiating effect on satellite cells via the 
secretion of TNF-α, IFN-γ and IL-6[43-47]. Conversely, anti-inflammatory 
monocytes/macrophages that dominate the later stages of healing (day 3 and onward) 
promote satellite cell differentiation, with IL-10 and IGF-1 identified as key molecules in 
the progression of late-stage myogenesis [24, 48]. In additional to soluble factors, cell-cell 
contacts between macrophages and myogenic progenitors have been shown to protect 
precursor cells from apoptosis [49]. Recent studies show that injection of pro-inflammatory 
human macrophages along with human myoblasts into immunocompromised mice 
enhanced the proliferative window of transplanted myoblasts, promoted their migration, 
and delayed differentiation, and ultimately resulted in more human-derived myofibers at 1 
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month post-transplantation, whereas co-injection of myoblasts with anti-inflammatory 
M2c-like macrophages enhanced myofiber number at an earlier day 5 timepoint[50].   
Inflammatory “M1” macrophages are classified by their activation via Th1-type 
cytokines (such as the aforementioned IFN and TNF)[51], which distinguishes them from 
M2 alternatively-activated, repair macrophages which are activated by Th2-type cytokines 
(such as IL-4 and  IL-10)[51]. However, the M1/M2 naming paradigm has been used to 
describe in vitro polarized macrophage states that often do not reflect the diverse and 
nuanced macrophage populations that are seen in vivo following muscle injury. 
Transcriptional profiling was performed on isolated muscle macrophages from injured 
CX3CR1-GFP transgenic mice that were sorted according to their Ly6C and CX3CR1 
expression (with Ly6CposCX3CR1lo cells representing the “M1” class and 
Ly6CnegCX3CR1hi representing the “M2” class of macrophages). Principle component 
analysis revealed that overall, macrophage populations segregated more by day 
(macrophages from days 1-2 clustered together, and macrophages from days 4-8 clustered 
together), than by their Ly6C immunophenotype. In vertical comparisons of macrophage 
subsets within each time point, canonical pro- and anti-inflammatory transcripts such as 
TNF-alpha, IL-1 beta (inflammatory) and TFG-beta and IL-10 (anti-inflammatory) were 
not significantly different between the Ly6Cpos and Ly6Cneg subsets. However, the modest 
differences in pro- and anti-inflammatory cytokines highlight the difficulty in defining in 
vivo macrophage phenotypes by conventional markers.  
At day 2, Ly6Cpos macrophages were upregulated in genes associated with innate 
immune response and cell motility, with IL1f9 being the top ranked inflammatory gene. 
Alarmins (molecules that are released upon tissue injury, eg. S100a8 and S100a9), and 
 18 
acute (inflammation) phase protein (Lcn2, Lrg1, Hp, and Saa3) genes were also 
upregulated in day 2 Ly6Cpos macrophages compared to day 2 Ly6Cneg macrophages. 
Interestingly, the inflammatory profile of day 2 Ly6Cpos macrophages was driven 
independently of the IFN--STAT signaling pathway, as several of the inflammatory genes 
(Saa3, Il1f9, S100a9) were not differentially expressed in day 2 CD45+ cells collected from 
STAT1 knockout mice compared to wild-type mice (though coinjection of LPS along with 
toxin did induce their expression, showing that these genes were expressed based on a pro-
inflammatory muscle environment). Conversely, Ly6Cneg macrophages at day 2 and day 4 
post injury were upregulated in genes that governed cell cycle progression and cell 
division, showing the proclivity of anti-inflammatory macrophages to proliferate. 
Importantly, there was an early upregulation of genes (between days 1 and 2) of genes 
associated with oxidative phosphorylation and TCA cycle, followed by subsequent 
downregulation of genes associated with glycolysis and glucose metabolism in both 
Ly6Cpos and Ly6Cneg macrophages, indicating that macrophages shift their metabolic 
profile from glycolysis to oxidative metabolism prior to shifting their inflammatory status  
from a pro-inflammatory to anti-inflammatory state. 
Horizontal comparisons of the Ly6Cpos macrophage population along the 
timecourse of regeneration showed that the most important changes in gene expression 
happened between days 2 and 4 post-injury, right when inflammatory Ly6Cpos 
macrophages are undergoing the phenotypic switch to repair Ly6Cneg macrophages. 
Upregulated genes at day 4 compared to day 2 were molecules associated with macrophage 
interactions with the adaptive immune system (such as Cd7, Ifng, Cd2, Ciita, among 
others), whereas genes encoding both pro-inflammatory and anti-inflammatory secreted 
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effector molecules (Il6, Il10, Itga1) and genes involved in transcription, translation and 
lipid metabolism were downregulated.  
Ly6Cneg macrophages first upregulate genes associated with cell proliferation and 
cell division up until day 4 post-injury, and downregulate chemotaxis and cell motility 
associated genes (e.g. Itga1, Ccl2 Pecam1, Itgal) within this acute phase. Later on in the 
regenerative process, genes associated with immune response and cell 
communication/cytokine production were upregulated (e.g Il6, Il10, CD81, Ccl22, Pdgfb 
for immune response, and Itk, Map2k3, Dusp16 for signal transduction) while genes 
governing metabolism of ribosomes/RNA, glucose, and other macromolecules were 
downregulated at the late stages of regeneration. Molecules that are known to be secreted 
by macrophages and play roles in myogenesis such as insulin-like growth factors 
(IGF)[48], platelet derived growth factor-alpha, hepatocyte growth factor, and bone 
morphogenic protein 2,  were shown to increase along the time course of regeneration 
within the Ly6Cneg macrophage subset in particular. Late-phase Ly6Cneg macrophages 
highly express genes that code for both extracellular matrix (ECM) proteins, as well as 
ECM remodeling proteins, indicating that these repair macrophages not only remodel the 
early ECM but directly contribute to ECM scaffolding network as well.  
It is worth re-noting that this detailed information on muscle injury macrophages 
was only recently gathered from muscles that had underwent cardiotoxin induced muscle 
injury. More of experiments of this nature should be conducted on other types of muscle 
injury, such as nerve denervation injury and volumetric muscle loss, to more clearly 
understand the role that injury context plays in macrophage gene activation and subsequent 
functional behavior.  
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The diverse and time-dependent gene expression profiles (broadly, inflammatory, 
then anti-inflammatory) stemming from the sequentially dominant macrophage phenotypes 
likely affect other processes necessary for functional muscle healing including ECM 
deposition and reorganization, angiogenesis and vascular remodeling, and nerve 
regeneration. Knowledge of how different macrophage subsets affect the various tissue 
microcompartments within injured muscle is especially important in a volumetric defect 
context in which all tissue architecture must be regenerated de novo. We focus on the 
alternatively-activated macrophages that govern the later phases of healing as wounds tend 
to quickly switch from an inflammatory environment to an anti-inflammatory, pro-healing 
environment only a few days after injury [52].  
ECM deposition and reorganization is crucial for the healing of tissue injuries in 
which the native matrix has been damaged or lost. During the proliferative phase of wound 
healing, fibroblasts can migrate into the defect space and initiate the deposition of a 
provisional ECM that is composed mostly of fibrin and fibronectin. This provisional ECM 
encourages fibroblast adhesion and migration into the damaged tissue space, where 
granulation tissue is formed and a vascular network is established [52].  Fibroblasts and 
myofibroblasts continue to secrete ECM, predominately collagen, that can either restore 
tissue mechanical properties, or lead to the formation of scar tissue (fibrosis).  
Alternatively-activated macrophages have been shown to control collagen fibril formation 
in regenerating skin[53] and promote the deposition of ECM by fibroblasts[54]. However, 
it has been shown that the unchecked production of TGF-1 by macrophages present in 
chronic inflammation can promote the differentiation of fibroadipogenic progenitors into 
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robust matrix-producing fibroblasts that leads to unchecked deposition of collagen and 
ultimately, fibrosis [55].  
Skeletal muscle is a heavy consumer of bioresources such as oxygen and nutrients, 
and consequently produces a lot of biowaste that must be cleared. To facilitate this rapid 
exchange of molecules, this tissue is highly vascularized, possessing larger blood vessels 
and an intricate network of capillaries. Restoration of an appropriate vascular network 
within regenerated muscle is crucial to proper functionality. Monocytes and macrophages 
appear to promote both angiogenic and arteriogenic expansion of the vasculature[56-58]. 
Macrophages are the primary source of angiogenic growth factors such as VEGF[59] and 
robust vascularization is associated with increased macrophage presence in and around 
biomaterial implants[60, 61]. M2-polarized macrophages (IL-4- or IL-10-stimulated) are 
considered pro-angiogenic both in vitro and in vivo[62-64], though recent studies have 
demonstrated that M1-polarized macrophages may also play key roles in angiogenesis [65, 
66]. Promotion of both angiogenic expansion of vascular length and arteriogenic diameter 
network expansion in dorsal skin is correlated with the presence of Ly6Clo monocytes in 
higher proportion to Ly6Chi monocytes[67]. Hydrogel vascularization in response to 
growth factor delivery (platelet-derived growth factor and fibroblast growth factor) in the 
cornea was accompanied by accumulation of macrophages that produce both M1- and M2-
associated mRNA transcripts, such as Tnfa and Arg1, respectively [60]. Matrigel implants 
rich in alternatively-activated (M(IL-4 or IL-10) macrophages show increased 
vascularization after subcutaneously implantation compared to implants supplemented 
with inflammatory macrophages (M(IFN-)) [63] . The robust difference in matrigel plug 
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vascularization was attributed to upregulated expression of fibroblast growth factor and 
placental growth factor within the M2 polarized macrophages.  
Monocytes and macrophages have also been shown to interact closely with 
remodeling vasculature[57, 68, 69].  We have shown in vitro that anti-inflammatory 
CX3CR1hi monocytes preferentially associated with endothelial cell networks and in vivo, 
exhibit closer homing to inflamed vasculature[36]. During development, M2-like 
macrophages serve as physical bridges between sprouting angiogenic tip cells, as if guiding 
them towards fusing together into a vascular intersection. Indeed, macrophages are seen to 
remain in close contact with these anastomoses even after formation of a vessel 
junction[57].  It has been suggested that vasculature can provide microenvironmental cues 
that educate non-classical monocytes to convert into alternatively activated macrophages 
via signaling with the endothelium[70], and consequently signal back to promote vessel 
remodeling. The importance of spatial positioning of monocytes and macrophages during 
healing is only beginning to be understood, but we have demonstrated that increased 
proximity of CD206+ cells to vasculature in ischemic tissues coincides with increased 
vessel density [36]. Thus, both the phenotype of monocytes and macrophages, as well as 
their spatial distribution is likely an important feature when assessing their function.  
Skeletal muscle contracts in response to electrical stimulus from specialized nerves 
called motor neurons. In addition to facilitating movement, muscles must also be 
innervated simply to maintain muscle tone and avoid atrophy. Motor neurons branch 
throughout the muscle and connect with muscle fibers at the neuromuscular junction. The 
proper coupling of the pre-synaptic and post-synaptic junction is crucial for the 
transmission and translation of neural electrical signal (action potential) to the chemical 
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signal (acetylcholine - ACh) that crosses the synaptic cleft and binds to clusters of 
acetylcholine receptors on the muscle fiber [71]. Binding of ACh to the Ach receptors 
triggers an action potential within the muscle fiber, releasing calcium stores, and ultimately 
results in muscle contraction. Following injury, motor neurons undergo degeneration in the 
axonal portion distal to the injury site, a process known as Wallerian degeneration[72]. 
Within a few days, circulation-derived macrophages will enter the distal stump of the nerve 
and clear myelin debris[73]. Depletion of blood monocytes with clodronate liposomes in 
rats undergoing peripheral nerve transection resulted in significantly reduced macrophages 
within nerves and less myelin debris clearance, a process necessary to nerve 
regeneration[74]. Axons regenerate starting from the proximal stump, and macrophages 
promote axonal growth by secreting proteases, growth factors, and ECM remodeling 
proteins[75]. Macrophages at the site of nerve injury can be educated by molecules in the 
local microenvironment to polarize towards an anti-inflammatory M2 phenotype. Such 
molecules include apolipoprotein E, collagen VI, and CCL2/CCR2, which are all enhanced 
following peripheral nerve injury. Collagen VI and CCR2 knockout mice both display 
macrophage phenotypes skewed towards the M1 inflammatory phenotype. Several studies 
have investigated the therapeutic benefit of locally delivering macrophage polarizing 
cytokines to peripheral nerves. Locally delivering IFN- (a canonical M1-polarizing 
cytokine) from nerve guidance channels polarizes local macrophages to an M1 phenotype 
but did not result in increased Schwann cell infiltration or axonal growth. However, local 
delivery of IL-4 (canonical M2-polarizing cytokine) did promote increased Schwann cell 
infiltration and increased axonal growth, and the group showed that increased 
CD206+/CCR7+ (M1/M2) macrophage ratio is linearly correlated with improved axonal 
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growth [76]. Another group delivered IL-10 (canonical M2-polarizing cytokine) to intact 
peripheral nerves and saw increased M2 polarization by immunofluorescence staining for 
Arginase 1 and CD206, however they did not look at the benefits in a nerve injury 
model[77].  
Taken together, it is evident that monocytes and macrophages are able to influence 
repair processes in skeletal muscle and the various sub-tissue compartments within. Thus, 
therapies that leverage the pro-regenerative activities of myeloid cells represent a 
promising strategy to promote the regeneration of not only muscle tissue, but also motor 
neurons and vasculature crucial to the proper function of skeletal muscle as a whole.  
2.2.6 Contributions of Macrophages within Muscle Pathology and Aging 
 Though macrophages are required for muscle regeneration after acute injuries, their 
unchecked activity within muscle pathologies can lead to tissue destruction and fibrosis. In 
Duchenne Muscular Dystrophy, there is constant infiltration of CD4+, CD8+ T-
lymphocytes, macrophages, eosinophils, and natural killer T-cells[78]. Depletion of 
F4/80+ macrophages in dystrophic mice result in significant reductions in muscle 
membrane lesions characteristic of dystrophic muscle[79]. However, knockout of the 
inflammatory cytokine IFN- polarized macrophages in dystrophic muscle to a more anti-
inflammatory phenotype and improved gross motor function in the later stages of disease. 
Macrophages extracted from dystrophic muscle can display either a canonical 
inflammatory (Ly6Chi,, tumor necrosis factor-alpha/TNF-hi) or anti-inflammatory 
(Ly6Clo, transforming growth factor-beta/TGF-hi) phenotype, or interestingly, a mixed 
phenotype in which macrophages express both TNF- and TGF-[55]. However, the dual 
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presence of these cytokines, and in particular TGF-, was shown to impair apoptosis of 
fibroadipogenic progenitors that promote fibrosis in dystrophic mice. Thus, it appears that 
anti-inflammatory macrophages can be either beneficial or deleterious within the context 
of muscular dystrophies and further studies to more closely categorize these macrophages 
and their contributions to the severity of muscular dystrophy are needed.  
 Aged muscle displays similar characteristics to dystrophic muscle, and the role of the 
immune system in sarcopenia is equally less understood. Studies in geriatric mice (22-24 
months) have shown increases in anti-inflammatory M2 macrophages within skeletal 
muscle that can promote the fibrosis seen in resting aged skeletal muscle[80]. 
F4/80+MHCII- monocytes/macrophages were decreased in aged muscles damaged with 
cardiotoxin, and studies in humans show decreased macrophage infiltration in exercise-
induced muscle injury in older patients vs younger patients. Indeed, unpublished data from 
our lab in aged mice (14-16 months) show decreased infiltration of both inflammatory 
(Ly6C+,CD206-) and anti-inflammatory (Ly6C-,CD206+) macrophages after volumetric 
muscle injury. Though it is clear that immune homeostasis and inflammatory response to 
muscle injury is dysregulated with age, further exploration of key altered aspects and how 
their modulation can reduce muscle wasting and/or improve regeneration is needed.  
2.2.7 Lymphocytes within Skeletal Muscle Repair 
Though the contributions of monocytes and macrophages to skeletal muscle repair 
have been well established in recent years, the role that the adaptive immune system plays 
in muscle healing is less understood. Recently, a population of regulatory T-cells (Tregs) 
was identified within regenerating skeletal muscle that displayed a transcriptome unique to 
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the injury niche compared with Tregs isolated from lymphoid organs such as the spleen 
[81]. The transcriptomic analysis revealed that muscle Tregs overexpress the chemokine 
IL-10, as well as the growth factors platelet-derived growth factor (PDGF) and 
Amphiregulin (Areg), compared to splenic Tregs and conventional T-cells (Tconv) from 
either injured muscle or spleen. Tregs accumulate in toxin-injured muscle at around 4 days, 
coinciding with the time frame around which accumulated myeloid cells undergo an 
inflammatory to anti-inflammatory phenotypic switch. Depletion of Tregs in Foxp3-
diptheria toxin receptor mice resulted in failure for inflammatory, Ly6Chi cells within the 
injured muscle to undergo a proper phenotypic switch to the more anti-inflammatory 
Ly6Clo stage[81]. Concomitant with this stalled inflammatory phase was impaired muscle 
regeneration as detected by lower numbers of centrally nucleated, regenerating muscle 
fibers, and increased fibrotic collagen deposition. Indeed, aged mice that are impaired in 
muscle regeneration exhibit decreased Treg recruitment[82].  
CD8+ T-cells have been shown to exert a positive impact on muscle regeneration 
through the secretion of monocyte chemoattractant protein-1 (MCP-1) that recruits 
inflammatory macrophages at the initial phase of muscle regeneration, promoting satellite 
cell proliferation[83]. However, depletion of CD8+ and CD4+ T-cells in dystrophic mice 
significantly reduces the skeletal muscle pathology seen in these animals[84].   Overall, the 
role of CD8+ cytotoxic T-cells and CD4+ helper T-cells within muscle injury and 
regeneration largely remains unknown.  
2.2.8 Harnessing immune cells for the treatment of skeletal muscle injuries 
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Immunologically smart interventions that exploit the division of labor between 
different monocyte, macrophage, and lymphocyte populations require an understanding of 
the roles that these cells play in promoting repair. Though significant advances have been 
made in elucidating the immunobiology within toxin-induced skeletal muscle repair 
(Figure 2), further exploration of the role these immune cells play within volumetric 
skeletal muscle injury is required. 
 
Figure 2.  Immuno-biology within skeletal muscle injury. Within muscle injury, 
monocytes are recruited from circulation and become macrophages over a spectrum of 
phenotypes. In the acute phases of injury, inflammatory myeloid subsets promote the 
proliferation of muscle stem cells or satellite cells. Towards the midstages of repair, 
myeloid subsets undergo a switch from the inflammatory phenotype to the anti-
inflammatory or repair phenotype, which then promote satellite cell differentiation. This 
phenotypic switch is thought to be governed at least in part by the activity of recruited 
regulatory T-cells. 
A fine balance exists within successfully regenerated, from the subtypes of immune 
cells that are present, to the time at which they exert functional activity. The present work 
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will improve our understanding of the role that myeloid and lymphoid cells play in 
promoting endogenous mechanisms of tissue repair after traumatic injuries. In Chapter 3, 
we track the fate of circulating classical and non-classical monocyte subsets and identify 
non-classical Ly6Clo monocytes as biased progenitors of alternatively-activated CD206+ 
macrophages. In Chapter 4, we establish a novel model of volumetric muscle injury (VML) 
in the murine spinotrapezius, which enables the whole-mount visualization of cell 
populations and tissue microstructures critical in muscle repair (Figure 3). We demonstrate 
for the first time that non-classical monocytes are directly recruited to volumetric muscle 
injury. We use the knowledge that non-classical monocytes are biased progenitors of 
alternatively activated macrophages as motivation to locally enrich their frequency in 
injured muscle tissue. We show that selective recruitment of non-classical monocytes to 
injured muscle coincides with increased CD206+ alternatively-activated macrophages in 
peri-defect tissue and improves muscle healing. In Chapter 5, we expand the spinotrapezius 
model to encompass a non-healing defect and demonstrate that implantation of FTY720 
nanofibers over 2mm diameter muscle defects induces acute changes in lymphoid and 
myeloid cell subset accumulation. Assessment of muscle healing metrics reveal that 
increased alignment of regenerated muscle fibers to the pre-injury fiber axis was observed 
in animals treated with FTY720 nanofibers. Taken together, we will demonstrate an 
improved understand of the role that pro-regenerative subsets of immune cells play in the 
promotion of endogenous mechanisms of tissue repair after traumatic soft-tissue injuries. 
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Figure 3.  Whole mount confocal images of uninjured spinotrapezius muscle. A) Pax7-
ZsGreen satellite cells lie along the basal lamina of muscle fibers. B) CD68+CD206+ cells 
in resting spinotrapezius muscle associate with blood vessels. C) Skeletal muscle possesses 





3. NON-CLASSICAL MONOCYTES ARE BIASED PROGENITORS 
OF WOUND HEALING MACROPHAGES2 
3.1 Abstract 
Successful tissue repair requires the activities of myeloid cells such as monocytes 
and macrophages that guide the progression of inflammation and healing outcome. 
Immunoregenerative materials leverage the function of endogenous immune cells to 
orchestrate complex mechanisms of repair; however, a deeper understanding of innate 
immune cell function in inflamed tissues and their subsequent interactions with implanted 
materials is necessary to guide the design of these materials. Blood monocytes exist in two 
primary subpopulations, characterized as classical inflammatory or non-classical. While 
classical monocytes extravasate into inflamed tissue and give rise to macrophages, the 
recruitment kinetics and functional role of non-classical monocytes remains unclear. Here, 
we demonstrate that circulating non-classical monocytes are directly recruited to polymer 
films within skin injuries, where they home to a perivascular niche and generate 
alternatively activated, wound healing macrophages. Selective labeling of blood monocyte 
subsets indicates that non-classical monocytes are biased progenitors of alternatively 
activated macrophages. On-site delivery of the immunomodulatory small molecule 
FTY720 recruits S1PR3-expressing non-classical monocytes that support vascular 
remodeling after injury. These results elucidate a previously unknown role for blood-
                                                 
2 Portions of this chapter adapted from: Olingy CE, San Emeterio CL, Ogle ME, Krieger 
JR, Bruce AC, Pfau DD, et al. Non-classical monocytes are biased progenitors of wound 
healing macrophages during soft tissue injury. Sci Rep. 2017;7:447. Published under 
Creative Commons license. 
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derived non-classical monocytes as contributors to alternatively activated macrophages, 
highlighting them as key regulators of inflammatory response and regenerative outcome. 
3.2 Introduction 
The mononuclear phagocyte system plays a multi-faceted role in maintaining tissue 
homeostasis and responding to pathological processes such as autoimmune diseases, 
cancer, and aberrant wound healing. Monocytes circulate in the bloodstream during steady 
state and are robustly recruited to sites of inflammation, where they exert functions that 
include clearance of cellular debris, promotion of angiogenesis, and restoration of tissue 
integrity[85]. The ontogeny of macrophages varies in different tissues, such that some 
tissue resident macrophages are seeded embryonically and self-renew in a similar manner 
to stem cells, whereas other macrophages (such as in the dermis or gut) are continually 
replenished by blood-derived monocytes[14-18]. Consequently, circulating blood 
monocytes are considered a highly plastic and dynamic system of innate immune cells that 
initiate processes of organ and tissue remodeling[85-87].  
Two distinct subpopulations of monocytes have been identified in mouse and 
human blood, which can be distinguished by well-characterized surface protein expression 
profiles. Classical inflammatory monocytes are identified by Ly6ChiCX3CR1loCD43lo 
expression in mice (CD14hiCD16- in human), whereas non-classical alternative monocytes 
are Ly6CloCX3CR1hiCD43hi in mice (CD14+CD16+ in human)[14]. A third population of 
intermediate monocytes characterized by intermediate expression of Ly6C in mice 
(CD14hiCD16+ in humans) are thought to complement the functions of non-classical 
monocytes and may preferentially differentiate into dendritic cells within inflamed 
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tissues[20, 21]. Under homeostasis, classical monocytes in blood decrease Ly6C 
expression and become non-classical Ly6Clo monocytes[17, 22], which patrol the luminal 
side of resting endothelium[12]. Classical monocytes also survey steady-state tissues and 
can traffic to lymph nodes without differentiating into macrophages[13]. During 
inflammation, monocytes exit peripheral blood and extravasate into tissue, where they may 
transiently persist as monocytes without differentiation and exert a host of functions within 
the damaged tissue[13, 56, 88-90]. Classical inflammatory monocytes present in the acute 
phases of injury secrete pro-inflammatory cytokines such as IL-6, iNOS, and TNFα[90] 
and exhibit high levels of matrix metalloproteinase and cathepsin production[33]. 
Conversely, Ly6Clo monocytes present later during inflammation secrete high levels of 
vascular endothelial growth factor (VEGF) and IL-10 and can induce endothelial cell 
proliferation to promote arteriogenesis[29, 33, 56]. We have previously shown that 
strategies that enhance the early recruitment of Ly6Clo monocytes couple with later 
increases in arteriolar expansion and angiogenic activity[34, 67]. Recruited monocytes 
primarily differentiate into macrophages, serving as an alternative source of wound 
macrophages to those derived from in situ proliferation of tissue resident populations[91]. 
Macrophages are highly responsive to cues within the injury niche, enabling them 
to dynamically modify their behavior in response to changes in the microenvironment and 
display extremely varied phenotypes. Classically activated (“M1”) macrophages are 
primary players in pathogen destruction, secretion of inflammatory cytokines, and driving 
Th1-type responses[23]. Conversely, alternatively activated wound healing (“M2”) 
macrophages (of which a number of subtypes have been described[23]) are associated with 
pro-regenerative activities such as angiogenesis[25, 26], extracellular matrix 
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remodeling[27], secretion of anti-inflammatory cytokines[23], and resolution of 
inflammation[28]. The highly complex and heterogeneous nature of inflamed tissue 
microenvironments has rendered a general description of macrophage origin and function 
challenging. Within toxin-induced muscle injury[29], liver fibrosis[30], infection[31], and 
autoimmune disease[32], classical Ly6Chi monocytes are recruited from circulation and 
undergo in situ  differentiation to be the primary contributors of injury Ly6Clo 
monocytes/macrophages. In contrast, sequential recruitment of classical Ly6Chi followed 
by non-classical Ly6Clo monocyte subsets after myocardial infarction[33], and direct 
recruitment of adoptively transferred Ly6Clo monocytes within excisional skin injury[34] 
and during the development of inflammatory arthritis[35] have been reported. However, 
whether specific populations of blood monocytes give rise to defined macrophage 
phenotypes surrounding implanted materials remains unknown.  
Harnessing myeloid cell functions for regenerative medicine applications requires 
an understanding of the cues that direct the localization and fate of these cells. 
Immunoregenerative materials seek to leverage the function of endogenous immune cells 
to guide the progression of inflammation and repair damaged tissue[92]. For example, local 
delivery of stromal-derived factor-1 (SDF-1) from desulfated heparin-containing 
poly(ethylene glycol) (PEG) hydrogels increases the frequency of CXCR4hiLy6Clo 
monocytes, which promotes capillary network expansion[67]. Moreover, co-delivery of 
macrophage colony-stimulating factor (M-CSF) with VEGF from PEG hydrogels increases 
the density and maturity of corneal blood vessels compared to VEGF alone[60]. Recently, 
our lab demonstrated that poly(lactic-co-glycolic acid) (PLGA)-based delivery of the small 
molecule FTY720, an agonist of sphingosine-1-phosphate receptor (S1PR) 3, recruits non-
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classical monocytes to inflamed tissues and promotes arteriogenesis[34]. In the present 
study, we utilize cell labeling strategies to selectively track the fate of either classical 
Ly6Chi or non-classical Ly6Clo monocytes in response to biomaterial implantation within 
cutaneous wounds. We demonstrate that classical monocytes are able to give rise to both 
CD206- and CD206+ macrophages following monocyte depletion with clodronate 
liposomes, but labeled non-classical monocytes preferentially give rise to CD206+ M2-
like macrophages. On-site delivery of the immunomodulatory small molecule FTY720 
induces homing of extravasated non-classical monocytes to peri-implant vasculature.  
Subsequently, FTY720 promotes in situ generation of wound healing macrophages and 
vascular remodeling within ischemic skeletal muscle. These results shed light on the fate 
of specific monocyte populations following biomaterial implantation after injury and 
indicate that non-classical monocytes are a promising therapeutic target for harnessing pro-
regenerative inflammation to promote repair.  
3.3 Materials and Methods 
3.3.1 Material fabrication 
Films were fabricated as previously described[34]. Briefly, 350 mg PLGA (50:50 
DLG 5E – Evonik Industries) was dissolved in 2ml dichloromethane in a glass scintillation 
vial via high-speed vortexing. For drug-loaded films, 1.75 mg of FTY720 (Cayman 
Chemical) was added at a 1:200 drug:polymer weight ratio, and mixed until completely 
incorporated. Polymer solutions were poured into Teflon-coated petri dishes and allowed 
to dry at -20°C for 7 days. Before use, films were lyophilized overnight to remove any 
traces of solvent. 
 35 
3.3.2 Dorsal skinfold window chamber surgery  
All animal procedures were conducted according to protocols approved by the 
Georgia Institute of Technology or University of Virginia Institutional Animal Care and 
Use Committee. Male C57BL/6J or B6.129P-Cx3cr1tm1Litt/J mice (CX3CR1GFP/+) mice 
(8-12 weeks) were fitted with sterile dorsal skinfold window chambers (APJ Trading Co) 
as previously described[34]. Briefly, mice were anesthetized with an intraperitoneal (i.p.) 
injection of ketamine/xylanzine (100/10 mg/kg) in sterile saline. Dorsal skin was shaved, 
depilated, and sterilized with three alternating washes of 70% ethanol and chlorhexidine. 
A double-layered skin fold was elevated off the back of the mouse and fitted with the 
titanium frame of the window chamber on the underside. The epidermis and dermis were 
removed from the top side of the skinfold in a ~12mm diameter circular area via surgical 
microscissors to reveal underlying vasculature. Exposed tissue was superfused with sterile 
saline to prevent desiccation. The titanium frame was then mounted on the top side of the 
skinfold, attached to the underlying frame counterpart, and sutured to the surrounding 
tissue. Two films were placed on top of the exposed subreticular dermis layer immediately 
after surgery (day 0) and exposed tissue was sealed with a sterile glass window. Mice were 
euthanized 72 hours after surgery via CO2 asphyxiation. The vasculature was immediately 
flushed with intracardiac infusion of saline follow by an intracardiac infusion of 4% 
paraformaldehdyde, prior to whole mounting of tissue and immunohistochemistry. 
3.3.3 Spinotrapezius ischemia model 
Mice were anesthetized with an i.p. injection of ketamine⁄xylazine⁄atropine 
(60⁄4⁄0.2 mg⁄kg). Ligation surgeries were performed as previously described[68]. Briefly, 
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a small incision was made on the dorsum above the lateral edge of the right spinotrapezius 
at the edge of the fat pad. The fascia was separated from the top of the muscle and the fat 
pad moved before isolating an anatomically reproducible feeding arteriole entering the 
muscle from below. This feeding arteriole was ligated with 10-0 nonabsorbable suture in 
two places and cut. The fat pad and fascia were moved back into position and the skin was 
closed with 8-0 nonabsorbable suture. To allow visualization of vascular endothelium of 
arterioles in CX3CR1GFP/+ mice, anesthetized mice were administered an intra-jugular 
injection of labeled isolectin (IB4-Alexa Fluor 568; Life Technologies), which was allowed 
to circulate for 10 minutes. Anesthetized mice were euthanized via CO2 asphyxiation 72 
hours post-surgery. The vasculature was immediately flushed with an intracardiac infusion 
of adenosine (70 mg/L) in Ringer’s solution followed by an intracardiac infusion of 4% 
paraformaldehyde.  
3.3.4 Flow cytometry 
Peripheral blood was collected via cardiac puncture and bone marrow was collected 
via centrifugation (1000g for 5 mins) of isolated tibiae. The dorsal tissue circumscribing 
films was punched out with 6mm biopsy punches and pooled from both films within one 
animal for most studies. For adoptive transfer studies, all inflamed dorsal tissue was 
collected for analysis. Tissue was digested with collagenase (1mg/ml) at 37°C for 30 
minutes and further disaggregated with a cell strainer to create a single cell suspension. 
Single cell suspensions of tissues were stained for flow cytometry analysis according to 
standard procedures and analyzed on a FACS-AriaIIIu flow cytometer (BD Biosciences). 
The following antibodies were used for cell phenotyping: APC-Cy7- or BV421-conjugated 
anti-CD11b (BioLegend), APC- or BV510-conjugated anti-Ly6C (BioLegend), PerCP-
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Cy5.5-conjugated CD43 (Biolegend), PE-Cy7-conjugated anti-GR-1 (BioLegend), APC-
Cy7-conjugated anti-Ly6G (Biolegend), APC-conjugated anti-F4/80 (BioLegend), PE-
Cy7- or FITC-conjugated anti-CD206 BioLegend), PE-Cy7-conjugated anti-CD301b, 
BV711-conjugated anti-CD64 (BioLegend), PE-conjugated anti-MerTK (Biolegend), 
BV605-conjugated anti-CD45.1, BV785-conjugated anti-CD45.2, or PerCP-eFluor710 
conjugated anti-CD115 (eBioscience). Dead cells were excluded by staining with Zombie 
NIRTM (Biolegend) in protein-free buffer prior to antibody staining. Staining using BV 
dyes was performed in the presence of Brilliant Stain Buffer (BD Biosciences). Positivity 
was determined by gating on fluorescence minus one controls. Absolute quantification of 
cell numbers in blood and tissue was performed by adding 25μL of AccuCheck counting 
beads to flow cytometry samples (Thermo Fisher Scientific). S1PR3 flow cytometry was 
performed by first performing Fc block (Biolegend), followed by staining cells with 
primary unconjugated anti-S1PR3 antibody (Alomone Labs) and secondary staining with 
DyLight 650 anti-rabbit IgG (Abcam). Positivity was determined by staining CX3CR1GFP/+ 
cells with the secondary body only (no primary S1PR3 antibody). Gating for tissue 
monocytes and macrophages is shown in Figure 4.  
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Figure 4.  Gating strategy for dorsal skin tissue monocytes and macrophages. 
Classical monocytes are immunophenotyped as CD11b+, SSClo, and Ly6Chi. Non-
classical monocytes are immunophenotyped as CD11b+, SSClo, and Ly6Clo. 
Alternatively-activated macrophages are identified as CD11b+F4/80+CD206+. 
3.3.6 Whole mount immunohistochemistry 
Dorsal tissue and spinotrapezius muscles were explanted and permeabilized 
overnight with 0.1-02% saponin. The tissues were blocked overnight in 5-10% mouse 
serum. Tissues were incubated at 4˚C overnight in solution containing 0.1% saponin, 5% 
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mouse serum, 0.5% bovine serum albumin, and the following conjugated fluorescent 
antibodies: Alexa Fluor 594 anti-CD31 antibody (BioLegend) or Alexa Fluor 568 isolectin 
IB4 (Life Technologies) for blood vessel visualization, Alexa Fluor 647 anti-CD68 (AbD 
Serotec) for monocyte/macrophage visualization, and Alexa Fluor 488 anti-CD206 (AbD 
Serotec) or Alexa Fluor 647 anti-CD206 (Biolegend). Tissues were mounted in 50/50 
glycerol/phosphate buffered saline and imaged through the entire thickness of the muscle 
(~200 microns) on a Zeiss LSM 710 NLO confocal microscope or a Nikon confocal 
microscope.  
For monocyte/macrophage quantification, 3-4 different fields of view (FOVs) per 
muscle containing a collateral arteriole with monocytes/macrophages evident were located 
manually. Full-thickness z-stack (2μm step size) volume renders of these FOVs were 
generated using a 20X oil immersion objective. 20X confocal z-stack volume renders were 
used for cell association quantification. A threshold at which only the brightest 
CX3CR1GFP/+ cells (CX3CR1hi) were visible was applied to all images. Vessel-associated 
CD206+ and CX3CR1hi cells were defined as cells falling within the 2-dimensional area 
of the vessel in question and within 50μm of the vessel border. ImageJ (NIH) imaging 
software was used to quantify vessel length and density. Arterioles were distinguished from 
venules by degree of lectin binding, vessel size, and morphology. Cell counts and green 
channel thresholding to designate CX3CR1hi cells were performed in Adobe Photoshop 
(Adobe Systems Incorporated). 
3.3.7 Statistical analysis 
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Data are presented as mean ± standard error of the mean (S.E.M.). All statistical 
analysis was performed in GraphPad Prism software. Comparisons of two groups were 
made using a two-tailed unpaired t-test, with Welch’s correction if standard deviations 
were not equal. For studies with two independent variables, two-way ANOVA with Sidak’s 
test for multiple comparisons was performed. Unless otherwise noted, p<0.05 was 
considered statistically significant. 
3.4 Results 
3.4.1 Injured skin recruits Ly6Clo monocytes that give rise to CD206+ wound 
macrophages. 
Circulating monocyte subsets were labeled in vivo prior to dorsal skinfold window 
chamber (DWC) surgery to facilitate cell tracking of each monocyte population as they 
entered inflamed dorsal tissue surrounding PLGA polymer implants. Non-classical Ly6Clo 
monocyte labeling was performed by intravenous administration of fluorescent latex 
beads[93, 94] (Figure 5). Within two hours of intravascular administration, latex beads are 
phagocytosed and equally distribute within Ly6Clo and Ly6Chi blood monocyte 
populations. However, by 24 hours after injection, latex beads primarily label Ly6Clo 
monocytes due to physiological conversion of labeled Ly6Chi monocytes and this labeling 
is sustained for up to 1 week[93].  Utilizing this strategy, blood Ly6Clo monocytes were 
selectively labeled compared to classical Ly6Chi monocytes after DWC (83.4 ± 9.7% 
Ly6Clo monocytes vs. 14.5 ± 9.3% Ly6Cint monocytes and 0.0 ± 0.0% Ly6Chi monocytes, 
day 1 post-injury) and the label was retained at similar proportions for the duration of the 
study (Figure 5).  
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Figure 5.  Intravascular administration of latex beads selectively labels circulating 
Ly6Clo monocytes, which persists for 3 days.  Data presented as mean ± S.E.M. 
Statistical analyses performed using two-tailed t-tests. *p<0.05, n=4-11 animals per 
group.  
Analysis of digested explanted dorsal skin tissue showed labeled cells originating 
as Ly6Clo monocytes primarily remained Ly6Clo within tissue. The lower frequency of 
Ly6Chi monocytes carrying the label in the tissue (9.6 ± 2.6% of LX+CD11b+SSClo cells) 
compared to the frequency of labeled Ly6Clo cells (44.3 ± 8.2% of LX+CD11b+SSClo 
cells) indicates that circulating Ly6Clo monocytes do not become Ly6Chi post-extravasation 
(Figure 6A). Approximately half of labeled cells expressed F4/80, indicating that around 
half of recruited Ly6Clo monocytes convert into macrophages or are phagocytosed by 
macrophages by 3 days post-injury (Figure 6B). LX+ labeled cells were more likely to be 
immunophenotyped as CD206+ macrophages (91.0±3.4% of LX+F4/80+CD11b+ cells) 
than CD206- macrophages (Figure 6C). These data suggest that blood-derived Ly6Clo 
monocytes preferentially give rise to CD206+ wound macrophages in inflamed tissue 
surrounding material implants. 
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Figure 6.  Fate of circulation derived Ly6Clo monocytes in injured skin tissue. (A) 
Frequency of either Ly6Chi or Ly6Clo monocytes carrying fluorescent latex bead label 
collected from digested dorsal tissue at day 3 post injury. (B) Frequency of bead-labeled 
F4/80+ or F4/80- cells in animals with labeled blood Ly6Clo monocytes. (C) Frequency 
of bead-labeled CD206+ cells out of total F4/80+CD11b+ cells. Data presented as mean 
± S.E.M. Statistical analyses performed using two-tailed t-tests. *p<0.05, n=4-11 animals 
per group.  
 We then tracked circulating Ly6Chi blood monocytes to explore whether these cells 
adopted similar fates during inflammation. Ly6Chi monocytes were labeled by sequential 
administration of clodronate-loaded liposomes 2 days prior to injury followed by latex 
beads 16 hours later (Figure 7), as previously described[93, 94]. Clodronate liposomes 
administered intravascularly transiently deplete all blood monocytes, resulting in 
accumulation of latex beads in bone marrow cells that reappear in circulating Ly6Chi 
monocytes 2 days later[93]. Pre-administration of clodronate liposomes before latex bead 
injection preferentially labeled Ly6Chi monocytes (70.8 ± 13.3% Ly6Chi monocytes vs. 
26.9 ± 12.9% Ly6Cint monocytes and 2.7 ± 0.9% Ly6Clo monocytes, day 1 post-surgery) 
for the duration of the study (Figure 7).  
A relatively low frequency of labeled Ly6Chi monocytes was detected in digested 
tissue (Figure 8A) confirming previous reports[29, 56, 88] that recruited Ly6Chi monocytes 
do not persist as Ly6Chi monocytes post-extravasation. Ly6Chi monocytes likely rapidly 
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convert in situ into Ly6Clo monocytes, as a significantly greater frequency of labeled 
Ly6Clo monocytes than Ly6Chi monocytes were detected (Figure 8A).  
 
Figure 7.  Depletion of monocytes via intravascular administration of clodronate 
liposomes followed by subsequent administration of latex beads selectively labels 
circulating Ly6Chi monocytes, which persists for 3 days.  Data presented as mean ± 
S.E.M. Statistical analyses performed using two-tailed t-tests. *p<0.05, n=4-11 animals 
per group.  
The frequency of F4/80+ cells within the latex bead-positive (LX+) population was 
not different between Ly6Chi monocyte and Ly6Clo monocyte labeling (47.5± 17.3% vs. 
48.0 ± 6.2% of LX+ cells), suggesting that both monocyte populations are equally capable 
of acquiring a macrophage phenotype after extravasation (Figure 8B) Labeled Ly6Chi 
monocytes showed no preference for acquiring CD206 expression within 3 days of injury 
(Figure 8C), indicating that although blood-derived Ly6Chi monocytes can contribute to 
CD206+ macrophages, they do so at a lower frequency than Ly6Clo monocytes after 
clodronate liposome administration.  
 44 
 
Figure 8.  Fate of circulation-derived Ly6Chi monocytes within injured skin tissue. 
(A) Frequency of either Ly6Chi or Ly6Clo monocytes carrying fluorescent latex bead label 
collected from digested dorsal tissue at day 3 post injury. (B) Frequency of bead-labeled 
F4/80+ or F4/80- cells in animals with labeled blood Ly6Chi monocytes. (C) Frequency 
of bead-labeled CD206+ cells out of total F4/80+CD11b+ cells. Data presented as mean 
± S.E.M. Statistical analyses performed using two-tailed t-tests. *p<0.05, n=4-11 animals 
per group.  
3.4.2 Reduction of circulating Ly6Clo monocytes impairs CD206+ macrophage 
generation.  
Intravascular administration of clodronate liposomes transiently depletes all circulating 
monocytes; however, because blood Ly6Clo monocytes are primarily derived from the 
conversion of Ly6Chi monocytes, there is a delay in the repopulation of circulating Ly6Clo 
monocytes[17, 22]. We employed this tool to examine how decreasing the quantity of 
circulating non-classical monocytes impacts the generation of CD206+ macrophages 
during wound healing. As expected, a deficit in blood Ly6Clo monocytes, but not Ly6Chi 
monocytes, was observed 5 days after clodronate administration (Figure 9A). No 
differences in either monocyte subtype (Figure 9B), total F4/80+ macrophages (Figure 9C), 
or CD206- macrophages (Figure 9D) were observed in digested tissue 3 days post-injury; 
however, a lower frequency of CD206+ macrophages was observed (Figure 9E). These 
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findings suggest that circulating Ly6Clo monocytes are likely major contributors to the 
population of CD206+ wound macrophages. 
 
Figure 9. Loss of Ly6Clo monocytes impairs generation of CD206+ alternatively 
activated macrophages. (A) Clodronate liposome (Clod Lip) administration two days 
before DWC surgery reduced the frequency in blood of Ly6Clo monocytes, but not 
Ly6Chi or Ly6Cint  monocytes. (B) Frequency of Ly6Clo, Ly6Cint, Ly6Chi monocytes after 
Clod Lip administration in digested dorsal tissue 3 days post-injury. (C) Total 
CD11b+F4/80+ macrophages, (D) CD206- macrophages, and (E) CD206+ alternatively 
activated macrophages 3 days post-injury. Data presented as mean ± S.E.M. Statistical 
analyses were performed using two-tailed t-tests *p<0.05, n=4-8 animals per group.  
.4.3 Adoptively transferred Ly6Clo monocytes preferentially differentiate into 
CD301b+CD206+ macrophages.  
To complement in vivo bead-based labeling strategies and further investigate the 
role that blood monocytes play in macrophage generation during inflammation, we 
adoptively transferred sorted CD45.1+ Ly6ChiCD43lo or Ly6CloCD43hi monocytes into 
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CD45.2 mice at the time of DWC surgery (Figure 11A, B). While Ly6CloCD43hi are a 
slightly more restricted population of Ly6Clo monocytes, these two populations primarily 
overlap and the same is true for Ly6ChiCD43lo monocytes (Figure 10).  
 
Figure 10.  Immunophenotype comparison of monocyte subsets. Ly6Chi and Ly6Clo 
monocyte populations overlap with Ly6Chi/CD43lo and Ly6Clo/CD43hi monocyte 
populations, respectively.  
At 3 days post-injury, we assayed donor cells for expression of monocyte and 
macrophage markers (Figure 11C). A very low frequency of CD45.1+CD45.2- cells were 
detected in digested dorsal tissue (Figure 11D) indicating that few donor cells are present 
3 days post-injury. We detected a modest, but insignificant increase in the number of total 
donor cells (normalized to tissue mass) originating as Ly6CloCD43hi relative to those 
adoptively transferred as Ly6ChiCD43lo (Figure 11E). CD301b marks a population of 
macrophages that appear in the midphase of skin wound healing and are required for 
effective cutaneous repair[95]. Following adoptive transfer of Ly6Chi monocytes, we found 
that 80.710.4% of donor-derived CD206+F4/80+ macrophages were CD301b+. 
Similarly, following adoptive transfer of Ly6Clo monocytes, we found that 84.2 6.4% of 
donor-derived CD206+F4/80+ macrophages were CD301b+. A greater frequency of 
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donor-derived wound healing CD301b+CD206+F4/80+ macrophages was detected in 
animals receiving adoptively transferred Ly6CloCD43hi monocytes compared to those that 
received Ly6ChiCD43lo monocytes (Figure 11F). While F4/80 is present on all 
macrophages, co-expression of CD64 and MerTK exclusively distinguishes macrophages 
from monocytes[96]. These two populations significantly overlap, as 25.3 ± 2.1%  of total 
F4/80+CD11b+ cells are also CD64+MerTK+, but nearly all CD64+MerTK+ cells are 
F4/80+ (Figure 12A) and 88.91.2% of CD206+F4/80+ cells are also CD64+MerTK+. 
Similarly, we detected a greater frequency of donor-derived 
CD301b+CD206+CD64+MerTK+ macrophages in animals receiving adoptively 
transferred Ly6CloCD43hi monocytes, supporting the conversion of these monocytes into 
pro-regenerative macrophages (Figure 12D). No changes in the frequency of CD301b-
CD206+F4/80+ (Figure 11G), CD301b-CD206+CD64+MerTK+ (Figure 12E), or total 
number of macrophages (Figure 12 B, C) were detected between the two grafts. These 
results further support the hypothesis that circulating non-classical monocytes differentiate 





Figure 11.  Adoptively transferred non-classical Ly6Clo monocytes differentiate into 
CD206+ macrophages within inflamed peri-implant tissue. (A) CD45.1+ Ly6Chi or 
Ly6Clo monocytes sorted from pooled bone marrow, blood, and spleen were adoptively 
transferred by i.v. injection to CD45.2+ mice at the time of DWC surgery. (B) Monocytes 
were sorted based on CD11b+SSCloLy6G-Zombie- expression and Ly6ChiCD43lo 
expression or Ly6CloCD43hi expression. (C) Macrophage subpopulations in dorsal tissue 
at 3 days post injury were immunophenotyped as MerTK+CD64+ or F4/80+CD11b+ and 
characterized for CD301b and CD206 surface expression. Monocyte subpopulations in 
dorsal tissue were immunophenotyped as CD11b+SSClo and characterized for Ly6C and 
CD43 surface expression.  (D) Donor-derived cells were identified in dorsal tissue 3 days 
post-injury as CD45.1+CD45.2-. (E) Total donor cells per milligram of tissue in mice 
receiving Ly6Chi or Ly6Clo monocytes. (F) Frequency of donor-derived 
CD301b+CD206+ macrophages (CD11b+F4/80+) in mice receiving adoptive transfer 
Ly6Clo monocytes compared to mice receiving Ly6Chi monocytes. (G) Frequency of 
donor-derived CD301b-CD206+ macrophages (CD11b+F4/80+). Data presented as mean 
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± S.E.M. Statistical analyses were performed using two-tailed t-tests *p<0.05, n=5-6 
animals per group. 
 
Figure 12.  CD64+MerTK+ macrophage population overlaps with F4/80+ 
macrophage populations.  (A) CD64+MerTK+is a more discriminating macrophage 
population within F4/80+CD11b+ cells. 25.3 ± 2.1% of all F4/80+CD11b+ cells are 
CD64+MerTK+; however, nearly all donor-derived F4/80+ cells are CD64+MerTK+ 
(90.0 ± 3.8%). (B) No differences in the number of donor-derived F4/80+ or (C) 
CD64+MerTK+ macrophages per milligram of tissue were detected in mice receiving 
adoptive transfer Ly6Clo monocytes compared to mice receiving Ly6Chi monocytes. (D) 
A higher frequency of donor-derived CD301b+CD206+ macrophages (CD64+MerTK+) 
were detected in mice receiving adoptive transfer Ly6Clo monocytes compared to mice 
receiving Ly6Chi monocytes. (E) No differences in the frequency of donor-derived 
CD301b-CD206+ macrophages (CD64+MerTK+) were detected in mice receiving 
adoptive transfer Ly6Clo monocytes compared to mice receiving Ly6Chi monocytes. Data 
presented as mean ± S.E.M. Statistical analyses were performed using two-tailed t-tests 
*p<0.05, n=5-6 animals per group. 
 
3.4.4 On-site delivery of FTY720 promotes accumulation of CD206+ 
macrophages.  
We have previously demonstrated that localized delivery of the small molecule 
FTY720 from PLGA thin films enhances the recruitment of Ly6Clo monocytes to inflamed 
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peri-implant tissue and supports arteriogenesis [34, 97]. We explored the fate of specific 
blood monocyte populations in response to localized immune modulation by selectively 
labeling Ly6Clo and Ly6Chi monocytes followed by implantation of FTY720-loaded PLGA 
films in the DWC.  
 
Figure 13.  On-site delivery of FTY720 recruits blood-derived non-classical 
monocytes and increases the frequency of alternatively activated macrophages. 
PLGA films loaded with FTY720 were implanted immediately after DWC surgery. 
(A) Proportion of latex bead-positive (LX+) Ly6Clo monocytes that were derived from 
blood in tissue 3 days post-injury following labeling of Ly6Clo monocytes. (B) Overall 
frequency of CD206+ macrophages in the presence of FTY720. (C) Proportion of LX+ 
Ly6Chi monocytes that were derived from blood following labeling of Ly6Chi monocytes 
with Clod Lip. (D) Overall frequency of CD206+ macrophages in the presence of 
FTY720 after Clod Lip administration. Data presented as mean ± S.E.M. Statistical 
analyses were performed using two-tailed t-tests. *p<0.05, n=4-10 animals per group. 
Though statistically insignificant, a trend of increased frequency of blood-derived 
Ly6Clo monocytes was observed with on-site delivery of FTY720 compared to blank 
implant (Figure 13A). FTY720 increased the frequency of CD206+ macrophages within 
injured tissue 3 days post-surgery (Figure 13B). Selective labeling of Ly6Chi monocytes 
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demonstrates that FTY720 does not increase the frequency of circulation-derived Ly6Chi 
monocytes in tissue when Ly6Clo blood monocytes are reduced with clodronate liposomes 
(Figure 13C). We observed no changes in the frequency of total CD206+F4/80+CD11b+ 
cells (Figure 13D), suggesting that FTY720 is unable to increase the number of 
alternatively activated macrophages after reduction of circulating Ly6Clo monocytes.  
To investigate the molecular mechanisms of FTY720-mediated recruitment, we 
probed non-classical monocytes for expression of the sphingosine-1-phosphate receptor 3 
(S1PR3), at which FTY720 exhibits agonist activity. We have previously demonstrated 
that FTY720 requires S1PR3 expression on hematopoietic cells in order to promote 
arteriogenic remodeling[34]. In addition to Ly6C, CX3CR1 (the fractalkine receptor) can 
be used to distinguish classical and non-classical blood monocytes[98]. While CXC3CR1 
is difficult to detect using antibody-based methods, CX3CR1GFP/+ transgenic mice enable 
real-time assessment of monocyte subset identity. CX3CR1hi monocytes primarily overlap 
with the Ly6Clo monocyte population, and conversely, CX3CR1lo monocytes are primarily 
Ly6Chi (Figure 14A). S1PR3 surface expression is selectively higher on CX3CR1hi blood 
monocytes (Figure 14B, C), which indicates that elevated S1PR3 expression is a signature 
of non-classical monocytes and is consistent with our previous studies that demonstrated 
higher S1PR3 mRNA and total protein in Ly6Clo monocytes[34]. Taken together, FTY720 
likely increases the tissue content of CD206+ macrophages by recruiting circulating 
S1PR3hi non-classical monocytes from circulation. 
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Figure 14. Sphingosine-1-phosphate receptor 3 (S1PR3) expression is upregulated 
on non-classical monocytes.  (A) Ly6C expression in CX3CR1hi monocytes and 
CX3CR1lo monocytes obtained from the blood of CX3CR1GFP/+ mice identify Ly6Clo 
monocytes and Ly6Chi monocytes, respectively. (B, C) Surface S1PR3 expression in 
blood CX3CR1hi cells and CX3CR1lo cells. To control for background staining, 
CX3CR1GFP/+ cells were stained with secondary antibody (2º Ab) only, which is shown in 
the gray histogram. Data presented as mean ± S.E.M. Statistical analyses were performed 
using two-tailed t-tests. *p<0.05, n=4 animals per group. 
3.4.5 FTY720 recruits non-classical monocytes that promote vascular network 
expansion after arteriole ligation.  
 The recruitment kinetics, fate, and function of myeloid cells during inflammation 
is heavily dependent on the specific type of tissue injury [30, 33]. Consequently, we sought 
to determine whether application of FTY720-loaded materials to ischemic muscle injury 
produces similar patterns of immunomodulation. Feeder arteriolar vessels within the 
murine spinotrapezius muscle were ligated in CX3CR1GFP/+ mice and unloaded or 
FTY720-loaded PLGA films were implanted over the muscle immediately after injury. We 
observed a decrease in the overall area of CX3CR1hi cells in FTY720-treated animals 3 
days post-injury (Figures 15 A, B). Conversely, we observed more CD206+ cells (Figure 
15C) and the area ratio of CD206+ cells to CX3CR1hi cells was higher in FTY720-treated 
animals (Figure 15D).  
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Figure 15.  FTY720 increases CD206+ macrophages after arteriole ligation in the 
spinotrapezius muscle. (A) Immunofluorescence of muscle tissue 3 days after ligation of 
spinotrapezius muscle arterioles in CX3CR1GFP/+ mice shows accumulation of CX3CR1hi 
monocytes (top) and CD206+ macrophages (blue, bottom) to lectin-stained vasculature 3 
days post-ligation. (B) % area of CX3CR1hi cells and (C) CD206+ cells in muscle tissue 
treated with unloaded PLGA or FTY720-loaded PLGA 3 days post-ligation. (D) Area 
ratio of CD206+ to CX3CR1hi cells. Data presented as mean ± S.E.M. Statistical analyses 
performed using two-tailed t-tests. *p<0.05, n=25-27 FOVs from 5 animals per group. 
Scale bars, 50µm. 
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Previous work has demonstrated that monocytes differentiate into alternatively activated 
macrophages in vascular niches[70]. We investigated the localization of CX3CR1hi and 
CD206+ cells with respect to lectin-perfused vasculature.  Fewer CX3CR1hi cells (Figure 
16A), but more CD206+ cells (Figure 16B) were found within 50μm of blood vessels in 
FTY720-treated animals, which is consistent with perivascular conversion of non-classical 
monocytes into alternatively activated macrophages. Additionally, FTY720-treated 
animals had a greater vessel density and total length of arterioles 3 days after ligation 
(Figure 16 D-E).  
 
Figure 16.  FTY720 promotes vascular network expansion after arteriole ligation in 
spinotrapezius muscle. (A) Number of CX3CR1hi cells and (B) CD206+ cells within 
50μm of blood vessels. (C, D) Total density of lectin+ blood vessels and (E) the length of 
arterioles in the spinotrapezius muscle treated with FTY720 3 days post-ligation. Data 
presented as mean ± S.E.M. Statistical analyses performed using two-tailed t-tests. 
*p<0.05, n=25-27 FOVs from 5 animals per group. Scale bars, 100µm. 
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3.5 Discussion 
Monocytes are blood-borne mononuclear phagocytes that support tissue 
homeostasis and exit the vasculature at increased rates to differentiate into macrophages 
during inflammation. The precise relationship of circulating classical and non-classical 
monocyte subsets to defined macrophage populations remains unknown. We have shown 
that after skin wounding and biomaterial implantation, circulating non-classical S1PR3hi 
monocytes extravasate into inflamed tissue and serve as biased progenitors of 
CD206+CD301b+ wound healing macrophages. Previous work has demonstrated that 
classical monocytes directly convert to non-classical monocytes and macrophages within 
inflamed tissue[29, 89]. Therefore, these studies elucidate a complementary role for non-
classical monocytes and argue that these cells primarily differentiate into alternatively 
activated macrophages.  Biomaterial-mediated strategies that increase recruitment of non-
classical monocytes through S1PR signaling are a promising strategy to increase 
accumulation of alternatively activated, wound healing macrophages (Figure 7).  
Intravascular non-classical Ly6Clo monocytes orchestrate the disposal of necrotic 
endothelial cells after activation with TLR7-targeted danger signals during 
inflammation[12, 99], whereas extravascular Ly6Clo monocytes can promote angiogenesis 
and matrix remodeling via secretion of VEGF and matrix metalloproteinases[33]. The 
unique protein signature of non-classical monocytes, characterized by higher VEGF, 
TGFβ, and IL-10, and lower TNFα and IL-1β expression compared to classical monocytes 
has resulted in the suggestion that these cells may constitute a class of “anti-inflammatory” 
monocytes[29, 33]. Previous studies have indicated that Ly6Clo monocytes in inflamed 
tissues such as skeletal muscle and focal hepatic injury are derived from cells recruited as 
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Ly6Chi monocytes from the blood and are converted in situ to Ly6Clo monocytes to promote 
wound healing and tissue repair[29, 89]. Other reports suggest that Ly6Clo monocytes are 
directly and robustly recruited from the blood, leading to extravascular accumulation 
during inflammation[12, 33, 35]. While we observed that blood-derived Ly6Chi monocytes 
enter inflamed tissue, reduce Ly6C expression (Figure 6A), and differentiate into 
macrophages (Figure 6 B,C), our studies indicate that Ly6Clo monocytes are also directly 
recruited from circulation to injured tissues and able to give rise to macrophages (Figure 
6). Previous studies have indicated that adoptively transferred Ly6CloMHCII- monocytes 
do not infiltrate the skin[13], but this may be a result of differences in the grafted cell 
population (Ly6CloMHCII- monocytes vs. Ly6CloCD43hi monocytes in our studies) or 
inflammatory stimuli (LPS injection vs. excisional skin injury). Though we observed a 
decrease in Ly6Clo blood monocytes after clodronate liposome administration, we did not 
detect a difference in the frequency of Ly6Clo monocytes within injured skin. Many studies 
have shown that Ly6Chi monocytes can convert to Ly6Clo monocytes in the blood or 
tissue[22, 29, 31]. Similarly, our data may reflect that, in the absence of Ly6Clo monocytes, 
circulation-derived Ly6Chi monocytes compensate and increase their rate of conversion 
into Ly6Clo monocytes in inflamed tissue. 
An important finding of our work is that circulating Ly6Clo monocytes 
preferentially contribute to the CD206+ wound macrophage pool within skin injury 
compared to Ly6Chi monocytes. Analysis of peri-implant tissue for recruited latex bead-
labeled Ly6Clo monocytes shows that this subset is predisposed to acquire a CD206+ 
alternatively activated M2-like[100] macrophage phenotype (Figure 6C). Administration 
of clodronate liposomes enables selective labeling of Ly6Chi monocytes, while 
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simultaneously reducing the frequency of Ly6Clo monocytes for 2-7 days after 
administration[22, 93]. Clodronate liposome-treated animals displayed no change in the 
frequency of overall macrophages within the skin injury after 3 days, but exhibited a 
decrease in the proportion of CD206+ macrophages (Figure 8C). Because tissue monocyte 
composition was unaffected by clodronate liposomes, these results may reflect a delay in 
generation of CD206+ macrophages. We cannot exclude the possibility that transient 
monocyte depletion alters myeloid cell responses and recruitment during inflammation, as 
monocyte subsets are known to communicate with each other[17].  
Latex bead-based labeling strategies are useful because they overcome many of the 
limitations of adoptive transfer, including ex vivo cell manipulation, pooling of donor cells, 
and low sensitivity due to poor cell recovery[101]. Importantly, there is no evidence that 
these labeling techniques alter monocyte recruitment or systemic inflammation[101].  
However, our interpretation of these studies relies on retention of latex beads within the 
cell that was originally labeled and no transfer to other cells. Therefore, cell tracking is best 
performed by use of complimentary tracking methods, including adoptive transfer, 
selective labeling techniques, and transgenic or knockout mice. We adoptively transferred 
5.55x105 CD45.1+ Ly6Chi or Ly6Clo monocytes by intravascular injection into CD45.2 
mice at the time of DWC surgery. We did not detect differences in the total number of 
CD45.1+ donor-derived cells per milligram of dorsal tissue between the two monocytes 
grafts, and further probed for markers of macrophage differentiation and polarization 
within donor cells. CD301b+CD206+ macrophages drive midstage skin regeneration by 
promoting fibroblast repopulation, cellular proliferation, and re-epithelialization[95]. In 
our adoptive transfer studies, a higher frequency of donor Ly6Clo monocytes acquired a 
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CD301b+CD206+ macrophage phenotype compared to donor Ly6Chi monocytes (Figure 
11F), indicating that circulation-derived Ly6Clo monocytes may be intrinsically 
predisposed to convert to dermal wound healing macrophages. Conversely, there was no 
difference in the frequency of donor-derived CD301b-CD206+ or number of total 
macrophages between mice receiving Ly6Chi or Ly6Clo monocytes (Figure 11G, Figure 
12). These data, along with the observation that FTY720 administration increases CD206+ 
macrophages within injured skin (Figure 13), further supports the hypothesis that non-
classical monocytes undergo local conversion into alternatively activated macrophages. 
While macrophages are key mediators of the host response to implanted materials 
that govern the integration of implants into host tissue[102, 103], the role that their 
monocytic precursors play in regulating implant outcome has been largely unexplored. In 
our studies, around 45% of monocytes surrounding PLGA implants were Ly6Clo/int. In 
previous work[67], we demonstrated that around 40% of monocytes around heparin-
containing PEG hydrogels were Ly6Clo/int. While lymphocyte, granulocyte, and 
macrophage accumulation are impacted by the type of material implanted[104], future 
studies are needed to determine how different classes of materials impact infiltration of 
monocyte and macrophage subsets. Interestingly, we observed model-specific differences 
in the kinetics of monocyte recruitment during FTY720 delivery. While FTY720 increases 
the frequency of Ly6Clo monocytes 3 days after skin wounding[34] (Figure 13A), we 
observed a decrease in CX3CR1hi monocytes 3 days after arteriole ligation in the 
spinotrapezius muscle (Figure 15B). The progression of inflammation may be expedited 
during ischemia because of the need to rapidly restore blood supply and oxygen transport. 
FTY720 increases the frequency of F4/80+CD206+ macrophages both in wounded skin 
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(Figure 13B) and CD68+CD206+ macrophages in ischemic muscle (Figure 15C). 
Previously, we have detected more M2-like macrophages within mandibular bone defects 
3 weeks after implantation of FTY720-loaded polymer nanofibers[61]. Taken together, 
these findings suggest that FTY720 delivery from different biomaterials can enhance pro-
regenerative myeloid cell recruitment, but the kinetics may vary depending on the type of 
injury.  
We found that ischemic muscles treated with FTY720 have increased numbers of 
perivascular CD206+ cells located (Figure 16B), which coincided with increased arteriolar 
length and total vessel density (Figure 16C-E). FTY720 likely acts on both immune cells 
and the endothelium, as loss of S1PR3 in hematopoietic or parenchymal cells impairs 
FTY720-induced arteriogenic remodeling[34]. Delivery of FTY720 similarly induced both 
increased accumulation and perivascular localization of alternatively activated 
macrophages after volumetric muscle loss, which was accompanied by enhanced re-
vascularization and muscle healing[105]. Consequently, both the phenotype of monocytes 
and macrophages, as well as their spatial distribution is likely an important feature when 
assessing their function.  
3.6 Conclusions 
Taken together, our studies shed light on the functions of non-classical monocytes 
during inflammation and wound healing. Monocytes and macrophages are increasingly 
appreciated for their roles in regulating tissue homeostasis and coordinating repair after 
damage. Acute modulation of the inflammatory response has been shown to regulate repair 
of tissue at longer time scales, including bone[61] and skeletal muscle[29]. An 
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understanding of the origin of monocyte and macrophage populations during wound 
healing and the cues governing their in situ fate is critical to harnessing endogenous 
mechanisms of repair. The work in this chapter establishes non-classical monocytes as 
biased progenitors of alternatively activated wound healing macrophages. We will  
leverage this knowledge in the next two chapters to develop next-generation 
immunoregenerative biomaterials capable of finely tuning the inflammatory response 




4. SELECTIVE RECRUITMENT OF NON-CLASSICAL 
MONOCYTES PROMOTES SKELETAL MUSCLE REPAIR 3 
4.1 Abstract 
Regeneration of traumatic defects in skeletal muscle requires the synchronized 
behavior of multiple cells that participate in repair. The inflammatory cascade that is 
rapidly initiated after injury serves as a powerful node at which to guide the progression of 
healing and influence tissue repair. Here, we examine the role that myeloid cells play in 
the healing of traumatic skeletal muscle injury, and leverage their pro-regenerative 
functions using local delivery of the immunomodulatory small molecule FTY720. We 
demonstrate that increasing the frequency of non-classical monocytes in inflamed muscle 
coincides with increased numbers of CD206+ alternatively activated macrophages. 
Animals treated with immunomodulatory materials had greater defect closure and more 
vascularization in the acute phases of injury. In the later stages of repair, during which 
parenchymal tissue growth occurs, we observed improved regeneration of muscle fibers 
and decreased fibrotic tissue following localization of pro-regenerative inflammation. 
These results highlight non-classical monocytes as a novel therapeutic target to improve 
the regenerative outcome after traumatic skeletal muscle injury. 
                                                 
3 Portions of this chapter adapted from: San Emeterio CL, Olingy CE, Chu Y, Botchwey 
EA. Selective recruitment of non-classical monocytes promotes skeletal muscle repair. 
Biomaterials. 2017;117:32-43. License No. 4143750636563 
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4.2 Introduction 
Recovery of traumatic skeletal muscle injury relies on precise regulation of the 
inflammatory cascade that is initiated immediately after injury. While muscle progenitor 
cells called satellite cells directly differentiate into muscle fibers to regenerate injured 
skeletal muscle [5], their success is dependent on supportive cues from innate immune 
cells, such as monocytes and macrophages, that are acutely recruited to damaged tissue and 
remain until repair is complete [29, 37, 41]. Monocytes and macrophages are phagocytes 
that are highly sensitive to inputs from their  microenvironment and can synthesize this 
information to direct healing processes [59, 89]. In vivo, monocyte subsets appear 
sequentially after injury, with classical, inflammatory monocytes accumulating in the 
muscle after the onset of injury and peaking at around one day post-injury [29]. Non-
classical, anti-inflammatory monocytes numbers steadily rise thereafter, and return to 
baseline once regeneration is complete [29]. Monocyte recruitment following the onset of 
injury is crucial for repair, as multiple studies have shown that depletion of circulating 
monocytes before toxin-induced muscle injury results in incompletely healed, fibrotic 
muscle [29, 37, 41].  
Following extravasation from blood, recruited monocytes may transiently remain 
monocytes [56] or differentiate into macrophages that persist through the resolution of 
inflammation [29, 42, 88]_ENREF_6. Macrophages designated as classical inflammatory 
“M1” macrophages predominate early after injury, while alternatively-activated “M2” 
macrophages (AAMs) orchestrate the later phases of tissue repair. Inflammatory 
macrophages respond to tissue damage signals and upregulate genes associated with 
alarmins and acute inflammatory-phase proteins [106]. Later during the inflammatory 
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response, AAMs are a potent source of insulin-like growth factor (IGF-1) required for 
muscle regeneration [48] and highly express genes encoding extracellular matrix (ECM) 
and ECM remodeling proteins [106]. Though some resting tissues such as the lung, liver, 
and brain have macrophage populations that are seeded embryonically [15, 17], skeletal 
muscle possesses very few macrophages during homeostasis [29]. Upon inflammatory 
insult, circulating classical monocytes are recruited to muscle injury and substantially 
contribute to the wound macrophage pool [29]. However, whether non-classical monocytes 
are directly recruited to volumetric skeletal muscle injury or play a role in repair remains 
unknown.  
Knowledge of how different myeloid populations affect tissue micro-compartments 
within injured muscle is especially important in a volumetric defect context in which all 
tissue architecture must be regenerated de novo. Deposition of new ECM provides 
scaffolding for nascent vasculature [107], and AAMs have been shown to control collagen 
fibril formation in regenerating skin [53] and promote ECM deposition by fibroblasts [54]. 
However, the unchecked activity of AAM in chronic muscle inflammation can perpetuate 
fibrosis [55], which impairs restoration of native mechanical properties [108]. Muscle 
tissue must also be revascularized in order to provide necessary oxygen, nutrients, and 
metabolic waste removal. AAMs promote angiogenesis [63, 65] and arteriogenesis [109], 
distinct processes that regulate post-injury vascular remodeling.  Additionally, failure to 
reinnervate skeletal muscle after injury results in muscle fiber atrophy [110] that 
significantly impairs motor function. Increasing AAMs in peripheral nerve transections by 
hydrogel-based delivery of IL-4 enhances both Schwann cell infiltration and axonal growth 
[111]. Consequently, biomaterial-based strategies that increase the number of AAMs 
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within volumetric muscle loss are a promising approach to enhance endogenous programs 
of muscle repair.  
Sphingosine-1-phosphate (S1P) is a pleiotropic bioactive signaling lipid that is 
produced endogenously by red blood cells, platelets, and endothelial cells [112]. S1P 
activates signaling through five known G protein-coupled receptors, S1PR1-5, which are 
differentially expressed in almost every cell type. We have previously demonstrated that 
non-classical anti-inflammatory Ly6Clo monocytes express relatively high levels of 
S1PR3, which they leverage to exert pro-regenerative effects in vivo [113]. Local delivery 
of FTY720, a small molecule agonist of S1P1 and S1PR3-5, selectively recruits non-
classical Ly6Clo monocytes upon local delivery to inflamed skin injuries and promotes 
arteriogenic microvascular growth in an S1PR3-dependent manner. Release of FTY720 
from polymer nanofibers to mandibular bone defects increases the frequency of AAMs, 
promotes  re-vascularization, and facilitates boney ingrowth [61]. Thus, S1PR3 has 
emerged as a therapeutic target that can orchestrate the inflammatory response and 
subsequent healing of musculoskeletal injuries. 
In this work, we explore the role of specific monocyte and macrophage populations 
after volumetric muscle loss. Using a novel model of volumetric muscle injury within the 
murine spinotrapezius muscle, we demonstrate that biomaterial-based delivery of FTY720 
increases anti-inflammatory Ly6Clo monocytes and amplifies the number of CD206+ 
AAMs. The localization of pro-regenerative inflammation in the injured skeletal muscle 
increases the kinetics of wound healing, leading to earlier vascularization and collagen 
deposition. Additionally, we observed improved regrowth of muscle fibers at later time 
points and less fibrotic collagen architecture within regenerated tissue.  These results 
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indicate that immunomodulatory biomaterials that target specific monocyte populations 
can coordinate favorable healing outcomes within volumetric skeletal muscle injuries.  
4.3 Materials and Methods 
4.3.1 Film fabrication  
Films were fabricated as previously described [113]. Briefly, 350 mg PLGA (50:50 
DLG 5E – Evonik Industries) was added to 2 ml dichloromethane in a glass scintillation 
vial and vortexed on high-speed for 30 minutes. For drug loaded films, 1.75 mg of FTY720 
(Cayman Chemical) was added at a 1:200 drug:polymer weight ratio, and polymer solution 
was vortexed until completely incorporated. The polymer solutions were then poured into 
Teflon-coated petri dishes and dried at -20°C for 7 days. Films were lyophilized overnight 
before implantation to remove any traces of solvent. 
4.3.2 Spinotrapezius volumetric muscle loss model 
All animal procedures were conducted according to protocols approved by the 
Georgia Institute of Technology Institutional Animal Care and Use Committee. Male 
C57BL/6J (The Jackson Laboratory) or B6.129P-Cx3cr1tm1Litt/J mice (CX3CR1GFP/+) 
(The Jackson Laboratory) of age 8-12 weeks old were used for all animal studies. A 1mm 
full thickness defect in the spinotrapezius muscle was created as follows. The dorsum of 
the mouse was shaved and hair removal cream applied to completely remove hair. Skin 
was sterilized with three washes of 70% ethanol and chlorhexidine. A longitudinal 1 inch 
incision (cranial to caudal) was made just after the bony prominence of the shoulder blade. 
The overlying fascia was dissected away and the spinotrapezius muscle identified. Using 
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flat-tipped tweezers, the edge of the spinotrapezius was lifted up. The muscle was reflected 
and positioned against a sterile piece of wood. A 1mm biopsy punch was made through the 
muscle, using the wooden piece as support. The muscle was replaced and 1.5 mm implant 
placed over the punch defect. The incision was closed with mouse wound clips. 
4.3.3 RAW264.7 macrophage and C2C12 myoblast culture and 
immunohistochemistry 
RAW264.7 macrophages (ATCC) were maintained in growth media (DMEM 
supplemented with 10% fetal bovine serum (FBS), 1% sodium pyruvate, 1% L-glutamine, 
1% penicillin/streptomycin) according to manufacturer protocols. To generate RAW 264.7 
macrophage conditioned media (CM), RAW 264.7 macrophages were treated 18 hours 
with polarization cytokines. For M(IFN-γ, LPS) polarization, cells were treated with 
1μg/ml LPS (Sigma) and 20 ng/ml IFN-γ (Peprotech). For M(IL-4) polarization, cells were 
treated with 10 ng/ml IL-4 (Peprotech). Polarization media was removed after treatment, 
cells were washed with phosphate-buffered saline (PBS), fresh RAW264.7 media was 
replaced into the wells. Cells were allowed to condition media for an additional 24 hours.  
C2C12 cells (ATCC) were maintained in growth media (DMEM supplemented with 10% 
FBS, 1% sodium pyruvate, 1% L-glutamine, 1% penicillin/streptomycin) according to 
manufacturer protocols. To investigate the effects of polarized macrophage soluble factors 
on C2C12 myogenic differentiation, C2C12 cells were cultured on fibronectin-coated glass 
coverslips in 50% C2C12 differentiation media (DMEM supplemented with 2% horse 
serum, 1% sodium pyruvate, 1% L-glutamine, 1% penicillin/streptomycin), and 50% RAW 
264.7 CM for 5 days, with daily media change. At the 5 day timepoint, cells were fixed in 
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4% paraformaldehyde (PFA), permeabilized with 0.1% Triton-X, and blocked using 5% 
goat serum for 1 hour. Cells were stained with myosin heavy chain antibody (MF-20, 
DSHB) overnight at 4°C in humidity chamber. Cells were washed, then stained with 
Dylight 488-conjugated anti-chicken antibody for 1 hour at room temperature. Cells were 
washed, counterstained with DAPI, then overturned onto glass slides with Vectashield 
mounting media (Vector Labs). Cells were imaged on a Zeiss LSM 700 confocal 
microscope. A total of 12 field of views (640.2m x 640.2m) were used for 
histomorphometric analysis of myosin heavy chain-positive cells. 
4.3.4 Labeling of blood Ly6Clo monocytes in CX3CR1GFP/+ mice  
In order to visualize cells within injured muscle originating as circulating Ly6Clo 
monocytes, CX3CR1GFP/+ mice were administered Fluoresbrite® Polychromatic Red latex 
beads (0.5μm, Polysciences) intravenously 1 day prior to surgery via jugular vein injection. 
Prior to injection, latex beads were diluted 1:25 in sterile saline as previously described 
[101]. Labeling was confirmed by retro-orbital blood draw immediately prior to surgery (1 
day after bead administration) and subsequent flow cytometry analysis. 
4.3.5 Flow cytometry 
To collect blood (days 0, 3 and 7) and tissue for flow cytometry analysis (days 1, 3, and 7), 
mice were euthanized via CO2 asphyxiation. Blood was then collected via cardiac puncture. 
Red blood cells were lysed in ammonium chloride (1 part blood, 9 parts ammonium 
chloride) prior to immunostaining for flow cytometry. For characterization of myeloid cell 
composition in spinotrapezius muscles without an implant, a 6mm biopsy punch of muscle 
tissue centered on the defect was taken. For studies with an implant (unloaded or FTY720-
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loaded), the entire spinotrapezius muscle was collected. Spinotrapezius muscles were 
harvested and digested in collagenase I (Sigma) for 45 minutes at 37C. The digested 
muscles were filtered through a cell strainer to obtain a single cell suspension. The standard 
recovery of cells from a 6mm biopsy of the spinotrapezius muscle is 5501±1965 cells/mg 
tissue (measured in similar, but unrelated studies). Single-cell suspensions from were 
stained for flow cytometry analysis in 3% FBS according to standard procedures and 
analyzed on a FACS AriaIIIu flow cytometer (BD Biosciences). The following antibodies 
were used for cell phenotyping: BV510-conjugated anti-CD11b (BioLegend), PerCP 
eFluor-710-conjugated anti-CD115 (eBioscience), APC-Cy7 conjugated anti-CD11b 
(BioLegend), BV421-conjugated anti-CD11c (BioLegend), APC conjugated anti-Ly6C 
(BioLegend), PE-Cy7 conjugated anti-GR-1 (BioLegend), BV711-conjugated anti-CD64 
(BioLegend), PE-conjugated anti-MerTK (R&D Systems), APC-Cy7-conjugated anti-
Ly6G (BioLegend), PE-Cy7-conjugated anti-CD206 (BioLegend).  
4.3.6 Whole mount immunohistochemistry of muscle tissue  
Mice were euthanized 3 or 7 days after surgery via CO2 asphyxiation. For lectin-based 
labeling of the vasculature in CX3CR1GFP/+ mice, Alexa Fluor 568 isolectin IB4 (1mg/mL, 
Life Technologies) was diluted (50μL of isolectin, 150μL saline) and administered by 
jugular vein injection 15 minutes prior to euthanasia. Post-euthanasia, mouse vasculature 
was perfused with warm saline followed by 4% PFA until tissues were fixed. The entire 
spinotrapezius muscle was explanted and permeabilized overnight with 0.2% saponin, then 
blocked overnight in 10% mouse serum. For immunofluorescence, tissues were incubated 
at 4˚C overnight in a solution containing 0.1% saponin, 5% mouse serum, 0.5% bovine 
serum albumin, and the following conjugated fluorescent antibodies: PE anti-CD31 
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antibody (1:100 dilution, eBioscience), Alexa Fluor 488 anti-CD206 (1:200 dilution, ABD 
Serotec), and Alexa Fluor 647 anti-CD68 (1:200 dilution, ABD Serotec). For desmin 
immunostaining, identical tissue processing procedures were followed and muscles were 
incubated overnight with Alexa Fluor 488 anti-desmin (1:200 dilution, Abcam) alone or in 
combination with PE anti-CD31 and Alexa Fluor 647 anti-CD206 (1:200 dilution, 
BioLegend). Following immunostaining, tissues were washed 4 times for 30 minutes each, 
and then mounted in 50/50 glycerol/PBS.  
4.3.7 Imaging and quantification of whole mount immunohistochemistry  
Tissues were imaged on a Zeiss LSM 710 NLO confocal with acquisition parameters kept 
identical across all animals. For collagen imaging, a two-photon chameleon laser (tuned to 
λ=810nm) and collection range of 380-420nm was utilized with acquisition parameters 
kept identical across animals. Z-stacks were collected from the beginning to end of 
collagen signal visible across the entire x-y plane analyzed. Max intensity projections were 
generated from 3D confocal images for 2D analysis in Zen software (Zeiss). Quantification 
of vascularization and collagen deposition was performed in ImageJ software (NIH).  An 
elliptical region of interest (1.370mm high by 1.778mm wide) was centered over each 
defect and the image was thresholded to display only areas of positive fluorescence signal. 
The number of pixels positive for the fluorescence channel of interest was normalized to 
the total area of the region of interest. In Figures 1 and 6, defect area was determined by 
tracing the edges of desmin-positive immunostaining to outline the desmin-negative area. 
The defect area was identified as the area that was desmin-negative. In Figure 5, the 
percentage of cell infiltration was determined by tracing the border between lectin- or 
CD31-positive regions and the avascular zone. The area of this region was measured. A 
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secondary trace between the cellular (CX3CR1+ or CD206+) region and acellular zone 
was made. The area of this region was measured and subtracted from first measurement to 
measure the region of cell infiltration into the defect. This value was normalized to the first 
measurement. In Figure 6, “void area” was measured by tracing the edges of collagen-
positive signal and identifying void area as the area that is collagen-negative. 2D fiber 
diameter was determined by measuring the widest portion of each regenerated muscle fiber 
(determined based on the morphology of desmin-positive regions) within the defect region 
from the day 7 2D maximum intensity projections.  
For 3D analysis in Imaris (Bitplane), 1 crop per animal of 332x332µm was taken from the 
area adjacent to the defect to show immune cell distribution in the close surrounding tissue. 
Crops were chosen based on matching anatomical vessel morphology from both 
CX3CR1GFP/+ images and the subsequently stained CD206, CD68, and CD31 images. 
Simultaneous visualization of CX3CR1-GFP cells with immunohistochemical markers is 
not possible due to leakage of GFP from the cells following permeabilization. Therefore, 
imaging of CX3CR1-GFP spinotrapezius muscles occurred immediately after perfusion 
fixation and further immunostaining was performed as described in the previous methods 
section. Cells co-expressing CD68 and CD206 were identified in Imaris using the surface 
tool. CD68+ surfaces were identified by smoothing with a 1.5μm grain size and an 
automatic threshold on absolute intensity. Touching objects were split using a seed points 
diameter of 13.8μm. Cells that co-expressed two markers were identified by applying an 
additional filter to select surfaces with a high fluorescence intensity in the CD206 channel 
(above 17.7 mean intensity). Vessels were identified in Imaris by drawing a surface on the 
CD31 fluorescent channel with a 1.66μm grain size, manually-selected threshold value 
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(determined based on each image), and manually-selected volume filter to remove small 
debris. To calculate the distance between CD68+CD206+ cells and the nearest blood 
vessel, a distance transformation was applied to CD31+ vessel surfaces and the median 
position of each CD68+CD206+ cell within this plane was recorded.  
4.3.8 Statistical analysis 
Data are presented as mean ± standard error of the mean (S.E.M.), unless otherwise noted. 
All statistical analysis was performed in GraphPad Prism software. For pairwise 
comparisons, unpaired t-test (according to experimental design) with Welch’s correction if 
variance was significantly different was used. For grouped analyses, two-way ANOVA 
with Sidak's post-test was used for multiple comparisons. Unless otherwise noted, p<0.05 
was considered statistically significant.  
4.4 Results 
4.4.1 Full-thickness defect in the murine spinotrapezius muscle results in 
dynamic myeloid cell kinetics both locally and systemically. 
In order to better model clinical muscle loss induced by trauma or surgery, we developed 
a novel model of volumetric muscle loss (VML) in the murine spinotrapezius (Figure 1A). 
The spinotrapezius muscle is a stabilizing muscle in the mouse dorsum that is extremely 
thin (60-200m) [114, 115], enabling the use of three-dimensional (3D) confocal 
microscopy to examine tissue microstructures. A 1mm circular defect in the spinotrapezius 
muscle heals over the course of 7 days, as observed by desmin immunostaining of muscle 
fibers (Figure 17).  
 72 
 
Figure 17.  Volumetric muscle loss in the murine spinotrazpeius. (A, B) A 1 mm 
circular volumetric defect made in the spinotrapezius of wildtype mice heals over 7 days, 
as quantified by (C) desmin immunostaining. Data presented as mean ± S.E.M. Statistical 
analyses were performed using two-tailed t-tests. *p < 0.05, n = 4–5 animals per group. 
Consequently, removal of a 1mm diameter muscle defect is not critical-sized, but enables 
investigations into the mechanisms, rate, and quality of muscle repair. We examined 
healing at the defect edge, specifically focusing on granulation tissue formation and 
myofiber ingrowth.  
 
Figure 18. VML in the murine spinotrapezius  enables study of cellular interactions 
during muscle healing. A) High-powered 3D images show granulation tissue under 
brightfield microscopy at days 3 and 7 post-injury, coinciding with accumulation of 
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immunostained CD206+ cells. (B) Revascularization (shown by CD31 immunostaining) 
occurs along the defect edge. (C) Merged 3D images show the distribution of CD206+ 
cells among muscle fibers and revascularized muscle tissue. 
Granulation tissue was defined as tissue lacking desmin+ mature muscle fibers, but 
including CD31+ and CD206+ immunostaining, as the proliferative phase of the wound 
healing response involves angiogenesis and the presence of fibroblasts and macrophages, 
the latter of which can express CD206 and play an active role in repair [52, 59, 116]. High 
power images of the defect edge reveals granulation tissue containing CD206+ cells, 
indicating the presence of AAMs (Figure 18A). CD31 immunostaining reveals vessel 
regrowth within the granulation tissue, with CD206+ cells interacting closely with nascent 
vasculature. This revascularization appears to occur before the regrowth of desmin+ 
muscle fibers at day 7 (Figure 18B, C). 
We then investigated the kinetics of myeloid cell trafficking in response to 
spinotrapezius VML injury. The phenotypic complexity of myeloid cells during 
inflammation necessitates understanding baseline healing conditions in order to design 
therapies that leverage their behavior. Blood neutrophils were transiently elevated roughly 
5 fold from baseline 3 days after VML injury (11.92.7% at day 3 vs. 2.10.8% at day 0, 
meanSD as a percentage of all cells), and subsequently decreased (Figure 19A). Blood 
classical Ly6Chi monocytes slowly increased over 7 days (1.00.3% at day 0 compared to 
3.81.6% at day 7), while blood non-classical Ly6Clo monocytes increased more rapidly 
from baseline by 3 days (2.60.8% at day 0 to 8.51.6%) and plateaued at 7 days post-
injury (Figure 19B). Within injured spinotrapezius muscle tissue, neutrophils peaked at 3 
days post-injury (0.70.2% of all cells) and quickly decreased to baseline levels by 7 days 
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post-injury (0.10.3%) (Figure 19C). Ly6Chi monocytes decreased from days 1 (0.71.2%) 
to 7 (0.30.5%), while Ly6Clo monocytes peaked at day 3 (1.50.9%) post-injury and were 
retained at a similar frequency at day 7 (Figure 19D). MerTK and CD64 exclusively 
identify macrophages (MerTK+CD64+) [117], which steadily increase from day 1 
(0.50.6%) to day 7 (3.01.0%) (Figure 19E). CD206+ macrophages also similarly 
increase over time (0.40.6% at day 1 to 2.81.0% at day 7) (Figure 19F). Other cells 
involved in wound healing may express CD206, including fibrocytes [118] and immature 
dendritic cells [119], but further immunophentoyping of these cells is necessary to identify 
other CD206+ populations within injured skeletal muscle. Taken together, our kinetic data 
suggest that neutrophils and Ly6Chi monocytes accumulate in the acute inflammatory 
phase of VML injury, while macrophages, particularly CD206+ AAMs, predominate in the 
later phases of muscle injury and healing.  
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Figure 19.  Spinotrapezius volumetric muscle loss results in dynamic myeloid cell 
kinetics at both the systemic and tissue levels. (A) Following volumetric muscle injury 
in wildtype mice, blood neutrophils peak at day 3 post-injury and return to baseline levels 
by day 7 (blood neutrophils gated on CD11b+SSChiLy6Ghi). (B) Blood 
Ly6Chi monocytes increase over 7 days, while blood Ly6Clo monocytes gradually 
increase and plateau over days 3–7 (blood monocytes gated on 
CD11b+ SSCloCD115+). (C) Neutrophils in injured muscle tissue peak at day 3 and 
decrease by day 7 post-injury (tissue neutrophils gated on CD11b+SSChiLy6GhiMerTK-
CD64-CD11c-). (D) Ly6Chi monocytes in injured muscle tissue decrease from day 1 to 
day 7 post-injury, while Ly6Clo monocytes increase from day 1–3 and decrease by day 7 
(tissue monocytes gated on CD11b+SSCloMerTK-CD64-CD11c-
). (E) MerTK+CD64+ macrophages increase from day 1–7 post-
injury. (F) CD206+ macrophages increase from day 1–7 post-injury. Data presented as 
mean ± S.E.M. Statistical analyses were performed using one-way ANOVA. †p < 0.05 
compared to Day 0 for Ly6Clo monocytes or *p < 0.05 compared to Day 0 for all other 
cell types, n = 4–12 animals per group. 
4.4.2 Non-classical blood monocytes are directly recruited to volumetric muscle 
injury.  
Intravascular administration of latex (LX) beads can be used to track the 
recruitment and fate of circulating monocytes [90, 101]. We administered LX beads one 
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day prior to injury in heterozygous CX3CR1GFP/+ mice, which constitutively express green 
fluorescence protein (GFP) under the CX3CR1 promoter (Figure 21A).  
 
Figure 20. CX3CR1GFP/+ transgenic mice were injected i.v. with rhodamine-labeled 
LX beads 1 day prior to blood draw.  (A, B) Ly6Chi monocytes are predominately 
CX3CR1lo, and Ly6Clo monocytes are predominately CX3CR1hi. (C) LX+ cells are 
Ly6Clo, CXCR1hi (D) LX beads preferentially label Ly6Clomonocytes. Data presented as 
mean ± S.E.M. Statistical analyses were conducted using two-tailed t-tests. *p<0.05, n=3 
animals per group. 
Circulating Ly6CloCX3CR1hi monocytes are selectively labeled with LX beads 1 day after 
injection (Figure 20). During surgery, a 1.5mm poly(lactic-co-glycolic acid) (PLGA) film 
was placed over the defect (Figure 19B) to model biomaterial implantation within VML.  
Accumulation of LX+ cells in injured skeletal muscle tissue was monitored with confocal 
microscopy. Both CX3CR1lo and CX3CR1hi monocytes were present in spinotrapezius 
muscle tissue 3 days post-injury (Figure 21C). Interestingly, a high frequency of LX+ cells 
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were also seen in the muscle tissue, indicating that labeled Ly6Clo monocytes were directly 
recruited from circulation to the injured tissue (Figure 21C). This phenomenon stands in 
contrast to studies conducted using a toxin-induced muscle injury model in which no LX 
bead-labeled Ly6Clo monocytes were recruited from blood [29].  
 
Figure 21. Circulating latex bead-labeled non-classical monocytes are directly 
recruited to injured spinotrapezius muscle. (A) Ly6Clomonocytes were selectively 
labeled by intravenous (i.v.) injection of latex (LX) beads 1 day prior to VML surgery in 
CX3CR1GFP/+ mice. (B) PLGA thin films were acutely implanted over spinotrapezius 
VML defects. (C) Both CX3CR1hi and CX3CR1lo cells, as well as LX+ cells, are 
recruited to the defect 3 days post-injury.  
 
High-power 3D images of immunostained peri-defect muscle tissue at 3 days post-injury 
show LX+ cells spatially co-localizing with CD68+CD206+ cells, an immunophenotype 
indicative of pro-regenerative AAMs (Figure 22). These results suggest direct conversion 
of blood-derived Ly6Clo monocytes into CD206+ macrophages within muscle tissue and 
provide a novel therapeutic target for regulating the accumulation of pro-regenerative 
macrophages in inflamed tissue.  
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Figure 22.  Whole-mount immunofluorescence images of injured spinotrapezius 
muscle receiving blank polymer implant 3 days post-injury. LX beads co-localize 
spatially with immunostained CD68+CD206+ macrophages 3 days post-injury. 
4.4.3 M(IL-4) macrophage conditioned media promotes myogenic 
differentiation of C2C12 myoblasts. 
To more closely probe effects of macrophage phenotype on myogenesis, we 
conducted an in vitro differentiation assay using C2C12 myoblasts treated for 5 days with 
conditioned media from polarized RAW264.7 macrophages stimulated with either LPS and 
IFN- (M(LPS, IFN-)), or IL-4 (M(IL-4)). C2C12 cells treated with M(LPS, IFN-) 
macrophage conditioned media exhibited no differentiation over the course of 5 days 
(Figure 23, Table 1). Conversely, C2C12 cells treated with M(IL-4) macrophage 
conditioned media exhibited high myogenic differentiation, with the presence of several 
multinucleated myotubes in the culture. These results indicate that secreted factors from 
M(IL-4) AAM-like macrophages support myogenesis, and provides further motivation for 
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developing therapeutic strategies that increase this phenotype of macrophage within 
injured muscle. 
 
Figure 23.  Assessment of myogenic differentiation of C2C12 cells in response to 
polarized macrophage conditioned media. Conditioned media from alternatively-
activated macrophages stimulated with IL-4 (M(IL-4)) promotes differentiation of 
C2C12 cells in vitro compared to conditioned media from inflammatory macrophages 
stimulated with LPS and IFN-γ (M(LPS, IFN-γ)). 
Table 1.  Number of Myosin Heavy Chain positive cells in response to macrophage 




M(LPS, IFN-γ) 0 ± 0 





4.4.4 Local delivery of FTY720 from polymeric biomaterials increases Ly6Clo, 
CX3CR1hi monocytes and CD206+ macrophages in injured muscle tissue.   
Previous work in our lab demonstrated that local administration of FTY720 to skin 
injury increases the frequency of CD206+ macrophages that were derived from blood 
Ly6Clo monocytes [113]. We sought to determine whether this strategy could be leveraged 
in VML injury to enhance accumulation of CD206+ macrophages within damaged muscle 
tissue. Implantation of an FTY720-loaded PLGA thin film over the muscle defect increased 
the frequency of Ly6Clo, but not Ly6Chi, monocytes compared to PLGA only or no implant 
controls, as determined by flow cytometry (Figure 24A).  
 
Figure 24.  On-site delivery of FTY720 increases Ly6Clo, CX3CR1hi monocytes in 
injured muscle. (A) Delivery of FTY720 from PLGA thin films to VML injury in 
wildtype mice increases the frequency of Ly6Clo monocytes, but not Ly6Chi monocytes 3 
days post-injury compared to unloaded PLGA and no implant controls (tissue monocytes 
gated on CD11b+SSClo). (B) Few CX3CR1-GFP+ cells are seen in uninjured, 
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contralateral spinotrapezius muscle in CX3CR1GFP/+ mice. (C) More CX3CR1hi cells are 
recruited to peri-defect tissue at day 3 in CX3CR1GFP/+ mice treated with 
FTY720. (D) LX+ cells cluster around defect in FTY720-treated CX3CR1GFP/+ mice at 
day 3 post-injury. Data presented as mean ± S.E.M. Statistical analyses were performed 
using two-way ANOVA. *p < 0.05 compared to Ly6Clo monocytes in PLGA and no 
implant controls, n = 3–4 animals per group. 
After induction of VML injury in CX3CR1GFP/+ mice, very few CX3CR1-GFP+ 
cells were detected in the uninjured contralateral spinotrapezius muscle (Figure 24B). 
Qualitative analysis of whole mount tissues shows that on-site delivery of FTY720 
increased accumulation of CX3CR1hi cells in the peri-defect muscle tissue (Figure 24C), 
which is consistent with the flow cytometry data that shows increased Ly6Clo monocyte 
frequency following FTY720 treatment, and analysis of blood monocytes shows inverse 
correlation of surface CX3CR1 and Ly6C expression (Figure 20). Ly6Clo blood monocytes 
were labeled in CX3CR1GFP/+ mice with LX beads 1 day prior to VML surgery to track the 
fate of Ly6Clo monocytes during FTY720-mediated immunomodulation. Inspection of 
whole mount confocal images reveals more LX+ beads in the muscle tissue of FTY720-
treated animals and that these LX+ beads were positioned closely around the defect (Figure 
24D).  
 To measure cellular infiltration into the defect, we measured the relative size of the 
avascular region with high myeloid cellularity (both CX3CR1+ and CD68+CD206+ cells). 
FTY720-treated animals had a larger percentage of the defect filled with CX3CR1+ cells 
(Figure 25A, B). We observed a similar, but insignificant, trend following quantification 
of the proportion of the defect filled with CD68+ and CD206+ cells (Figure 25C, D). 
Interestingly, we noticed cellular regions that were sparse in CX3CR1+ cells but contained 
numerous CD68+ CD206+ cells.  
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Figure 25.  FTY720 increases the frequency of CD68+CD206+ cells in injured 
muscle of CX3CR1GFP/+ mice. (A) FTY720-treated mice have a greater proportion of the 
defect region filled with infiltrating cells at 3 days post-injury, including LX+ and 
CX3CR1+ cells. (B) Quantification of cellular infiltration in CX3CR1/LX bead/lectin-
labeled muscles shows a higher percentage of cellular infiltration in defects treated with 
FTY720. (C) FTY720-treated mice have a greater proportion of the defect region filled 
with CD68+CD206+ cells compared to PLGA controls 3 days post-
injury. (D) Quantification of cellular infiltration in CD68/CD206/CD31 immunostained 
muscles shows a higher percentage of cellular infiltration in defects treated with 
FTY720. (E, F) Mice receiving FTY720 have increased density of CD68+CD206+ cells 
3 days post-injury. (G) CD68+CD206+ cells are significantly closer to CD31+ blood 
vessels in the presence of FTY720 3 days post-injury. Data presented as mean ± S.E.M. 
Statistical analyses were performed using two-tailed t-tests. *p < 0.05, n = 3–4 animals 
per group. 
Since we observed conversion of Ly6Clo monocytes into CD206+ macrophages 
(Figure 22), we investigated whether FTY720 also increases the frequency of CD206+ 
 83 
macrophages in injured muscle. Animals treated with FTY720 had more CD68+CD206+ 
macrophages in peri-defect tissue 3 days post-injury (Figure 25E, F). Close interactions of 
macrophages and endothelial cells have been associated with enhanced vascular 
remodeling and arteriogenesis [68, 113]. Quantification of the distance between 
CD68+CD206+ macrophages and the nearest CD31+ blood vessel within damaged 
spinotrapezius muscles revealed that AAMs homed closer to vasculature with FTY720 
treatment (Figure 25C, G).   
4.4.5  Ly6Clo monocytes / CD206+ macrophages promote skeletal muscle 
healing after traumatic injury.  
To investigate whether FTY720-induced perivascular accumulation of CD206+ 
macrophages was associated with repair of injured skeletal muscle, we assessed wound 
healing parameters. By 3 days post-injury, local delivery of FTY720 was able to induce 
increased revascularization of the defect region (Figure 26A, B), as quantified by CD31 
immunostaining. Interestingly, the amount of revascularization in FTY720-treated animals 
was similar to animals with no implant (Figure 26B), indicating that PLGA may impair 
revascularization. Increased collagen deposition within the defect area, as measured by 
imaging the second harmonic generation (SHG) signal, was observed in FTY720-treated 
animals (Figure 26C, D) coinciding with a significantly decreased non-collagenous void 
area. Regrowth of mature desmin+ muscle fibers was more prominent in muscles treated 
with FTY720 and these animals demonstrated a trend of reduced defect area at 3 days post-
injury (Figure 26E, F). Defects left untreated (no implant) had a lower average defect area 
than PLGA-treated mice and a lower average defect area than FTY720-treated mice 
(Figure 26F), indicating that PLGA may impair defect closure.  
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Figure 26.  On-site delivery of FTY720 promotes muscle healing 3 days post-injury 
in CX3CR1GFP/+ mice. (A) FTY720-treated mice have increased vascularization in the 
defect region, as detected by CD31 immunostaining and (B) quantification of 
CD31+ vessel density. (C) FTY720-treated mice have more collagen deposition within 
the defect region, as visualized by two-photon microscopy and (D) quantification of the 
non-collagenous void area. (E) Mice treated with FTY720 have a smaller defect area as 
measured by desmin immunostaining and (F) quantification of desmin-negative area 
(dotted red line indicates the mean value of wildtype mice undergoing VML and treated 
with no implant). Data presented as mean ± S.E.M. Statistical analyses were performed 
using two-tailed t-tests. *p < 0.05, n = 3–4 animals per group.  
At day 7 post-injury, injured muscles were imaged with two-photon confocal 
microscopy for immunostained desmin and SHG collagen signal. We rendered the 3D 
images in ImarisTM to generate quantitative volumes of desmin and collagen signal. 
FTY720-treated animals displayed a lower volume ratio of collagen to desmin compared 
to PLGA animals (Figure 27A, B), indicating less interstitial fibrosis. Furthermore, control 
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animals displayed highly aligned collagen fibrils compared to uninjured muscle, which is 
indicative of fibrotic scarring [120]. Regenerated fiber diameter was significantly higher 
in animals treated with FTY720 compared to PLGA only (Figure 27C, D), and comparable 
to that observed qualitatively in uninjured spinotrapezius muscle. Taken together, these 
findings demonstrate that immunomodulatory biomaterial strategies that tune myeloid cell 
infiltration can improve skeletal muscle repair.  
 
Figure 27.  Local immunomodulation with FTY720 improves muscle repair 7 days 
post-injury in wildtype mice. (A) FTY720-treated mice have larger and more 
desmin+ muscle fibers (detected by immunostaining) that more closely recapitulates the 
structure of an uninjured contralateral control, as well as less dense and aligned collagen 
(detected by two-photon microscopy) compared to PLGA controls. (B) FTY720-treated 
mice have a reduced volume ratio of collagen to desmin. (C–D) FTY720-treated mice 
have regenerated muscle fibers with a larger diameter (dotted red line indicates the mean 
value of wildtype mice undergoing VML and treated with no implant). Data presented as 
mean ± S.E.M. Statistical analyses were performed using two-tailed t-tests. *p < 0.05, 




4.5 Discussion  
In the present work, we have demonstrated that blood-derived non-classical 
monocytes infiltrate skeletal muscle after volumetric injury and convert into perivascular 
CD68+CD206+ macrophages. Biomaterial-based strategies that increase recruitment of 
non-classical monocytes concomitantly increase perivascular accumulation of AAMs, 
which correlates with the initiation of repair programs such as injury site re-vascularization, 
collagen deposition, and regeneration of damaged skeletal muscle. We demonstrate that 
accelerating the progression of muscle healing by targeting pro-regenerative monocytes 
and macrophage populations improves muscle regeneration while minimizing fibrotic 
scarring.  
Volumetric muscle injury appears to elicit an inflammatory cascade similar to that 
observed in toxin-induced injury with peak accumulation of Ly6Chi monocytes at 1 day 
post-muscle injury and continued increase in Ly6Clo monocytes following toxin insult [35].  
Within the spinotrapezius VML model, Ly6Chi inflammatory monocytes are present at 1 
day post-injury and decrease over time, whereas Ly6Clo anti-inflammatory monocytes peak 
at 3 days post-injury. Both monocyte subsets may exert pro-regenerative effects through 
production of key enzymatic and soluble cues such as inducible nitric oxide synthase 
(iNOS) by Ly6Chi monocytes [121, 122], and vascular endothelial growth factor (VEGF) 
[33] and IGF-1 [123] by Ly6Clo monocytes. Once extravasated, however, monocytes 
mostly differentiate into macrophages that continue to support repair [124]. In vitro, 
monocyte/macrophage subpopulations exert differential effects on myogenic precursors 
through their secreted factors [42]. Conditioned media from inflammatory macrophages 
promotes myogenic precursor cell proliferation and motility, whereas the soluble factors 
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from anti-inflammatory macrophages promote myogenic differentiation and myotube 
formation [29, 42]. Monocytes and macrophages may also direct their own behavior and 
fate through paracrine and autocrine signaling. Monocytes and macrophages produce 
tumor necrosis factor-alpha (TNF-) and IL-1 which leads to self-amplification of 
inflammatory responses [125], and their phagocytosis of cellular debris results in 
downregulation of inflammatory cytokine expression [126]. Thus, controlling the 
accumulation of specific monocyte and macrophage populations in vivo represents an 
important step in better understanding their role in the intricate wound healing process. 
Several studies have documented the recruitment of Ly6Chi inflammatory 
monocytes to injury where they convert in situ to Ly6Clo monocytes and become the 
primary contributor to wound macrophages [29-32]. Conversely, accounts of direct 
recruitment of Ly6Clo monocytes have been reported in myocardial infarction [33] and 
excisional skin injury [113]. Recruitment of non-classical Ly6Clo monocytes may therefore 
be dependent on the type of injury and tissue of origin.  We have built upon this knowledge 
by demonstrating for the first time that endogenous Ly6Clo monocytes are directly recruited 
to VML (Figure 21C), suggesting that Ly6Clo monocytes may play an indispensable role 
in the healing of traumatic injuries that require the de novo growth of tissue. Use of LX 
bead-based labeling of Ly6Clo monocytes in the CX3CR1GFP/+ mouse enables tracking of 
GFP+LX+ monocytes in tissue, and also LX+ cells that may have lost GFP expression due 
to differentiation into macrophages [101]. LX+ cells appear in spinotrapezius muscle 
following VML (Figure 21C, Figure 24D), indicating direct recruitment of Ly6Clo 
monocytes from circulation.  Important to the interpretation of trafficking studies, previous 
work has indicated that intravenous LX bead administration does not alter the kinetics of 
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Ly6Chi and Ly6Clo monocyte recruitment [101]. Additionally, LX bead administration 
does not induce changes in monocyte gene expression or systemically elevate plasma 
inflammatory mediators such as TNF-α, IFN-γ, or IL-6 [101]. In CX3CR1GFP/+ mice, blood 
monocyte composition is the same compared to wildtype mice [127, 128] and CX3CR1 is 
not required for transendothelial migration of monocytes in a model of acute peritonitis 
[129], thus simplifying interpretation of data collected in CX3CR1GFP/+ mice.  
VML defect healing follows similar phases to that of wound healing in injured 
skin[52]. 3D confocal microscopy of explanted spinotrapezius muscles at 3 days post-
injury shows granulation tissue and nascent vasculature within the defect next to truncated 
muscle fibers (Figure 18 A, B). This region of granulation tissue appeared to co-localize 
with CD206+ cells. The distribution of CD206+ cells is consistent with studies that indicate 
AAMs directly promote collagen production in fibroblasts [54] and support vascularization 
of Matrigel subcutaneous implants [63]. In the resolving phases of inflammation, muscle 
macrophages upregulate genes for ECM construction and remodeling [106], and depletion 
of these macrophages severely impairs muscle regeneration [29]. These findings motivated 
us to investigate whether preferentially increasing AAMs within injured skeletal muscle 
would enhance healing of volumetric muscle defects.  
Biomaterial-based therapies such as ECM-derived scaffolds and macrophage-
polarizing hydrogels [111] can increase the ratio of anti-inflammatory to inflammatory 
macrophages [130, 131] and improve regenerative outcome, but the origin of the AAMs 
(whether resident or circulation-derived) remains unknown. Recent intriguing insights into 
the functional differences between resident AAMs and those derived from circulating 
monocytes have highlighted the importance of considering AAM origin when designing 
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pro-regenerative biomaterials. Monocyte-derived AAMs have a unique gene expression 
profile compared to tissue resident AAMs, upregulating genes important during 
inflammation such as Socs2, IL-31ra, Ccl17, Ch25h, Jag2, and Ccl22 [132].  Monocyte-
derived AAMs also specifically drive the differentiation of CD4+ T cells to Foxp3+ 
regulatory T cells in a retinoic acid dependent manner [132]. Foxp3+ regulatory T cells are 
crucial to the healing of damaged skeletal muscle [81], and increasing their recruitment via 
IL-33 delivery to injured skeletal muscle in aged mice improves regeneration [82]. 
Therefore, circulating monocytes likely possess an intrinsic capacity for promoting wound 
repair and should be strongly considered in the design of biomaterials that seek to leverage 
pro-regenerative inflammation. Previously, we have used local delivery of the small 
molecule FTY720 as a means to localize circulating pro-regenerative monocytes to sites of 
bone and skin injury to coordinate microvascular expansion and bone healing. In this work, 
we utilized on-site delivery of the small molecule FTY720 to explore the contributions of 
circulating non-classical monocytes within VML injury. The effects of FTY720 are 
pleiotropic, as all cells express some combination of S1P receptors [133]. When 
administered systemically, FTY720 induces lymphopenia and bradycardia [133]; however, 
systemic effects are avoided during the local delivery strategies that we have extensively 
investigated in previous work [61, 113, 134] and the current study.  
FTY720 delivery from a polymer PLGA thin film was able to significantly increase 
the frequency of Ly6Clo monocytes within injured muscle (Figure 24A). Adoptively-
transferred non-classical monocytes differentiate into CD206+ macrophages in injured 
skin [113]. Therefore, we investigated whether increasing non-classical monocyte 
frequency would also result in increased numbers of CD206+ macrophages. Analysis of 
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CD68+CD206+ macrophages in peri-defect tissue revealed increased numbers of this 
population in FTY720-treated animals (Figure 25F). Monocytes and macrophages are 
known to position themselves strategically by remodeling blood vessels [57, 68, 113], 
where the crosstalk between vasculature and immune cells can provide instructional cues 
for AAM differentiation [70]. During chronic arterial occlusion, CD163+ AAMs are 
clustered in the perivascular space at sites of collateral growth in remodeling vasculature 
[135]. Here, spatial analysis reveals that CD68+CD206+ cells are positioned significantly 
closer to vessels with FTY720 treatment (Figure 25G). This increased perivascular 
positioning of AAMs coincides with increased density of vasculature in the muscle defect 
area (Figure 26 A, B) compared to PLGA control animals.  AAMs also support healing of 
damaged skeletal muscle by providing a source of regenerative growth factors such as IGF-
1 [48] and promoting satellite cell differentiation into mature myotubes [29, 42]. AAMs 
control collagen deposition from fibroblasts in an IL-4r-dependent manner [53], a process 
that is vital to wound healing within the skin. Assessment of the defect area via SHG 
imaging of collagen showed that FTY720 results in increased collagen content and a 
smaller defect area 3 days post-injury (Figure 26 C-F). By 7 days post-injury, regenerated 
fiber diameter was significantly higher in FTY720 animals and the collagen architecture 
more closely mimicked that of native uninjured muscle (Figure 27 C, D).  
Though we have focused primarily on FTY720’s effects on the behavior of 
monocytes and macrophages, agonism of S1PR1 and S1PR3 on other cell types present 
within the injury may have contributed to the accelerated healing we observed in muscle 
regeneration. S1PR1 and S1PR3 are differentially expressed during toxin-induced muscle 
injury, indicating that specific S1P receptors differentially regulate phases of healing [136]. 
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S1PR3 in muscle tissue is highly expressed during the acute inflammatory phase post-
injury, and S1PR3 may positively regulate the growth of regenerating fibers [136]. 
Conversely, S1PR1 expression increases during regeneration and S1PR1 agonism 
produced a net decrease in regenerated fiber cross-sectional area [136]. Genetic knockout 
of S1PR3 promotes satellite cell proliferation and attenuates muscle degeneration in the 
mdx mouse model that simulates Duchenne muscular dystrophy [137]. Our work 
demonstrates that the signaling induced by FTY720 likely affects multiple cell types during 
muscle repair, given that we observed changes in myeloid cells, blood vessels, and 
myofibers. Because the current work is unable to distinguish between direct and paracrine 
effects induced by FTY720, additional studies employing loss-of-function models are 
needed to understand the precise interplay between different compartments during skeletal 
muscle repair.  
 A major clinical concern with large volumetric muscle injuries is the debilitating 
fibrosis that often occurs in place of satisfactory healing [108, 138]. Fibrotic muscle not 
only lacks the contractility of healthy muscle, but also exhibits decreased elasticity, 
rendering the tissue more susceptible to re-injury [139]. While granulation tissue formation 
and its subsequent remodeling into mature ECM is crucial for the restoration of functional 
tissue in the volumetric void, a fibrotic response often progresses faster than a myogenic 
response [140]. Macrophages have the capacity to sense the injury microenvironment and 
instruct fibroblasts to either continue producing matrix or undergo apoptosis [55]. 
Increasing the frequency of AAMs may provide an endogenous command center capable 
of controlling and alleviating hyper-fibrotic responses within volumetric muscle defects. 
We utilized 3D analysis of the SHG collagen signal along with fluorescently-labeled 
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desmin to determine extent of fibrosis between fibers 7 days post-injury. Strikingly, areas 
of regrown fibers within FTY720-treated animals displayed a lower ratio of collagen to 
desmin volume (Figure 27B), indicating either faster healing in place of fibrosis, or 
attenuation of hyper-fibrotic responses in the defect to allow for increased parenchymal 
muscle fiber ingrowth. These observations are particularly promising for the treatment of 
larger, critically sized volumetric defects where prolonged fibrotic response after injury 
results in impaired progenitor and stromal cell migration and subsequently, decreased 
angiogenesis, reinnervation, and skeletal muscle regrowth [141, 142]. Future studies 
should explore how acute modulation of inflammatory cell recruitment impacts long-term 
reconstruction of critical sized traumatic muscle injury.  
4.6 Conclusions 
Taken together, our data strongly suggest that greater accumulation of 
CD68+CD206+ cells achieved through increased recruitment of non-classical Ly6Clo 
monocytes promotes early volumetric muscle wound closure and improves healing 
outcome within regenerated muscle. These findings indicate that localizing endogenous 
pro-regenerative inflammation with material-based FTY720 delivery is a promising 
strategy to promote healing of traumatic musculoskeletal injuries.  We use the knowledge 
gained from these studies to design a nanofiber scaffold releasing FTY720. We will 
evaluate the immune cell response and muscle healing in response to FTY720 nanofibers 
in a non-healing volumetric defect within the murine spinotrapezius.  
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5. LOCALIZING PRO-REGENERATIVE INFLAMMATION VIA 
NANOSCALE FIBER SCAFFOLDS IMPROVES VOLUMETRIC 
MUSCLE DEFECT HEALING 
5.1 Abstract 
The current gold-standard of therapy for volumetric muscle loss involves the 
autologous transfer of tissue which exhibits limited success and donor site morbidity. 
Strategies for treating volumetric muscle injuries will require the delivery of cues that 
initiating and promoting endogenous repair programs. We demonstrate that nanofiber-
based delivery of FTY720, a novel recruitment cue acting through the S1P signaling axis, 
acutely decreases CD4+ and CD8+ T-lymphocytes within a non-healing model of 
volumetric skeletal muscle injury. Animals treated with immunomodulatory materials 
exhibited increased numbers of pro-regenerative non-classical monocytes, and 
alternatively-activated CD206+ macrophages. Muscle stem cells, or satellite cells, were 
also increased in response to local immunomodulation. Assessment of regenerating muscle 
defects revealed that biomaterial-based delivery of FTY720 improves regenerated fiber 
alignment with the pre-injury fiber axis. These findings elucidate a possible connection 
between lymphoid and myeloid immune cell subset distribution after muscle injury, and 
demonstrate that FTY720 nanofibers are able to positively impact aspects of regeneration 




Though skeletal muscle possesses robust potential for healing after injury, large 
volumetric wounds that occur during combat, accidents or surgical resection often do not 
heal completely, resulting in fibrotic scarring and limited range of motion[140]. Current 
standard of care involves the autologous transfer of tissue but exhibits limited success and 
complications at both the donor and injury site[143]. Moreover, extensive soft tissue injury 
and concomitant damage to collateral blood vessels results in inadequate vascularization 
and can result in chronic muscle strength deficits. 
Monocytes and macrophages have become increasingly recognized as key 
regulators of microenvironmental cues within injured skeletal muscle[29, 42]. Tightly 
coordinated signals from monocyte/macrophages subpopulations govern the endogenous 
muscle stem (satellite) cell niche and dictate either regenerative or fibrotic healing 
outcomes. Monocytes within circulation exist as two subsets, distinguished by 
characteristic surface marker profiles. The classical, inflammatory monocyte is 
Ly6ChiCX3CR1lo whereas non-classical, anti-inflammatory monocytes are 
Ly6CloCX3CR1hi[98]. Ly6Chi monocytes are rapidly recruited to injury, where they can 
convert in situ into Ly6Clo monocytes and become the primary contributors to 
alternatively-activated macrophages[29]. Most notably during muscle injury recovery, 
monocyte-derived cells release mitogenic growth factors that protect muscle progenitor 
cells from apoptosis, and stimulate myogenic processes[49]. Monocytes and macrophages 
are highly plastic immune cells that display a range of phenotypes in vivo broadly classified 
as inflammatory (“M1”), or anti-inflammatory (“M2”), and are able to change their 
phenotype in response to cues that come from other myeloid and/or lymphoid cells within 
the injury microenvironment. T-lymphocytes have been shown to accumulate in injured 
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muscle[81, 83]. In particular, regulatory T-lymphocytes (Treg) cells are crucial to muscle 
regeneration and are though to govern the critical phenotypic switch in the injury niche 
from an inflammatory environment to an anti-inflammatory, pro-regenerative 
environment[81]. However, functions of lymphocyte subsets in the repair of volumetric 
muscle defects remains unknown. To address this question, we seek to develop biomaterial 
delivery systems that modulate adaptive and innate immune cell accumulation kinetics 
towards the goal of enhancing volumetric muscle healing outcomes.  
In the present studies, we expand our knowledge of the possible interplay between 
lymphoid and myeloid cell subset distribution in a non-recovering model of volumetric 
muscle injury. Using nanofiber scaffold-based delivery of the immunomodulatory signal 
FTY720, we demonstrate how decreasing acute CD8+ lymphocyte accumulation within 
injured skeletal muscle may positively influence the accumulation of pro-regenerative 
subsets of monocytes and macrophages. This increase in non-classical and alternatively-
activated macrophages coincides with amplified satellite cell numbers in peri-defect 
muscle tissue. We observed increased deposition of collagen with FTY720 treatment in the 
non-healing muscle defect, and revealed increased alignment of regenerated muscle fibers 
to the pre-injury fiber axis. These results indicate that modulation of lymphoid and myeloid 
cell subpopulations can positively impact the organization of regenerated muscle tissue 
after traumatic injury.  
5.3 Materials and Methods 
5.3.1 Nanofiber scaffold fabrication 
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Electrospun nanofiber scaffolds were fabricated as previously described[61]. 
Polycaprolactone (PCL, Sigma) and PLGA were combined in a 1:1 weight/weight ratio at 
18% polymer concentration for blank fibers and 20% polymer concentration for FTY720-
loaded fibers. Polymers were dissolved in a 1:3 volume ratio solution of methanol to 
chloroform and vortexed for 2+ hours prior to spinning. For FTY720 loaded fibers, drug 
was added to the polymer solution at a 1:200 drug:polymer weight ratio. 2 mL of either 
polymer solution was loaded into a 3 mL syringe with diameter of 10mm. Electrospinning 
was performed at an applied voltage of 19 kV, and flow rate of 1 mL/hr for both blank and 
FTY720 fibers. Working distance was set at 10 cm for blank fibers and 12 cm for FTY720 
fibers. After 2 mL of polymer was spun, fibers were wrapped in low-binding plastic folders 
and stored at -20C.  
5.3.2 Drug release from nanofiber scaffolds 
3mm circular biopsy punches were used to punch out 3mm discs from electrospun 
nanofiber sheets. Discs were placed in 100L of simulated body fluid containing 4% fatty 
acid-free bovine serum albumin. Releasate was collected at the defined timepoints and 
replaced with fresh release medium.  
5.3.3 Mass Spectrometry quantification of FTY720 release samples 
FTY720 was extracted from release samples using a long chain base spingolipid 
extraction protocol. 100L of release media was placed in glass culture tubes with screw 
caps (tubes: Kimble-Chase 73750-13100, caps: Kimble-Chase 73802-13415)  and 50L of 
phosphate buffered saline was added to bring total sample volume to 150L. 1.5mL of  2:1 
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methanol to dichloromethane (by volume) extraction solvent was added to each tube. 50 
picomoles of C17 sphingosine was added to each tube to serve as an internal standard. 
Tubes were capped, sonicated for 1 min, vortexed briefly, and incubated overnight at 48C. 
The following day, tubes were allowed to cool to room temperature. 150L of 1N KOH 
was added to each tube, sonicated for 1 min, vortexed briefly, and tubes were incubated at 
37C for two hours. Samples were allowed to cool to room temperature, and 8L of glacial 
acetic acid was added to each tube before being sonicated for 1 min, and vortexed briefly. 
Each sample was checked to ensure a neutral (7.0) pH. Samples were centrifuged at 
3000rpm and supernatant collected in separate open top glass tubes. 0.5mL of extraction 
solvent was added to each original sample tube, and samples were sonicated for 1 min and 
vortexed briefly before being centrifuged again at 3000rpm. The second supernatant was 
collected and added to first supernatant. Extraction solvent was evaporated off overnight 
by speed vac. The next day, 300L of mass spectrometry analysis solvent was added to 
each tube before being sonicated for 2 mins. Samples were transferred to microcentrifuge 
tubes and centrifuged at 18,000 xg for 10 minutes. 200L of each supernatant was 
transferred to mass spectrometry sample vials. Samples were analyzed on a Micromass 
Quattro LC mass spectrometer.  
5.3.4 Scanning Electron Microscopy 
Nanofiber scaffolds were sputter coated with gold for 30 seconds at 20 mA (~7nm 
of gold deposited) and imaged on a Hitachi SU8010 Scanning Electron Microscope. 
5.3.5 Spinotrapezius Volumetric Muscle Loss Surgery and Nanofiber Scaffold 
Implantation 
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All animal procedures were conducted according to protocols approved by the 
Georgia Institute of Technology Institutional Animal Care and Use Committee. Unless 
otherwise noted, male C57BL/6J (The Jackson Laboratory) of age 8-12 weeks old were 
used for all animal studies. A 2mm full thickness defect in the spinotrapezius muscle was 
created as follows. The dorsum of the mouse was shaved and hair removal cream applied 
to completely remove hair. Skin was sterilized with three washes of 70% ethanol and 
chlorhexidine. A longitudinal 1 inch incision (cranial to caudal) was made just after the 
bony prominence of the shoulder blade. The overlying fascia was dissected away and the 
spinotrapezius muscle identified. Using flat-tipped tweezers, the edge of the spinotrapezius 
was lifted up. The muscle was reflected and positioned against a sterile piece of wood. A 
2mm biopsy punch was made through the muscle, using the wooden piece as support. The 
muscle was replaced and 3 mm nanofiber scaffold disc implant placed over the punch 
defect. The nanofiber scaffold disc was sutured at the top to the spinotrapezius muscle with 
a 10-0 suture. The incision was closed with mouse wound clips. For FTY720 superfusion, 
a 3mm blank nanofiber scaffold was sutured over the defect, and 0.3mg/kg of FTY720 was 
superfused on top of the scaffold/muscle, before the incision was closed with wound clips.  
5.3.6 Flow cytometry 
To collect blood and tissue for flow cytometry analysis, mice were euthanized via 
CO2 asphyxiation. Blood was then collected via cardiac puncture. Red blood cells were 
lysed in ammonium chloride (1 part blood, 9 parts ammonium chloride) prior to 
immunostaining for flow cytometry. For analysis of cell composition in spinotrapezius 
muscles, a 6mm biopsy punch of muscle tissue centered on the defect was taken and 
weighed. For analysis of lymphocyte populations, spinotrapezius muscles were harvested 
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and digested in 1mg/ml collagenase I (Sigma) for 45 minutes at 37C. For analysis of 
satellite cell populations, injured spinotrapezius muscle punches were harvested and 
digested with 5,500U/ml collagenase II and 2.5U/ml Dispase II for 1.5 hours in a shaking 
37C water bath.The digested muscles were filtered through a cell strainer to obtain a single 
cell suspension. Single-cell suspensions from were stained for live cells using either 
Zombie Green or Zombie NIR (Biolegend) dyes in cell-culture grade PBS per 
manufacturer instructions. Cells were then stained with cell phenotyping antibodies in a 
1:1 volume ratio of 3% FBS and Brilliant Stain Buffer (BD Biosciences) according to 
standard procedures and analyzed on a FACS AriaIIIu flow cytometer (BD Biosciences). 
The following antibodies were used for cell phenotyping: BV605-conjugated CD4 
(Biolegend), BV785-conjugated CD8 (Biolegend), PE-Cy7-conjugated CD3 (Biolegend), 
PE-conjugated anti-CD115 (BioLegend), PerCP-Cy5.5-conjugated anti-CD115 
(BioLegend), PE-conjugated anti-CD25, FITC-conjugated anti-FoxP3 (eBioscience), 
BV510-conjugated anti-CD11b (BioLegend), BV421-conjugated anti-CD11b 
(BioLegend), BV510-conjugated APC (BioLegend), APC conjugated anti-Ly6C 
(BioLegend), BV711-conjugated anti-CD64 (BioLegend), PE-conjugated anti-MerTK 
(Biolegend), APC-Cy7-conjugated anti-Ly6G (BioLegend), PE-Cy7 conjugated anti-
CD206 (BioLegend) FITC-conjugated anti-CD206 (BioLegend), APC-conjugated Lineage 
antibody cocktail (BD Pharmigen), PE-Cy5 conjugated anti-CD29 (BioLegend), PerCP-
Cy5.5-conjugated anti-CXCR4 (BioLegend),  30L of Accucheck Counting Beads ( 
Invitrogen) were added per sample for absolute quantification of cell populations.  
5.3.7 Whole mount immunofluorescence of spinotrapezius tissues 
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Mice were euthanized 14 days after surgery via CO2 asphyxiation. Post-euthanasia, 
mouse vasculature was perfused with warm saline followed by 4% PFA until tissues were 
fixed. The entire spinotrapezius muscle was explanted and permeabilized overnight with 
0.2% saponin, then blocked overnight in 10% mouse serum. For immunofluorescence, 
tissues were incubated at 4˚C overnight in a solution containing 0.1% saponin, 5% mouse 
serum, 0.5% bovine serum albumin, and the following conjugated fluorescent antibodies: 
Alexa Fluor 488 or Alexa Fluor 650 anti-desmin (1:200 dilution, Abcam), Alexa Fluor 594 
anti-CD31 (1:100 diltuion), Alexa Fluor 650 anti-CD68 (1:200 dilution), Alexa Fluor 488 
anti-GFP tag (1:200 dilution), rhodamine alpha-bungarotoxin (1:200 dilution). Following 
immunostaining, tissues were washed 4 times for 30 minutes each in 0.2% saponin for the 
first two washes, 0.1% saponin for the third wash, and PBS for the final wash, and then 
mounted in 50/50 glycerol/PBS.  
5.3.8 Imaging and Quantification of Whole-Mount Immunofluoresence 
3-dimensional, tiled scans of whole-mount spinotrapezius muscles was performed 
on a Zeiss LSM 710 confocal microscope. Immunofluorescence imaging parameters were 
kept similar across all samples, with adjustments made only to keep image quality similar. 
Second harmonic generated signal was collected via 40x objective using a Chameleon laser 
to excite tissues at 790nm and signal collected over 380-420nm with acquisition parameters 
kept identical across animals. Quantification of 2-dimensional fiber diameter was 
performed as described in the previous chapter. Briefly, the widest portion of each 
regenerated muscle fiber (determined based on the morphology of desmin-positive regions) 
within the defect region was measured in ZEN from the day 14 2D maximum intensity 
projections. Desmin and SHG signal from 3-D z-stacks were rendered in Imaris as surfaces 
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to quantify volume. For desmin surfaces the following parameters were used: auto-
smoothing, thresholding set to 14 units, surfaces selected by eye. For SHG surfaces, the 
following parameters were used: no smoothing, auto-threshold set, all surfaces selected. 
To quantify alignment, a parallel grid was overlaid on the 3-D maximum intensity 
projection of desmin, following the axis of uninjured fibers. The angle between regenerated 
fibers (determined based on morphology of desmin positive regions) and the parallel lines 
in the grid was measured in FIJI. All angles were measured to be between 0 and 90.  
5.3.9 Functional Assessment of Injured Spinotrapezius Muscles 
The length of the lateral edge of the spinotrapezius muscle was measured in situ 
(L) via electronic calipers, and then explanted. The length of the lateral edge was measured 
again ex vivo. The difference in length was calculated as x and residual strain was 
calculated as =x/L. Muscle ends were wrapped in aluminum foil to evenly distribute 
tension across width of muscle and pinned close to in situ length on Sylgard 184 coated 
petri dishes, with pinned muscles submerged in skinning solution. In the case of nanofiber 
implant treated animals, the nanofiber implant was left attached to the muscle. Per 100mL, 
the skinning solution was composed of: 12.5 mL 1M propionate (7.56 mL propionic acid 
in 100 mL H2O. Add KOH pellets & pH to 7.0), 10 mL 200mM Imidazole pH 7.0 , 2 mL 
100mM EGTA, 0.1 mL 1M MgCl2 , 25.4 mL autoclaved deionized water , 245 mg ATP 
(Sigma A7699, ATP disodium salt hydrate), and 50 mL Glycerol. pH of skinning solution 
was adjusted to 7.0 and stored at -20C until use.  
Relaxing and activating solutions for contractile force testing were prepared as 
follows. Per 250 mL, relaxing solution was composed of:  12 mL 100mM ATP,  36 mL 
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100mM phosphocreatine, 25 mL 200mM Imidazole pH 7.0, 17.5 mL 100mM EGTA, 20 
mL 1M KCl, 40 L 100mM CaCl2, 1.4 mL 1M MgCl2, and diluted to 250 with autoclaved 
deionized water. pH was adjusted to 7.0 with KOH and HCl. Per 250 mL, activating 
solution was composed of: 12 mL 100mM ATP, 36 mL 100mM phosphocreatine, 25 mL 
200mM Imidazole pH 7.0, 17.5 mL 100mM EGTA, 16 mL 1M KCl, 17.5 mL 100mM 
CaCl2, 1.3 mL 1M MgCl2, and diluted to 250 with autoclaved deionized water. pH was 
adjusted to 7.0 with KOH and HCl. For best results, activating and relaxing solutions were 
prepared without the addition of ATP and PC and frozen at -20C for storage, and ATP 
and PC solutions prepared fresh at the time of testing, and added to activating and relaxing 
solutions. Additional ATP (100mM) and CaCl2 (700mM) was added to the activating 
solution at the time of testing each at 5% (by volume) of the original activating solution 
volume.  
At the time of contractile force testing, muscles were unpinned and removed from 
skinning solution and washed for 2 minutes in relaxing solutions. The muscles were cut 
into 3.5 x 8mm strips with the aid of razor and sapphire blades. The muscles were mounting 
onto a custom built contractile force measuring setup. One end of the muscle strip was 
attached to an SI-KG2 force transducer (World Precision Instruments) via a spring clip 
(#97924, World Precision Instruments), and the other end was attached to a 1/2" (12mm) 
XZ dovetail translation stage (ThorLabs) via another spring clip. The force transducer was 
connected to an SI-BAM21-LC optical transducer amplifier (World Precision Instruments) 
which was connected to a USB-1608G data acquisition device (Measurement Computing 
Corporation). DASYlab software was used to collect force data. The setup is shown in 
Figure 28.  
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Figure 28. Contractile force testing apparatus. Muscle is mounted via spring clips and 
submerged in relaxing or activating bath by raising or lowering the lab jack as necessary.  
The muscle strip was clipped under slack. The translation stage was moved to 
extend the muscle under tension until voltage change due to tension began to register. This 
length was measured and then L was calculated from the residual strain. The muscle was 
then stretched to length L via translation stage before being submerged for 2 minutes in 
relaxing solution, at which time data acquisition commenced. After 2 minutes, the muscles 
were switched into activating solution (additional ATP and CaCl2 added as described in 
previous paragraph) and contractile force monitored until force did not change for 1 
minute. The muscles were then switched back into relaxing bath and monitored for further 
force generation. When force decreased down to 0, the muscle was then switched back into 
activating solution and force generation monitored until there was no change in force 
detected for one minute, at which time data acquisition was terminated.  
To assess creatine kinase activity within regenerated skeletal muscle, 4mm punches 
centered on the defect were taken from injured spinotrapezius muscle. In the case that 
nanofiber scaffolds were implanted, the scaffolds were collected along with the muscle. 
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Muscle was mechanically homogenized with Pyrex glass pestle tissue grinders in 100mM 
phosphate buffer and 1x HALT protease and phosphatase inhibitor. Creatine kinase activity 
was assessed with a creatine kinase activity kit from Sigma-Aldrich (MAK-116). Creatine 
kinase activity per muscle sample was normalized to total protein determined by Pierce 
BCA protein analysis kit (Thermo Fisher).  
5.3.10 Statistical Analysis 
Data are presented as mean ± standard error of the mean (S.E.M.), unless otherwise 
noted. All statistical analysis was performed in GraphPad Prism software. Normality was 
assumed for all data sets possessing a sample size too small to run the D’Agostino and 
Pearson test of normality. For pairwise comparisons, unpaired t-test (with Welch’s 
correction if variances was significantly different) was used. For instances where the data 
failed the D’Agostino and Pearson test of normality, two-tailed Mann-Whitney test was 
used. For comparisons of more than two means, one-way ANOVA with Sidak’s post-test 
was used. For grouped analyses, two-way ANOVA with Tukey’s post-test was used. 
Unless otherwise noted, p<0.05 was considered statistically significant.  
 Power analysis was performed via G*Power software at a power set at 80%. Sample 
effect sizes were taken from statistically significant results from previously published 
data[105], when available. The flow cytometry experiments presented in this chapter 
represent the first studies of their kind in the spinotrapezius volumetric muscle loss model, 
and thus the effect sizes from observed statistically significant differences were used to 
compute required sample size for future studies. For flow cytometry, we computed a 
necessary sample size of 5 to detect differences in lymphocyte populations, and a sample 
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size of 18-21 was necessary to detect differences in satellite cells and myeloid cell 
populations. For image analysis, we computed a necessary sample size of 7 to detect 
statistically significant differences in collagen:desmin ratio, a sample size of 3 to detect 
significant differences in desmin+ fiber diameter, and a sample size of 4 to detect 
significant differences in regenerated muscle fiber aligment. Based on this analysis, some 
of our flow cytometry studies and imaging studies where the sample size is less that 
described above (sample sizes denoted in figure legends) are considered underpowered, 
and warrant the addition of more animals.  
5.4 Results 
5.4.1 Characterization of FTY720-loaded electrospun nanofiber scaffolds 
Scanning electron micrographs of FTY720-loaded 50/50 (by weight) Poly-lactic co-
glycolic acid (PLGA)/ Polycaprolactone (PCL) electrospun nanofibers (NF) reveal 
morphology similar to that of blank 50/50 PLGA/PCL electrospun nanofibers (Figure 29). 
The average diameter of PLGA/PCL nanofibers was 1.2 ± 0.71 μm whereas the average 
diameter of FTY720-NF was 0.45 ± 0.17 μm. 
 106 
 
Figure 29. Scanning electron micrographs of electrospun nanofiber scaffolds. Blank 
and FTY720-loaded nanofiber exhibit similar morphology.  
Drug release was measured from 3mm discs (Figure 30A-B) via mass spectrometry. 
1.91  0.27 g of FTY720 was released over the course of 75 hours, with approximately 
98  0.02% of drug release occurring over the first 24 hours. After 75 hours, 96.7  0.22% 
of incorporated drug was released from the scaffold, with 0.065  0.004 g FTY720 
remaining within the scaffold.  
 
Figure 30.  Drug release from 3mm diameter FTY720 nanofiber scaffolds. (A) 
Cumulative FTY720 drug release from 3mm diameter nanofiber discs. (B) FTY720 
released versus FTY720 remaining in nanofiber scaffold after 75 hours. Data presented as 
mean  S.E.M.  
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5.4.2 FTY720 delivery from composite nanofiber scaffolds alters systemic and 
local tissue lymphocyte levels at 1 day post-injury. 
A 2mm full-thickness defect in the murine spinotrapezius was created and was either left 
untreated, or underwent implantation of 3mm blank or FTY720 loaded nanofiber scaffolds 
over the defect. Because systemically-administered FTY720 is known to induce 
lymphopenia, we sought to determine if any system-level effects were detectable with 
scaffold-based, local administration of drug. Analysis of blood lymphocyte populations by 
flow cytometry 1-day post-injury revealed that both CD3+CD4+ and CD3+CD8+ T-
lymphocytes were significantly decreased in the circulation of FTY720-NF treated animals 
compared to no implant control (Figure 31A-C).  
 
Figure 31. FTY720 nanofiber implantation within spinotrapezius volumetric muscle 
defect induces acute lymphopenia. A) CD4+ and CD8+ T-lymphocytes are decreased 
in blood 1 day after volumetric muscle defect creation and FTY720 nanofiber scaffold 
implantation. B-C) CD4+ and CD8+ blood counts at days 1, 3, 7, and 14 days after 
surgery. Data presented as mean ± S.E.M. Statistical analyses were performed by two-
way ANOVA with Tukey’s post-hoc test to compare means, *p<0.05, n=4-6 animals per 
group. 
We hypothesized that the systemic decrease of these lymphocytes would 
correspond to decreases in injured muscle tissue. Indeed, we observed a decrease in 
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CD3+CD8+ lymphocytes within injured spinotrapezius muscles 1 day post-injury (Figure 
32A, B). Since regulatory T-cells have been shown to play a crucial role in skeletal muscle 
repair, we also examined the frequency of Foxp3+CD25+ Tregs within the injured tissue. 
Interestingly, blank NF implant treatment reduced the frequency of Tregs within the 
CD3+CD4+ lymphocyte population compared to no implant, whereas treatment of the 
muscle with FTY720 NF implants raises the frequency of Tregs back to no implant levels 
(Figure 32C). There were no significant treatment-specific differences observed in overall 
CD11b+ cells, Ly6Chi or Ly6Clo monocyte subpopulations within the injured tissue 1 day 
after surgery and FTY720 nanofiber implantation (Figure 32D-F). 
 
Figure 32. FTY720 nanofiber scaffolds induces changes in lymphocyte accumulation 
in injured spinotrapezius muscle 1 day after injury.  A) No significant changes 
detected in muscle CD4+ lymphocytes with blank or FTY720 NF implantation. B) 
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Muscle C8+ lymphocytes are decreased with FTY720 NF implantation. C) No significant 
changes detected in muscle regulatory T-lymphocytes were detected between groups. No 
changes in D) CD11b+ cells, E) Ly6Chi, or F) Ly6Clo monocytes were detected in 
spinotrapezius muscle tissue 1 day after FTY720 nanofiber implantation. Data presented 
as mean ± S.E.M. Statistical analyses were performed within each day with one-way 
ANOVA with Sidak’s post-hoc test to compare means, *p<0.05 compared to no implant, 
n=4-6 animals per group.  
5.4.3 Enrichment of pro-regenerative myeloid cells within muscle injury 
coincides with increased satellite cell numbers 
We have previously shown that FTY720 delivery from a polymer thin film 
increases the frequency of Ly6Clo and CD206+ macrophages within sub-critically injured 
muscle at 3 days post-injury. We sought to determine if FTY720 delivery from a nanofiber 
scaffold to a larger, 2mm defect would elicit similar responses. Interestingly, we observed 
significantly higher live cellularity within FTY720-NF treated animals compared to blank 
NF, though the percentage of live cells out of total single cells was not significantly 
different between groups (Figure 33A, B). Though there was no difference in the number 
of classical Ly6Chi monocytes per milligram of injured tissue (Figure 33C), the number of 
non-classical Ly6Clo monocytes/mg tissue was significantly higher in animals treated with 
FTY720 NF treatment (Figure 33D). Because Ly6Clo monocytes have been demonstrated 
to be biased progenitors of CD206+ alternatively-activated macrophages[36], we 
hypothesized that the observed increase of Ly6Clo monocytes would correspond to an 
increase in CD206+ macrophages. Indeed, though there was no difference in the number 
of inflammatory Ly6C+CD206- MerTK+CD64+ macrophages between blank and 
FTY720 NF animals (Figure 33E), we detected a significantly higher number of Ly6C-
CD206+ macrophages in FTY720 NF animals (Figure 33F).  
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Figure 33. FTY720 nanofiber scaffolds increases pro-regenerative myeloid cell 
populations within injured spinotrapezius muscle 3 days post-injury. (A) FTY720 
NF scaffolds induces higher live cell count but does not affect cell viability (B). C) No 
difference in number of Ly6Chi monocytes was detected in injured spinotrapezius tissue. 
D) Ly6Clo monocytes are increased in response to FTY720 nanofiber implantation. E) No 
difference in number of inflammatory CD206-Ly6C+ macrophages were detected 
between treatment groups. F) CD206+Ly6C- anti-inflammatory macrophages are 
increased in response to FTY720 nanofiber implantation. Data presented as 
mean ± S.E.M. Statistical analyses were performed using two-tailed t-tests with Welch’s 
correction or two-tailed Mann-Whitney tests. *p < 0.05, n = 7-8 animals per group. 
Since macrophages are known to affect satellite cell proliferation and 
differentiation, we looked at the number of cells possessing an immunophenotype 
indicative of satellite cells (lineage-, Beta-1 integrin+, CXCR4+) within blank and FTY720 
NF treated muscle (Figure 34A). Interestingly, FTY720 NF treated animals possessed a 
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higher number of Lin- Beta-1 integrin+ CXCR4+ cells within injured muscle compared to 
blank scaffold control (Figure 34B). 
 
Figure 34.  FTY720 nanofibers increases satellite cells in injured spinotrapezius 
muscle 3 days post-injury. A) Satellite cells were defined as live, lineageneg, Beta-1 
integrin+, CXCR4+. B) Satellite cells were increased in response to FTY720 nanofiber 
treatment. Data presented as mean ± S.E.M. Statistical analyses were performed using 
two-tailed t-test. *p < 0.05, n = 7-8 animals per group. 
5.4.4 FTY720 nanofibers increases alignment of regenerated muscle fibers  
We assessed healing parameters by confocal imaging in injured skeletal muscles at 
14 days post-injury. Though not statistically significant, desmin+ regenerated muscle fiber 
diameter in animals treated with FTY720 nanofiber implants displayed a mean diameter 
value higher than that observed in blank nanofiber implants (Figure 35A), and warrants the 
addition of more animals to the study. Though untreated defects exhibited a fiber diameter 
mean comparable to FTY720 nanofiber treated animals, qualitative assessments of fiber 
diameter within 40x crops rendered in Imaris show improved circular fiber morphology in 
FTY720 treated animals compared to untreated animals (Figure 35B).  
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Figure 35.  FTY720 nanofibers improves regenerated fiber diameter compared to 
blank implant control 14 days after injury. A) 2-dimensional fiber diameter measured 
from maximum intensity projection images reveals higher fiber diameter in FTY720 NF 
treated animals compared to blank NF control, but not untreated controls. B) 3-
dimensional Imaris renderings of desmin and backward SHG generated signal show that 
the regenerated fibers in the FTY720 NF group have improved circular fiber morphology 
compared to untreated animals. Data presented as mean ± S.E.M. Statistical analyses 
were performed with one-way ANOVA with Sidak’s post-hoc test to compare means, 
*p<0.05 compared to no implant, n=4 animals per group. 
Macrophages are known to interact with satellite cells via contact dependent 
mechanisms to prevent satellite cell apoptosis[49]. However, it is unclear whether 
macrophages interact directly with regenerating muscle fibers. We observed close spatial 
interactions between CD68+ cells and regenerating desmin+ muscle fibers in all three 
treatment conditions (Figure 36). In addition, FTY720 nanofiber treated animals exhibited 
distinctly formed vasculature amongst regenerating fibers, whereas untreated and blank 
nanofiber treated animals did not display a fully formed vascular network (Figure 37). 
Qualitatively, FTY720 nanofiber treated animals possess increased CD68+ macrophage 
staining in the area of regenerating fibers (Figure 37). 
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Figure 36.  Immunofluorescence images of CD68+ cells (blue) and regenerating 
desmin+ muscle fibers (green) 14 days post-injury.   CD68+ cells (blue closely interact 
with regenerating muscle fibers (green).  
 
Figure 37.  Immunofluorescence images of CD68+ cells (blue), blood vessels (red) 
and regenerating desmin+ muscle fibers (green) 14 days post-injury. FTY720 
nanofiber treated animals display a distinct vascular network (red) amongst regenerated 
muscle fibers, and increased CD68+ cells (blue), compared to no implant, and blank 
implant controls.  
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We then examined the relationship between desmin+ muscle fibers and collagen 
architecture. The second harmonic generated signal generated by collagen was imaged on 
a 40x objective, only in the z-depth range where fluorescently labeled muscle fibers were 
detected. Qualitatively, we observed increased collagen deposition around regenerating 
fibers (identified by central nucleation) in the FTY720 NF treated animals compared to 
both untreated and blank NF implant controls (Figure 38, 39). The architecture of collagen 
superficial to the regenerating muscle fibers exhibited a crosslinked morphology, 
compared to the aligned collagen bundles seen immediately adjacent to regenerating 
muscle fibers (Figure 38) which are deeper in z-depth. Assessing the quantitative volume 
ratio of collagen to desmin reveals that FTY720 nanofiber scaffolds induces a higher 
collagen:desmin ratio compared to no implant and blank implant controls (Figure 39).  
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Figure 38.  Fluorescence images of injured skeletal muscle 14 days post-injury. 
Second harmonic generated signal (white) produced by collagen reveals differences in 
density of collagen deposited among regenerating muscle fibers between treatment 
groups, as well as tissue depth.  
 116 
 
Figure 39.  FTY720 nanofiber scaffolds induces higher collagen:desmin ratio 
compared to no implant 14 days post-injury. Data presented as mean ± S.E.M. 
Statistical analyses were performed with one-way ANOVA with Sidak’s post-hoc test to 
compare means, *p<0.05 compared to no implant, n=4-5 animals per group. 
Extracellular matrix can serve as structural guides for cell migration[144, 145]. We 
hypothesized that the increased collagen seen in FTY720 treated animals could serve as an 
architectural conduit along which muscle fibers could elongate in an aligned manner. Thus, 
we measured the angle between centrally nucleated regenerating fibers and the axis of 
original, uninjured muscle fibers, with a higher angle measurement (0 - 90) between new 
and old fibers indicating poorer alignment. FTY720 NF treated defects exhibited 
significantly lower angle measurement (17.82  5.4) compared to both untreated and 
blank NF treated defects (50.07  3.2 and 43.1  8.79, respectively), indicating 
improved alignment. We attributed this increased alignment to FTY720 release from the 
nanofiber scaffold, as FTY720 superfusion with blank nanofiber implant did not induce 
improved alignment of muscle fibers (Figure 40).  
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Figure 40.  FTY720 nanofibers induce higher alignment of regenerated muscle 
fibers to original fiber axis 14 days post-injury. Data presented as mean ± S.E.M. 
Statistical analyses were performed with one-way ANOVA with Sidak’s post-hoc test, 
*p<0.05, n=4-5 animals per group. 
We then sought to determine if this improved alignment was attributed to the 
immunomodulatory effects of FTY720 or the nanofibrous architecture of the electrospun 
scaffold. We similarly measured the angle in 1mm defects either left untreated, or treated 
with blank and FTY720 loaded polymer thin films. We have shown previously that 
FTY720-loaded films are able to locally modulate inflammation in skeletal muscle, but do 
not possess nanofibrous architecture. Interestingly, animals receiving FTY720 from 
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polymer thin films also exhibit higher alignment (lower angle measurement) with the pre-
injury fiber axis compared to untreated or blank film controls. (Figure 41). 
 
Figure 41.  FTY720 film induces higher alignment of regenerated muscle fibers to 
original fiber axis 7 days post-injury. Data presented as mean ± S.E.M. Statistical 
analyses were performed with one-way ANOVA with Sidak’s post-hoc test, *p<0.05 
compared to no implant, n=4-5 animals per group.  
Restoration of functional properties of skeletal muscle relies on reinnervation of 
regenerated fibers. FTY720 nanofibers were implanted into Thy1-YFP mice, in which 
motor neurons are labeled wi th YFP and able to be detected via immunofluorescence. We 
observed in preliminary studies thaanimals receiving FTY720 nanofibers displayed greater 
axonal density in regenerating muscle regions 28 days post-injury (Figure 42). Regenerated 
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neuromuscular junctions were detected by identifying regions of overlap of Thy1+ 
presynaptic junctions and acetylcholine receptor+ post-synpatic junction, and the junctions 
seen in FTY720 treated animals adopted similar morphology to that in healthy muscle 
(Figure 43). Further studies adding additional animals to each group will be necessary in 
order to fully elucidate FTY720-NF mediated effects on motor neuron regeneration. 
Desmin marks activated pericytes which stabilize nascent vasculature during muscle 
regeneration. Interestingly, Thy1+ axons could be observed running alongside desmin+ 
vascular-like structures in close spatial proximity (Figure 44).  
 
Figure 42.  Immunofluorescence images of regenerating motor neurons (white), 
regenerating post-synpatic neuromuscular junctions (red), and regenerating 
desmin+ muscle fibers (green) 28 days post-injury. FTY720 nanofiber treated animals 
display increased motor axon regrowth in regenerating tissue area compared to no 
implant control.  
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Figure 43.  High powered immunofluorescence images of regenerating motor 
neurons (white), regenerating post-synpatic neuromuscular junctions (red) 28 days 
post-injury. FTY720 nanofiber treated animals exhibit regenerated pre-synapatic and 
post-synaptic neuromuscular junctions (white arrow) with similar morphology to that 
observed in uninjured muscle.  
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Figure 44.  Immunofluorescence image of regenerating motor neurons (white), 
regenerating post-synpatic neuromuscular junctions (red)  and pericyte covered 
vascular structure (green) 28 days post-injury. Regenerating motor axon (white) 
closely follows desmin+ pericyte vascular structure (green) (white arrows).  
We then sought to determine if the improved healing metrics seen with FTY720 
nanofiber treatment would manifest in functional differences. We designed and built a 
custom testing apparatus that would enable the measurement of contractile force generated 
from injured spinotrapezius muscles at 28 days post-injury. We collected three data points: 
the peak force generated upon the muscle’s initial submersion into the high calcium, high 
ATP activating bath, the peak force generated upon the muscle’s return into relaxing bath, 
and the peak force generated upon the muscle’s second entry into the activating bath. While 
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it is unclear why the muscle continues to generate force upon return to the relaxing bath, 
we suspect that the muscle may experience a form of tetanus in the activating bath, and 
upon return to the low calcium, low ATP bath, the extra calcium and ATP within the muscle 
that has not diffused out may be able to then stimulate additional force generation. An 
example force plot is shown in Figure 43A.  Though we were able to detect a statistically 
significant difference in force generation between healthy and injured muscles 28 days 
post-injury, we could not detect differences in force generation between injured treatment 
groups at the 3 peak forces collected (Figure 45B-D).  
 
Figure 45.  Contractile force measurements in healthy vs. injured spinotrazpeius 
muscles 28 days post-injury. A) Force vs time plot of healthy muscle. B-D) Healthy 
muscle generates significantly higher force than injured muscles that were left untreated, 
treated with blank NF, or treated with FTY720. Data presented as mean ± S.E.M. 
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Statistical analyses were performed with one-way ANOVA with Sidak’s post-hoc test or 
Kruskal-Wallis with Dunn’s post-hoc test, *p<0.05 compared to all other groups, 
†p<0.05 compared to healthy muscle, n=7-8 animals per group. 
Creatine kinase activity was measured in muscle lysate samples collected 28 days 
post-injury, and normalized to total protein content. Muscles undergoing a 2mm defect 
injury that were allowed to heal without an implant displayed significantly higher CK 
activity than healthy muscles, or injured muscles treated with blank nanofibers or FTY720 
nanofibers. There were no statistically significant differences between treatment groups in 
injured muscles (Figure 46.)  
 
Figure 46.  Creatine kinase activity in muscle lysates collected 28-days post-injury. 
Data presented as mean ± S.E.M. Statistical analyses were performed with one-way 
ANOVA with Sidak’s post-hoc test, *p<0.05 compared to no implant, n=5-6 animals per 
group. 
5.5 Discussion 
Volumetric muscle defect injuries comprise 50-70% of combat injuries and are the 
cause of 80% of limb amputations in soldiers[143]. The therapeutic options for volumetric 
muscle loss are few (autologous tissue transfer, muscle flap transposition) and exhibit poor 
clinical prognosis due to donor site morbidity, and inadequate integration of donor tissue 
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into the local vascular and motor neural network. Extracellular matrix-derived scaffolds 
have been utilized as void filling substitutes for autografts, and promote M2 macrophage 
polarization in the injury vicinity, however immunogenicity of allogenic or xenogenic 
ECM scaffolds remains a concern [146],[147]. Scaffolds seeded with mesenchymal stem 
cells or myoblasts have been shown to improve volumetric defect healing and functional 
outcome[148], [149], but translation of cell-based therapies into the clinic remains a 
regulatory challenge. The employment of endogenous tissue engineering techniques, in 
which cues are provided in situ to influence the mobilization, homing, phenotype, and 
function of key regenerative cell populations, represents an attractive therapeutic strategy 
for the treatment of volumetric muscle injuries.  
Our previous work utilized a 1mm diameter full-thickness defect in the murine 
spinotrapezius muscle to investigate the role that non-classical monocytes play within sub-
critically sized volumetric muscle injury (Chapter 4). In the present studies, 2mm diameter 
defects were created in the murine spinotrapezius to model a volumetric muscle injury of 
critical size. To test whether this defect size represented a critical injury, the contractile 
forces generated from uninjured spinotrapezius muscles and muscles that underwent 2mm 
defect injury were compared. These functional measurements revealed that 28-days post-
injury, injured muscles generated a significantly lower force than uninjured muscles 
(Figure 45), indicating that a 2mm defect is does not regain full contractile function at this 
longer term time point. Thus, we employed the 2mm defect model to further expand our 
knowledge of the roles that innate and adaptive immune cells have in the repair of a non-
healing volumetric muscle injury. 
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Nanoscale fiber scaffolds fabricated from biocompatible polymers are an easily 
tunable material platform that enables the incorporation of bioactive molecules suited to 
the application at hand. Here, we engineered PLGA/PCL nanofiber scaffolds encapsulating 
FTY720, an immunomodulatory molecule known to redirect non-classical Ly6Clo 
monocytes from peripheral circulation into injured tissues when locally applied [34]. The 
use of nanofiber technology enabled us to suture the implants over the spinotrapezius 
volumetric defect, ensuring localized drug release to the injury site. We observed that 
implantation of FTY720 nanofibers into 2mm volumetric muscle defects results in acute 
lymphopenia at day 1 (Figure 31). Within injured spinotrapezius tissue, CD4+ and CD8+ 
T lymphocytes were similarly decreased at day 1 with FTY720 NF treatment (Figure 30). 
Though the role of CD4+ and CD8+ T lymphocytes in volumetric muscle defect healing 
remains unclear, these cells are able to secrete cytokines that could influence the 
polarization of myeloid cells. CD4+ T lymphocytes produce IL-4 and IL-13[150], which 
may lead to anti-inflammatory M2 polarization[151], and CD8+ T lymphocytes secrete 
IFN-[152], promoting inflammatory M1 polarization[151]. Though both CD4+ and CD8+ 
T lymphocytes were reduced in muscle tissue with FTY720 treatment, the complex 
interplay between lymphoid and myeloid cells is such that even slight shifts in cytokine 
balance due to decreases in these lymphoid populations could result in a tissue 
microenvironment more favorable towards anti-inflammatory, M2 polarization.   
To test whether FTY720-mediated decreases in CD4+/CD8+ T-cells influenced 
myeloid phenotype distribution in injured skeletal muscle, we analyzed monocyte and 
macrophage subsets by flow cytometry. Though there were no differences in either 
classical Ly6Chi or non-classical Ly6Clo monocyte subsets at day 1 post-injury (Figure 32), 
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we did observe robust increases in non-classical Ly6Clo monocytes, and pro-regenerative 
Ly6C-CD206+ macrophages at day 3 post-injury (Figure 33). Since macrophages are 
known to impact satellite cell behavior, we evaluated the effect of FTY720 nanofiber 
treatment on satellite cell numbers. Interestingly, we detected a significantly increased 
number of Lin-CD29+CXCR4+ cells (an immunophenotype indicative of satellite cells) 
within injured spinotrapezius muscle upon treatment with FTY720 nanofiber scaffolds 
compared to blank scaffold control (Figure 34).  
Defining functional effects of alternatively-activated M2 macrophages on satellite 
cells remains a challenge due to the marked heterogeneity that M2 macrophages exhibit 
both in in vitro polarization paradigms, and in in vivo injury niches.  IL-4-polarized 
macrophages have been shown in vitro to suppress satellite cell proliferation and promote 
satellite cell differentiation [29], whereas macrophages polarized via IL-10 exposure 
promoted C2C12 myoblast proliferation but had no effects on myoblast differentiation as 
evaluated by myoD and myogenin protein expression[24]. An intriguing hypothesis to 
investigate in future work is that the decreases in CD4+ (which produce IL-4) and CD8+ 
T-lymphocytes (which produce IFN-) observed at day 1 with FTY720 nanofiber treatment 
may shift the injury cytokine milieu towards favoring IL-10-mediated M2 polarization. IL-
10 is secreted by regulatory T-lymphocytes (Treg)[23], and we observed increased 
CD25+Foxp3+ Treg cells in injured muscle with FTY720 nanofiber treatment at day 1 
compared to blank scaffold (Figure 33). Further studies that probe the muscle cytokine 
profile in response to FTY720 are necessary in order to further elucidate the connection 
between lymphoid and myeloid cell populations within skeletal muscle injury.  
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To explore whether the immunological profile and increased satellite cell numbers 
induced by FTY720 nanofibers at 3 days, we assessed healing parameters. FTY720 
nanofiber treated animals displayed increased fiber diameter compared to control animals, 
and increased collagen:desmin ratio. Though we have previously attributed high 
collagen:desmin ratio to an increased fibrotic response, those observations were made in 
1mm volumetric defects which close over 7 days (Figure 17) [105]. In this 2mm defect 
model, tissue must regenerate over 3-fold more area than that in the 1mm defect model. 
Thus, increased matrix deposition may be beneficial in this context to guide the growth of 
muscle fibers. Skeletal muscle fibers produce maximum force along a single axis. 
Consequently, it is crucial for injured fibers to regenerate in alignment with pre-existing 
muscle fibers. We observed a lower angle between regenerating muscle fibers and the 
original fiber axis in animals treated with FTY720 NF scaffolds, indicating improved 
alignment (Figure 40). This higher alignment may be primarily due to the effects of 
FTY720, and not the presence of nanoarchitecture within the scaffold, as polymer thin 
films released FTY720 also induced a degree of alignment comparable to that observed 
with FTY720 nanofiber treatment (16.73  2.35 in films, versus 17.82  5.6 in 
nanofibers) (Figure 41).The delivery of FTY720 from a biomaterial scaffold was crucial to 
inducing increased fiber alignment, as animals receiving superfusion of FTY720 with 
blank scaffold did not display increased fiber alignment (Figure 40).  
The mechanism by which FTY720 mediates fiber alignment is unknown at this 
point. Alternatively-activated macrophages have been shown to promote extracellular 
matrix synthesis within fibroblasts [53] and fibroadipogenic progenitors [55]. We observed 
increased collagen deposition in animals treated with FTY720 nanofibers. Recently, it was 
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demonstrated that fibroblasts encapsulated within a collagen matrix rapidly generate tensile 
forces to close micro surgically induced defects [153]. It is possible that the increases in 
CD206+Ly6C- macrophages (mediated by FTY720 nanofibers) enhances activity of 
infiltrating fibroblasts that generate mechanical contractile forces over the defect void that 
encourage muscle cell alignment (as has been demonstrated in vitro)[154]. Cells present 
within the injury niche may also interact directly with the provisional support provided by 
the nanofiber scaffolds themselves[155], and indeed, stem cell proliferation and 
differentiation [156] and fibroblast adhesion and proliferation [157]  has been shown to be 
dependent on nanofiber diameter. The average diameter of individual PLGA/PCL 
nanofibers was 1.2 ± 0.71 μm whereas the average diameter in that of FTY720-NF was 
0.45 ± 0.17 μm. Though both scaffolds possess individual fiber diameter on scales at which 
cells can interact [155], fibroblasts have been shown to exhibit increased proliferation in 
response to smaller diameter fibers (250-300 nm) versus larger diameter fibers (500 nm-1 
m)[158]. FTY720-NF scaffolds displayed smaller individual fiber diameter and this 
topographical feature may have encouraged increased fibroblast proliferation and matrix 
deposition compared to blank scaffolds in which fiber diameter was higher. Future studies 
that more closely pair fiber diameter between blank and drug-loaded scaffolds will be 
necessary. In addition, we observed aligned morphology of collagen fibers alongside the 
regenerated muscle fibers (Figure 38) within FTY720-NF treated animal. Mechanical and 
architectural cues from either the scaffold itself or from cells interacting with the scaffold 
may contribute to the increased alignment of regenerated muscle fibers observed in 
FTY720 treated animals. However, inspection of FT720 treated defects at later time points 
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will be crucial to ensure that the increased matrix seen with treatment is remodeled 
sufficiently so that persistent fibrosis does not occur.  
Though we observed improved healing metrics within volumetric muscle defects 
treated with FTY720 nanofibers, whether the regenerated muscle can undergo contractions 
and generate force cannot be determined from imaging. Thus, we designed a testing 
apparatus that enables the measurement of contractile forces generated by spinotrapezius 
muscles. Using this apparatus, we were able to detect a statistically significant difference 
in force generation between healthy and injured muscles 28-days post-injury. It is possible 
that this difference is due to atrophy of the muscle either from denervation [159], or from 
muscle underuse/disuse [160] following injury. The proportion of resected muscle out of 
the total muscle strip was 11%, and thus a theoretical decrease of 11% of muscle force 
generation in a completely unhealed defect may be expected. The mean initial force 
generation of healthy muscle spinotrapezius strips was 1.70.5 grams of force. An 11% 
theoretical decrease in force generation would be 1.5 grams, however, all injured groups 
exhibited a mean initial force generation less than 1.5g (untreated: 1.10.2 g, blank 
implant: 0.80.4 g, FTY implant: 0.650.3 g). However, fibrosis that occurs as a result of 
volumetric muscle injuries may also affect muscle stiffness [161] and thus affect 
contractility. Further studies will be needed to discern how force generation within injured 
murine spinotrapezius strips is impacted as a result of time after injury. Though we were 
unable to detect differences between treatment groups, our ability to detect differences in 
force generation between healthy and injured spinotrapezius muscle strips represents a 
sizable leap in method development for ex vivo functional testing. This will likely enable 
the field to assess force generation of other thin muscles such as the diaphragm. 
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Additionally, this method might be more effective in detecting contractile force differences 
in studies looking at systemic treatments in which the entirety of the muscle may be 
affected, rather than localized injury and treatment.  
We believe that the value of the spinotrapezius volumetric muscle loss model lies 
in its capacity to screen therapies for favorable acute cellular responses and in evaluating 
localized healing outcomes. With confocal imaging, we were able to demonstrate for the 
first time that CD68+ macrophages closely interact with regenerating muscle fibers (Figure 
34). Notably, we observed Thy1+ axons running along vascular structures marked with 
desmin+ pericytes. (Figure 44). The spatial coupling of axonal regrowth and vasculature 
provides evidence that regeneration of tissue microcompartments do not occur in isolation, 
but rather, rely on coordinated interplay between multiple cell types. 
Taken together, we have demonstrated that local immunomodulation of innate and 
adaptive immune responses via FTY720 nanofibers coincide with increased satellite cell 
numbers after volumetric muscle injury. Animals treated with FTY720 NF displayed 
improved muscle healing and alignment. Our work highlights the promise of engineering 
immunomodulatory biomolecules into electrospun biomaterial scaffolds that promote the 
regeneration of skeletal muscle.  
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6. CONCLUSIONS AND FUTURE DIRECTIONS 
6.1 Overall Summary 
In the present work, we expanded our knowledge of the origin of anti-inflammatory 
CD206+ macrophages within soft tissue injury by demonstrating that non-classical Ly6Clo 
monocytes are biased towards differentiation into wound-healing macrophages. We 
utilized this information to design biomaterial therapeutics that selectively recruit non-
classical monocytes to a novel model of volumetric skeletal muscle injury and show 
improved muscle regeneration.  
In Aim 1, we identified non-classical monocytes as biased progenitors of CD206+ 
alternatively-activated macrophages within excisional skin injury. Blood monocytes exist 
in two primary subpopulations that are broadly characterized as inflammatory (classical) 
or anti-inflammatory (non-classical). Using latex bead-based labeling techniques, we show 
that labeled non-classical monocytes preferentially differentiate into alternatively-
activated macrophages, whereas labeled classical monocytes do not display this 
differentiation bias. Depletion of blood non-classical monocytes significantly reduces the 
generation of CD206+ alternatively-activated macrophages. We compared adoptive 
transfer of classical versus non-classical monocytes into the circulation of animals 
undergoing cutaneous injury, and show increased frequency of wound healing 
macrophages derived from Ly6Clo donor cells compared to Ly6Chi donor cells. Taken 
together, the results highlight non-classical monocytes as key contributors to the pool of 
alternatively activated macrophages within skin injury. The significance of this work lies 
in our improved understanding of the relationship between blood-derived monocytes and 
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injury macrophage subsets and provides a rationale for targeting non-classical monocytes 
in other models of soft tissue injury where alternatively-activated macrophages are known 
to exert beneficial roles.   
In Aim 2, we demonstrated for the first time that non-classical monocytes are 
directly recruited to volumetric muscle injury and that their recruitment can be increased 
by local delivery of the immunomodulatory molecule FTY720. Enrichment of non-
classical monocytes within muscle injury coincided with increased CD206+ alternatively-
activated macrophages in peri-defect tissue. Assessment of early wound healing 
parameters revealed that FTY720 increases collagen deposition and vascularization in the 
defect area. Evaluation of muscle healing at later time points showed increased regenerated 
muscle fiber diameter and decreased fibrotic collagen deposition with FTY720 treatment. 
Taken together, these results indicate that local immunomodulation of volumetric skeletal 
muscle injuries by targeting non-classical monocytes can accelerate muscle healing and 
attenuate the fibrotic response often seen in clinical VML injuries. The significance of this 
work lies both in the establishment of the spinotrapezius VML model as a tool to 
investigate mechanisms of de novo skeletal muscle regeneration, and in our enhanced 
understanding of the role that non-classical monocytes play in volumetric muscle defect 
healing.  
In Aim 3, we expanded the spinotrapezius VML model to include a 2mm diameter 
defect that does not regain full functional recovery over the experimental time course and 
further explored the mechanisms by which FTY720-encapsulating nanofiber scaffolds 
impact local immune modulation and muscle healing parameters. We demonstrate that 
implantation of FTY720 nanofibers over 2mm diameter muscle defects induces acute 
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lymphopenia and decreases acute CD4+ and CD8+ T lymphocyte accumulation in injured 
muscle. We hypothesized that the changes in T lymphoid cellular populations early after 
muscle injury may impact myeloid subset distribution, and indeed, we observed increases 
in both Ly6Clo non-classical monocytes and CD206+Ly6C- alternatively activated 
macrophages in response to FTY720 nanofiber treatment. We show for the first time that 
local immune modulation of adaptive and innate cell subsets coincides with increased 
numbers of satellite cells within volumetric skeletal muscle injury. Increased alignment of 
regenerated muscle fibers to the pre-injury fiber axis was observed in animals treated with 
FTY720 and we demonstrate that this increased alignment relies on the presentation and 
delivery of FTY720 from a biomaterial scaffold, but not the nano-architecutre. Taken 
together, these results indicate that FTY720 nanofibers are able to positively impact aspects 
of muscle regeneration in a non-healing volumetric defect. The significance of this work 
lies in elucidating a connection between lymphoid and myeloid immune cell subset 
distribution in a non-healing volumetric muscle defect, and demonstrating improved 
alignment of regenerated muscle fibers along the pre-injury fiber axis. These results 
highlight the need for additional mechanistic studies to better understand the complex 
interplay between adaptive and innate immune responses within traumatic muscle injury.  
6.2 Identification of regenerative niche components crucial to muscle repair 
In the current work, we explored the impact of biomaterial-based delivery of 
FTY720 on tuning local immune responses to volumetric muscle injury. This was 
motivated by our identification of non-classical monocytes as biased progenitors of 
alternatively activated macrophages, and the knowledge that M2-biased injury 
microenvironments support muscle regeneration, vascularization, and nerve repair. Future 
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improvements to immunomodulatory biomaterials for the treatment of muscle injuries 
should focus on 1) identifying components of the regenerative niche that are critical to 
muscle repair, and 2) incorporation of several cues, whether biological or architectural, to 
form multi-modal therapies that target more than one regenerative pathway.  
Volumetric muscle defects are unique from other models of muscle injury (such as 
toxin, crush, or cryo-injury) in that all tissue micro compartments must be regenerated de 
novo over large spatial gaps. Studies in toxin-induced muscle injury show that the residual 
basal lamina (“ghost fibers”) that remains after muscle fiber necrosis serves as a structural 
guide for activated satellite cells to migrate and proliferate along the original fiber axis. 
Removal of these ghost fibers in volumetric injury results in uncoordinated satellite cell 
migration, division along diverging axes, and generation of muscle fibers that exhibit 
chaotic organization [144]. In the current work, we provided a structural surface in the form 
of nanofiber scaffolds to a large volumetric defect, but did not see an improvement in 
regenerated fiber alignment due to scaffold alone. Logical next steps in improving the 
nanofiber therapy platform lies in engineering aligned nanofiber scaffolds that recapitulate 
the architectural guidance provided by ghost fibers.  
Our motivation for targeting the immune response to muscle injury lies in the 
concept that macrophages are highly sensitive to their microenvironments and adopt 
functional phenotypes to further orchestrate the behaviors of multiple cell types including 
vascular cells, satellite cells, and matrix-producing stromal cells. However, stages in 
myogenesis are tightly coupled to the inflammatory state of the tissue microenvironment. 
Satellite cell activation and proliferation primarily occurs in the acute pro-inflammatory 
phase of healing, and satellite cell differentiation occurs in the later, anti-inflammatory 
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phase of healing, and the failure to undergo each immune state leads to impaired muscle 
regeneration. In the present work, we aimed to augment the anti-inflammatory, pro-
regenerative phase of healing by locally enriching the injury pool of non-classical 
monocytes and alternatively-activated macrophages. However, the therapy was initiated at 
the time of injury. Moving forward, an interesting avenue of exploration is the design of 
biomaterials that release multiple cues that are temporally segregated so as to amplify both 
the inflammatory phase, and the pro-regenerative phases of healing. Such therapies could 
employ acute release of recruitment signals such as monocyte chemoattractant protein-1 
(MCP-1/CCL2) to attract inflammatory monocytes and macrophages that enhance satellite 
cell proliferation, and then delayed, sustained release of molecules such as FTY720 or 
fractalkine that are known to recruit pro-regenerative subsets of monocytes and 
macrophages to facilitate satellite cell differentiation and tissue remodeling and 
maturation. Use of other biomaterial platforms such as hydrogel materials enables the 
tethering of bioactive molecules to the gel via hydrolytically or enzymatically degradable 
moieties. Selection of the appropriate tethering mechanism per pro- or anti- inflammatory 
recruitment signal could augment both early and late phases of the immune response with 
precise temporal regulation.  
Other bioactive molecules have been delivered to models of ischemic skeletal 
muscle injury to promote vascularization (vascular endothelial growth factor – VEGF), to 
influence the behavior of satellite cells (IGF-1)[162], or to enhance the recruitment of 
regenerative stem cell populations (SDF-1)[163].  These strategies show varying degrees 
of success at promoting functional recovery of the muscle, but none have been tested in a 
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model of volumetric muscle loss. Future studies should test whether these therapies are 
successful at promoting regeneration of traumatic muscle injuries. 
6.3 Improved characterization of innate and adaptive immune cell function in 
volumetric muscle injury 
Much of the knowledge about immune cell subset functions in healing of skeletal 
muscle injuries have been performed in models of toxin-induced muscle injury. It is 
increasingly appreciated that immune biology is context dependent. Studies that deplete 
subpopulations of monocytes/macrophages along the timescale of volumetric muscle 
defect regeneration (as has been done in toxin induced muscle injury [29]) will elucidate 
whether particular populations of macrophages are primarily responsible for growth of 
muscle fibers versus attenuation of fibrosis and fatty infiltration. More detailed studies 
employing transcriptional profiling of monocyte/macrophage subpopulations present in 
each stage of muscle repair could reveal gene expression signatures unique to volumetric 
muscle defect healing. Use of single-cell RNA-sequencing or Mass Cytometry (CyTOF) 
techniques on immune cells isolated from traumatically-injured skeletal muscle, and 
downstream bioinformatics analysis could reveal novel subpopulations of muscle-specific 
wound healing myeloid cells, and additional therapeutic targets.  
Though alternatively-activated M2 macrophages (as identified by CD206+ and/or 
arginase-1 expression) are broadly accepted as pro-regenerative, the heterogeneity in M2 
subtypes depending on polarization stimulus (IL-4 vs IL-10) and their subsequent 
functional effects on tissue regeneration in vivo remains unclear. Adoptive transfer of 
polarized primary macrophages stimulated by either IL-4 or IL-10 into muscle injury and 
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analysis of satellite cell proliferation and differentiation could answer questions regarding 
the effects of M2 subtypes on satellite cell behavior in a volumetric muscle defect context.  
The role that T lymphocytes, and particularly CD4+CD25+Foxp3+ regulatory T-
cells (Treg), play in toxin-induced muscle injury is increasingly appreciated. Apart from 
directly promoting the growth of muscle fiber via secretion of Amphiregulin (Areg), Tregs 
are also thought to govern the myeloid phenotype switch from inflammatory to pro-
regenerative, however, the mechanisms by which they achieve this switch is unknown. 
Though CD4+ and CD8+ T-lymphocytes were detected in volumetrically injured skeletal 
muscle, their roles in the regenerative process are unclear. CD4+/CD8+ T cells have been 
shown to exacerbate pathophysiology in dystrophic mice[84], whereas ablation of CD8+ 
T-cells in toxin-injured muscle prevented the accumulation of inflammatory macrophages 
early after injury, imparing muscle regeneration[83]. Adding another layer of complexity 
is the understudied impact of lymphoid cell-secreted cytokines on macrophage 
polarization. Gain or loss of function studies that systematically target T-lymphocyte 
populations, and analyzing resulting changes in local cytokine profile and macrophage 
subset distribution would significantly advance our understanding of the relationship 
between adaptive and innate immunity in muscle regeneration.  
6.4 Extension of immunomodulatory therapies to other regenerative medicine 
applications 
 The spinotrapezius volumetric muscle loss model that we established in this work 
lends itself particularly well to the study of cellular responses and examination of healing 
progress on the microscopic level. However, the small size of the defect and muscle renders 
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the ability to detect functional differences extremely challenging. Future studies should test 
the developed immunomodulatory materials in volumetric defects created in larger muscles 
such as the murine or rat quadriceps. Due to the availability of the femoral nerve in the 
quadriceps muscle, in situ functional testing can be performed[164]. Though polymer films 
and electrospun nanofibers were utilized in the current studies, they are not themselves 
void filling. Incorporation of FTY720 into void filling, yet degradable materials (such as 
hydrogels or extracellular matrix-derived scaffolds) would provide initial structural 
support for the migration of cells into the defect, and favorably prime the immune 
microenvironment for regeneration. However, closely engineering the degradation rates of 
the void filling material is crucial so as to not impede new tissue growth.  
In the clinic, muscle flaps are implanted into volumetric injuries but exhibit poor 
integration into surrounding tissue. Flat biomaterials such as nanofiber strips or sheets 
could be sandwiched between muscle flap allografts to form a composite construct that fills 
the muscle defect void. Indeed, the spinotrapezius muscle itself could serve as a model for 
muscle flaps, by co-implanting an autograft derived from contralateral spinotrapezius 
muscle with a nanofiber scaffold over a full-thickness defect and assessing integration of 
the whole construct by imaging techniques that we have extensively developed. This would 
be particularly interesting in the context of aging muscle that exhibits a severe decline in 
regenerative capacity after injury.   
Because our work was based on the concept of tuning immune responses to soft 
tissue injury, rather than targeting tissue-specific cells, the findings from our studies can 
be extended to a multitude of regenerative medicine applications. Any tissue injury is 
accompanied by an inflammatory response, which provides opportunities for modulating 
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that response to accelerate or enhance repair. Such applications include using 
immunomodulatory biomaterials to promote cardiac muscle repair after infarct injury, to 
promote re-epithelialization of large or chronic cutaneous wounds, or to guide palatal tissue 
healing after surgical repair of cleft palate abnormalities.  
6.5 Conclusions 
By tracking and modulating the recruitment of myeloid cells to soft tissue injuries, 
we have identified non-classical monocytes as a key contributor to the pool of wound 
healing macrophages. We have demonstrated that locally enriching pro-regenerative 
monocytes and macrophages via biomaterial based delivery of FTY720 represents a 
promising strategy for overcoming aspects of clinical challenges faced in treating 
volumetric muscle loss injuries, such as attenuating fibrosis and improving alignment of 
regenerated muscle fibers. Taken together, we have gained an improved understand of the 
role that pro-regenerative subsets of immune cells play in the promotion of endogenous 
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